<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<meta content="" name="paf_template"/>
<meta content="pmc" name="ncbi_db"/><meta content="article" name="ncbi_pdid"/><meta content="" name="ncbi_acc"/><meta content="ascp" name="ncbi_domain"/><meta content="record" name="ncbi_report"/><meta content="fulltext" name="ncbi_type"/><meta content="" name="ncbi_objectid"/><meta content="/articles/PMC4636852/" name="ncbi_pcid"/><meta content="pmc" name="ncbi_app"/>
<title>Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders</title>
<link href="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/css/jig.min.css" rel="stylesheet"/><script src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/js/jig.min.js" type="text/javascript"></script>
<meta content="INDEX,NOFOLLOW,NOARCHIVE" name="robots"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/" rel="canonical"/><link href="http://purl.org/DC/elements/1.0/" rel="schema.DC"/><meta content="Addiction Science &amp; Clinical Practice" name="citation_journal_title"/><meta content="Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders" name="citation_title"/><meta content="Katherine A Belendiuk, Lisa L Baldini, Marcel O Bonn-Miller" name="citation_authors"/><meta content="2015" name="citation_date"/><meta content="10" name="citation_volume"/><meta content="10.1186/s13722-015-0032-7" name="citation_doi"/><meta content="/pmc/articles/PMC4636852/?report=abstract" name="citation_abstract_html_url"/><meta content="25896576" name="citation_pmid"/><meta content="Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders" name="DC.Title"/><meta content="Text" name="DC.Type"/><meta content="BioMed Central" name="DC.Publisher"/><meta content="Katherine A Belendiuk" name="DC.Contributor"/><meta content="Lisa L Baldini" name="DC.Contributor"/><meta content="Marcel O Bonn-Miller" name="DC.Contributor"/><meta content="2015" name="DC.Date"/><meta content="10.1186/s13722-015-0032-7" name="DC.Identifier"/><meta content="en" name="DC.Language"/><meta content="Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders" property="og:title"/><meta content="article" property="og:type"/><meta content="The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment of the most common medical and psychological conditions for which it has been allowed ..." property="og:description"/><meta content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/" property="og:url"/><meta content="PubMed Central (PMC)" property="og:site_name"/><meta content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" property="og:image"/><meta content="summary" name="twitter:card"/><meta content="@ncbi" name="twitter:site"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc.min.css" rel="stylesheet" type="text/css"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" media="print" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/common.min.js" type="text/javascript">//</script><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/NcbiTagServer.min.js" type="text/javascript">//</script><meta content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" name="citationexporter"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js" type="text/javascript">//</script><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js" type="text/javascript"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-ascp.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta content="" name="cited_in_systematic_reviews"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//pmc/articles/PMC4636852/epub/" rel="alternate" type="application/epub+zip"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/pdf/13722_2015_Article_32.pdf" rel="alternate" type="application/pdf"/>
<link href="//www.ncbi.nlm.nih.gov/favicon.ico" rel="shortcut icon"/><meta content="CE8CDA45D2ADCC4100000000088A04DB.m_8" name="ncbi_phid"/>
<meta content="origin-when-cross-origin" name="referrer"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" rel="stylesheet" type="text/css"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" rel="stylesheet" type="text/css"/><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
<body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
<div class="grid">
<div class="col twelve_col nomargin shadow">
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="https://www.ncbi.nlm.nih.gov/guide/browsers/#enablejs" target="_blank" title="Learn how to enable JavaScript">more...</a>
</p>
</noscript>
</div>
<div class="wrap">
<div class="page">
<div class="top">
<div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a accesskey="1" class="ui-ncbimenu-link-first" href="https://www.ncbi.nlm.nih.gov/" id="ncbihome" role="menuitem" title="NCBI Home"><span class="offscreen_noflow">NCBI</span><img alt="NCBI Logo" class="ncbi_logo" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" title="NCBI"/></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="3" href="https://www.ncbi.nlm.nih.gov/#maincontent" tabindex="0" title="Skip to the content">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="4" href="https://www.ncbi.nlm.nih.gov/#navcontent" tabindex="0" title="Skip to the navigation">Skip to
                        navigation</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" id="resource-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" role="menuitem" tabindex="-1">Resources</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first" id="all-howtos-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" role="menuitem" tabindex="-1">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" tabindex="0" title="About My NCBI Accesskeys">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe scrolling="no" src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4636852%2F" style="border:none; height:2.5em; width:40em;"></iframe></div></div>
<div class="header">
<div class="res_logo">
<h1 class="img_logo"><a class="pmc_logo offscreen" href="https://www.ncbi.nlm.nih.gov/pmc/">PMC</a></h1>
<div class="NLMLogo">
<a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
<br/>
<a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
</div>
</div>
<div class="search"><form action="/pmc/" method="get"><div class="search_form"><label class="offscreen_noflow" for="database">Search database</label><select id="database"><optgroup label="Recent"><option class="last" data-ac_dict="pmc-search-autocomplete" selected="selected" value="pmc">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option data-ac_dict="pmc-search-autocomplete" value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label accesskey="/" class="offscreen_noflow" for="term">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input aria-autocomplete="list" aria-haspopup="true" autocomplete="off" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" id="term" name="term" role="textbox" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." type="text" value=""/><a class="reset" href="https://www.ncbi.nlm.nih.gov/#" style="visibility: hidden;"><img alt="Clear input" src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/img/clear.png"/></a></div></div><button class="button_search nowrap" cmd="go" id="search" type="submit">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
</li><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
</li><li class="help">
<a href="https://www.ncbi.nlm.nih.gov/books/NBK3825/" target="_blank">Help</a>
</li></ul></div>
</div>
</div>
<div class="content">
<div class="container">
<div class="content eight_col col" id="maincontent">
<div class="navlink-box">
<ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal List</a></li><li class="archive"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/1002/">Addict Sci Clin Pract</a></li><li class="issue-page"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/issues/247429/">v.10; 2015</a></li><li class="accid">PMC4636852</li></ul>
</div>
<div class="pmc-page-banner whole_rhythm"><div><img alt="Logo of ascp" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-ascp.png" usemap="#logo-imagemap"/><map id="logo-imagemap" name="logo-imagemap"><area alt="BioMed Central" coords="0,0,162,75" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="BioMed Central"/><area alt="Biomed Central Web Site" coords="0,0,94,75" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="Biomed Central Web Site"/><area alt="search" coords="247,59,296,75" href="http://www.ascpjournal.org//search" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="search"/><area alt="submit a manuscript" coords="301,59,405,75" href="http://www.ascpjournal.org//manuscript" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="submit a manuscript"/><area alt="register" coords="415,59,458,75" href="http://www.ascpjournal.org//register" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="register"/><area alt="this article" coords="185,59,244,75" href="//dx.doi.org/10.1186/s13722-015-0032-7" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" shape="rect" target="pmc_ext" title="this article"/><area alt="Addiction Science &amp; Clinical Practice" coords="0,0,480,75" href="http://www.ascpjournal.org/" ref="reftype=publisher&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="Addiction Science &amp; Clinical Practice"/></map></div> </div>
<div class="">
<div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a aria-expanded="false" aria-haspopup="true" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem">Addict Sci Clin Pract</a></span>. 2015; 10: 10. </span></div><div><span class="fm-vol-iss-date">Published online 2015 Apr 21. </span> <span class="doi">doi: <a href="//dx.doi.org/10.1186%2Fs13722-015-0032-7" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI" target="pmc_ext">10.1186/s13722-015-0032-7</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4636852</span></div><div class="fm-citation-pmid">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/25896576">25896576</a></div></div></div></div><h1 class="content-title">Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a class="affpopup" co-class="co-affbox" co-rid="_co_idm139726595939936" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Belendiuk%20KA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25896576">Katherine A Belendiuk</a>,<sup></sup> <a class="affpopup" co-class="co-affbox" co-rid="_co_idm139726595204288" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Baldini%20LL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25896576">Lisa L Baldini</a>,<sup></sup> and  <a class="affpopup" co-class="co-affbox" co-rid="_co_idm139726597253152" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Bonn-Miller%20MO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25896576">Marcel O Bonn-Miller</a><sup><img alt="corresponding author" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/corrauth.gif"/></sup><sup></sup><sup></sup><sup></sup></div><div class="contrib-group aff-tip" style="display:none"><div id="_co_idm139726595939936"><h3 class="no_margin">Katherine A Belendiuk</h3><p><sup></sup>Institute of Human Development, University of California, 1121 Tolman Hall #1690, Berkeley, CA 94720 USA </p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Belendiuk%20KA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25896576">Katherine A Belendiuk</a></div></div><div id="_co_idm139726595204288"><h3 class="no_margin">Lisa L Baldini</h3><p><sup></sup>Palo Alto University, 1791 Arastradero Road, Palo Alto, CA 94304 USA </p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Baldini%20LL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25896576">Lisa L Baldini</a></div></div><div id="_co_idm139726597253152"><h3 class="no_margin">Marcel O Bonn-Miller</h3><p><sup></sup>Center of Excellence in Substance Abuse Treatment and Education, Philadelphia VA Medical Center, 3900 Woodland Avenue, Philadelphia, PA 19104 USA </p><p><sup></sup>Center for Innovation to Implementation and National Center for PTSD, VA Palo Alto Health Care System, 795 Willow Road (152-MPD), Menlo Park, CA 94025 USA </p><p><sup></sup>Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 3440 Market Street, Philadelphia, PA 19104 USA </p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Bonn-Miller%20MO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25896576">Marcel O Bonn-Miller</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm139726591926288_ai">Author information</a> <a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm139726591926288_an">Article notes</a> <a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm139726591926288_cpl">Copyright and License information</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139726591926288_ai" style="display:none"><div class="fm-affl" id="Aff1" lang="en"><sup></sup>Institute of Human Development, University of California, 1121 Tolman Hall #1690, Berkeley, CA 94720 USA </div><div class="fm-affl" id="Aff2" lang="en"><sup></sup>Palo Alto University, 1791 Arastradero Road, Palo Alto, CA 94304 USA </div><div class="fm-affl" id="Aff3" lang="en"><sup></sup>Center of Excellence in Substance Abuse Treatment and Education, Philadelphia VA Medical Center, 3900 Woodland Avenue, Philadelphia, PA 19104 USA </div><div class="fm-affl" id="Aff4" lang="en"><sup></sup>Center for Innovation to Implementation and National Center for PTSD, VA Palo Alto Health Care System, 795 Willow Road (152-MPD), Menlo Park, CA 94025 USA </div><div class="fm-affl" id="Aff5" lang="en"><sup></sup>Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 3440 Market Street, Philadelphia, PA 19104 USA </div><div><span class="fm-affl">Katherine A Belendiuk, </span><span class="fm-affl"><span class="email-label">Email: </span><a class="oemail" data-email="ude.yelekreb@bak" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//mailto:dev@null">ude.yelekreb@bak</a></span>.</div><div><a href="https://www.ncbi.nlm.nih.gov/#idm139726591926288aff-info">Contributor Information</a>.</div><div><sup><img alt="corresponding author" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/corrauth.gif"/></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139726591926288_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2014 Aug 29; Accepted 2015 Apr 15.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139726591926288_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">Copyright</a> © Belendiuk et al.; licensee BioMed Central. 2015</div><div class="license half_rhythm">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a data-ga-action="click_feat_suppl" href="http://creativecommons.org/licenses/by/4.0" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<a data-ga-action="click_feat_suppl" href="http://creativecommons.org/publicdomain/zero/1.0/" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</div></div></div><div class="links-box whole_rhythm" id="pmclinksbox"><div class="fm-panel"><div>This article has been <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div class="tsec sec" id="Abs1" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem" title="Go to other sections in this page">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="Abs1title">Abstract</h2><div><p class="p p-first-last" id="__p1">The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment of the most common medical and psychological conditions for which it has been allowed at the state level. Common medical conditions for which marijuana is allowed (i.e., those conditions shared by at least 80 percent of medical marijuana states) were identified as: Alzheimer’s disease, amyotrophic lateral sclerosis, cachexia/wasting syndrome, cancer, Crohn’s disease, epilepsy and seizures, glaucoma, hepatitis C virus, human immunodeficiency virus/acquired immunodeficiency syndrome, multiple sclerosis and muscle spasticity, severe and chronic pain, and severe nausea. Post-traumatic stress disorder was also included in the review, as it is the sole psychological disorder for which medical marijuana has been allowed. Studies for this narrative review were included based on a literature search in PsycINFO, MEDLINE, and Google Scholar. Findings indicate that, for the majority of these conditions, there is insufficient evidence to support the recommendation of medical marijuana at this time. A significant amount of rigorous research is needed to definitively ascertain the potential implications of marijuana for these conditions. It is important for such work to not only examine the effects of smoked marijuana preparations, but also to compare its safety, tolerability, and efficacy in relation to existing pharmacological treatments.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Cannabis, Medical marijuana, Marijuana, Medicine, Treatment, Alzheimer’s disease, ALS, Cachexia, Cancer, Crohn’s disease, Epilepsy, Seizures, Glaucoma, Hepatitis C virus, HCV, HIV, AIDS, Multiple sclerosis, MS, Pain, Nausea, Vomiting, Post-traumatic stress disorder, PTSD</span></div></div><div class="tsec sec" id="Sec1"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="Sec1title">Introduction</h2><p class="p p-first" id="__p2">National estimates suggest that 5.4 million people in the United States above the age of 12 have used marijuana daily or regularly within the past year [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR1" rid="CR1" role="button">1</a>]. This represents an increase of approximately 74.2 percent since 2006 [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR1" rid="CR1" role="button">1</a>]. Similar increases have also been noted among vulnerable populations in the U.S. (e.g., veterans and adolescents) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR2" id="__tag_540036976" rid="CR2" role="button">2</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR3" rid="CR3" role="button">3</a>].</p><p id="__p3">Marijuana is currently illegal in every country in the world. In 2012, Uruguay voted to legalize state-controlled marijuana sales but implementation of the law has been postponed until 2015. The policy in the Netherlands is mixed, with permissible retail sale of marijuana at coffee shops, but restrictions on production and possession. Notably, as the concentration of THC in marijuana has increased, Dutch coffee shops have begun to close, as perception of marijuana as a “soft” drug transitions to perceptions of marijuana as a “hard” drug.</p><p id="__p4">Like the Netherlands, the United States currently has a mixed drug policy; marijuana is an <em>illegal</em> Schedule I drug under U.S. Federal law. However, marijuana policies vary by state, with some states (e.g., Colorado and Washington) <em>legalizing</em> the use of recreational marijuana (i.e., allowing the legal possession and use of marijuana under state law), and other states <em>decriminalizing</em> marijuana (i.e., reducing the penalties for possession and/or use of small amounts of marijuana to fines or civil penalties). Furthermore, as of this review, 23 states and the District of Columbia have passed legislation allowing medical marijuana (i.e., individuals can defend themselves against criminal charges related to marijuana possession if a medical need is documented) for the treatment of a variety of medical and psychological conditions. Though the list of conditions for which medical marijuana has been allowed varies at the state level, the majority of states agree on its use for Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), cachexia/wasting syndrome, cancer, Crohn’s disease (CD), epilepsy and seizures, glaucoma, hepatitis C virus (HCV), human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), multiple sclerosis (MS) and muscle spasticity, severe and chronic pain, severe nausea, and post-traumatic stress disorder (PTSD).</p><p class="p p-last" id="__p5">The aim of the present review is to provide a summary of the existing empirical literature regarding the effects of marijuana/cannabinoids on each of the above-noted conditions. Though some recent work has reviewed the adverse effects of marijuana [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR4" id="__tag_540036981" rid="CR4" role="button">4</a>] or the efficacy of marijuana for certain conditions (e.g., neurologic) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR5" id="__tag_486182658" rid="CR5" role="button">5</a>], there has yet to be a comprehensive review of the effects of marijuana for each of the medical and psychiatric conditions for which it is currently used.</p></div><div class="tsec sec" id="Sec2"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="Sec2title">Methods</h2><p class="p p-first" id="__p6">The list of all conditions for which medical marijuana is allowed, according to the legislation of each U.S. state for which medical marijuana has been approved, was obtained and examined [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR6" rid="CR6" role="button">6</a>]. From this list, common conditions for which medical marijuana is allowed (i.e., those conditions shared by at least 80 percent of medical marijuana states) were identified as: AD, ALS, cachexia/wasting syndrome, cancer, CD, epilepsy and seizures, glaucoma, HCV, HIV/AIDS, MS and muscle spasticity, severe and chronic pain, and severe nausea. Though not presently a qualifying condition in at least 80 percent of states with medical marijuana laws, PTSD was also included in the review, as it is rapidly gaining attention and recognition as the sole psychological disorder for which medical marijuana is allowed.</p><p id="__p7">Studies for this narrative review were included based on a literature search in the following databases: PsycINFO, MEDLINE, and Google Scholar. Within each database, each combination of the following key marijuana terms and the above-listed conditions were used to conduct a search: cannabis, marijuana, marihuana, cannabinoid, delta-9-tetrahydrocannabinol, THC, cannabidiol, CBD, cannabinol, cannabigerol, Marinol, dronabinol, Sativex, Nabilone, and Nabiximols. References within each obtained article were also examined to assure that no studies were overlooked. Only published, English-language studies were included in this review.</p><p class="p p-last" id="__p8">Though the primary focus of this review is on studies of marijuana plant effects, as these are most relevant to recent medical marijuana legislation, synthetic or plant-derived cannabinoids (e.g., dronabinol, Nabilone) were also included due to the general dearth of marijuana plant studies for a number of conditions. Indeed, for purposes of the review, references to oral administrations of marijuana constitute a pharmaceutical grade extraction administered in tablet or liquid form (e.g., dronabinol, Nabilone, Nabiximols), while references to smoked administration of marijuana constitute the inhalation of smoke from burned marijuana leaves and flowers. Finally, the present review is organized alphabetically by condition for which marijuana is allowed, rather than in order of disorder for which it is most to least commonly recommended, or strength of the evidence. We chose this approach as there is currently only state-level data [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR7" id="__tag_486182689" rid="CR7" role="button">7</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR9" id="__tag_486182650" rid="CR9" role="button">9</a>], rather than national, representative data on the primary conditions for which medical marijuana is used or recommended, and the existing literature and state of the evidence for many conditions remains relatively poor.</p></div><div class="tsec sec" id="Sec3"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="Sec3title">Results</h2><div class="sec sec-first" id="Sec4"><h3 id="Sec4title">Alzheimer’s disease</h3><p class="p p-first-last" id="__p9">AD, the leading form of dementia in the elderly, is a progressive, age-related disorder characterized by cognitive and memory deterioration [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR10" id="__tag_486182680" rid="CR10" role="button">10</a>]. AD has several neuropathological markers, including neuritic plaques and neurofibrillary tangles [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR11" id="__tag_486182636" rid="CR11" role="button">11</a>]. Although several researchers have suggested dronabinol and Nabilone may act on these mechanisms to confer therapeutic effects for patients with AD [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR12" id="__tag_486182634" rid="CR12" role="button">12</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR13" id="__tag_486182660" rid="CR13" role="button">13</a>], a recent Cochrane systematic review found no evidence that dronabinol was effective in reducing symptoms of dementia [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR14" id="__tag_486182708" rid="CR14" role="button">14</a>]. The authors of a placebo-controlled crossover study of 15 patients with AD who were refusing to eat suggest that dronabinol increases weight gain and decreases disturbed behavior [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR15" id="__tag_486182741" rid="CR15" role="button">15</a>], but there is insufficient quantitative data to support this conclusion [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR14" id="__tag_486182653" rid="CR14" role="button">14</a>], and one study participant had a grand mal seizure following dronabinol administration [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR15" id="__tag_486182706" rid="CR15" role="button">15</a>]. Another pilot study of two patients with dementia found that dronabinol reduced nocturnal motor activity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR16" id="__tag_486182659" rid="CR16" role="button">16</a>]. No studies have examined the effects of smoked marijuana in patients with AD. In sum, there is insufficient evidence to recommend marijuana for the treatment of AD. Future directions should include conducting randomized controlled trials (RCTs) comparing both smoked and oral marijuana to placebo and existing treatments, with sample sizes large enough to detect treatment effects and the safety and tolerability of marijuana.</p></div><div class="sec" id="Sec5"><h3 id="Sec5title">Amyotrophic lateral sclerosis</h3><p class="p p-first-last" id="__p10">ALS is a fatal neurological disease with symptoms that include weakness, spasticity, and respiratory difficulties. Cannabinoids are hypothesized to act in the regions of established pathophysiology for ALS [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR17" id="__tag_486182615" rid="CR17" role="button">17</a>] and could be used for symptom management (e.g., pain, spasticity, wasting, respiratory failure, dysphagia, negative mood, and dysautonomia) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR18" id="__tag_486182620" rid="CR18" role="button">18</a>]. Although there is limited evidence from a survey of patients with ALS that marijuana consumed in a variety of forms (i.e., oral, smoked, vaporized, and eaten) improves speech and swallowing [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR19" id="__tag_486182718" rid="CR19" role="button">19</a>], the anti-salivatory components of marijuana may reduce the risk of aspiration pneumonia, while also increasing patient comfort [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR18" id="__tag_486182691" rid="CR18" role="button">18</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR19" id="__tag_486182679" rid="CR19" role="button">19</a>]. These survey findings indicate that up to 10 percent of patients use marijuana for symptom management, and these self-reports suggest efficacy in increasing appetite and mood and decreasing pain, spasticity, and drooling. However, as is consistent with the half-life of smoked marijuana, the beneficial effects of marijuana on symptoms of ALS were fewer than 3 hours in duration [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR19" id="__tag_486182657" rid="CR19" role="button">19</a>]. The only randomized, double-blind, placebo-controlled crossover trial of marijuana in patients with ALS has a small sample size (N = 27) and indicates that while 5 mg of dronabinol is well-tolerated, there was no effect on number or intensity of cramps, quality of life, appetite, sleep, or mood [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR20" id="__tag_486182693" rid="CR20" role="button">20</a>]. There is currently insufficient clinical evidence in humans with ALS to recommend cannabinoids as primary or adjunctive therapy.</p></div><div class="sec" id="Sec6"><h3 id="Sec6title">Cachexia/wasting syndrome</h3><p class="p p-first" id="__p11">Cachexia is the general wasting and malnutrition that occurs in the context of chronic diseases such as HIV/AIDS and cancer. In patients with HIV or cancer, smoked marijuana and dronabinol have been shown to increase weight gain [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR21" id="__tag_486182642" rid="CR21" role="button">21</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR22" id="__tag_486182605" rid="CR22" role="button">22</a>] and food intake [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR22" id="__tag_486182674" rid="CR22" role="button">22</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR23" id="__tag_486182662" rid="CR23" role="button">23</a>] compared to placebo. In a within-subject, double-blind, staggered, double-dummy study of nine individuals with muscle mass loss, dronabinol resulted in significantly greater calorie consumption than smoked marijuana [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR24" id="__tag_486182683" rid="CR24" role="button">24</a>]. A within-subject, double-blind, placebo-controlled trial with seven HIV-positive marijuana smokers taking antiretroviral medications found that compared to placebo, dronabinol increased caloric intake [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR25" id="__tag_540036979" rid="CR25" role="button">25</a>]. Additional studies indicate that dronabinol administration increases appetite, decreases nausea, and protects against weight loss [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR26" id="__tag_486182600" rid="CR26" role="button">26</a>], with effects on appetite and weight stability enduring in long-term follow-up [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR27" id="__tag_486182703" rid="CR27" role="button">27</a>].</p><p class="p p-last" id="__p12">Both dronabinol and smoked marijuana increase the number of eating occasions [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR22" id="__tag_486182713" rid="CR22" role="button">22</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR25" id="__tag_540036984" rid="CR25" role="button">25</a>], and smoked marijuana may also affect weight gain and calorie intake by modulating appetite hormones [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR28" id="__tag_486182646" rid="CR28" role="button">28</a>]. Importantly, weight gain in one study was greater than would have been expected based on increased calorie consumption alone [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR23" id="__tag_486182603" rid="CR23" role="button">23</a>], which may be particularly relevant for those who have impaired food intake and/or nausea. These studies demonstrate that marijuana has positive effects on cachexia resulting from a medical condition, but are largely limited by small sample sizes. Additionally, studies comparing THC to FDA-approved medication (i.e., megestrol) indicate that THC is less effective in promoting appetite and weight gain [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR29" id="__tag_486182704" rid="CR29" role="button">29</a>]. In sum, there is moderate support for the use of cannabinoids for cachexia/wasting, and dronabinol has been FDA-approved for anorexia associated with weight loss in individuals with AIDS. Additional studies with larger sample sizes that examine the efficacy of marijuana compared to nutritional support/calorie augmentation in the treatment of cachexia are indicated.</p></div><div class="sec" id="Sec7"><h3 id="Sec7title">Cancer</h3><p class="p p-first-last" id="__p13">Cancer is a qualifying medical condition in every state that has approved marijuana for medical use [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR30" id="__tag_486182609" rid="CR30" role="button">30</a>]. The majority of clinical research examining the relation between THC and cancer has evaluated the effect of smoked THC on the risk for cancer, or the palliative effects of THC on chemotherapy-related nausea and emesis, chronic pain, and wasting (reviewed in respective sections); few studies have studied the effect of marijuana in any form on the treatment of primary cancer pathology. <em>In vitro</em> and <em>in vivo</em> research suggests that cannabinoids inhibit tumor growth [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR30" id="__tag_486182619" rid="CR30" role="button">30</a>] via several proposed mechanisms (e.g., suppression of cell proliferation, reduced cell migration, increased apoptosis) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR31" id="__tag_540036977" rid="CR31" role="button">31</a>]; however, <em>in vitro</em> and <em>in vivo</em> studies also have shown that THC increases tumor growth due to reduced immune response to cancer [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR32" id="__tag_486182651" rid="CR32" role="button">32</a>]. The only clinical trial of THC on cancer examined intracranial administration of THC to nine patients with recurrent glioblastoma multiforme who had failed surgical- and radiotherapy, and results indicated that THC decreased tumor growth, while being well-tolerated with few psychotropic effects [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR33" id="__tag_486182692" rid="CR33" role="button">33</a>]. This study is limited by lack of generalizability, and clinical trials with larger representative samples that examine oral or smoked administration of THC are essential to elucidate the effects on cancer pathology. There is currently insufficient evidence to recommend marijuana for the treatment of cancer, but there may be secondary treatment effects on appetite and pain.</p></div><div class="sec" id="Sec8"><h3 id="Sec8title">Crohn’s disease</h3><p class="p p-first-last" id="__p14">CD is an inflammatory bowel disease (IBD) that has no cure; treatment targets include reducing inflammation and secondary symptoms. Between 16 percent and 50 percent of patients use marijuana to relieve symptoms of IBD [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR34" id="__tag_486182623" rid="CR34" role="button">34</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR36" id="__tag_486182707" rid="CR36" role="button">36</a>], and patients using marijuana for 6 months or longer are five times more likely to have had surgery for their IBD [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR34" id="__tag_486182684" rid="CR34" role="button">34</a>]; whether marijuana exacerbates disease progression or more severe disease results in self-medication is unclear. Only one placebo-controlled study of the effects of marijuana in patients with CD has been conducted [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR37" id="__tag_486182638" rid="CR37" role="button">37</a>]. This study found that there was no difference between placebo and smoked marijuana on CD remission (defined as a CD Activity Index (CDAI) of less than 100), and that marijuana was superior to placebo in promoting clinical response (a decrease in CDAI score greater than 100), reducing steroid use, and improving sleep and appetite [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR37" id="__tag_486182597" rid="CR37" role="button">37</a>]. Importantly, this study did not include objective measurement of inflammatory activity, and there was no significant difference in placebo and treatment groups 2 weeks after treatment cessation [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR37" id="__tag_486182678" rid="CR37" role="button">37</a>]. Until clinical trials with objective measurement of treatment effects over an extended period of time are conducted to examine the safety and efficacy of marijuana for the treatment of IBD, there is insufficient evidence for the use of marijuana for the treatment of IBD.</p></div><div class="sec" id="Sec9"><h3 id="Sec9title">Epilepsy and seizures</h3><p class="p p-first-last" id="__p15">The known effects of cannabinoids on epilepsy and seizures are largely from animal studies, surveys, and case studies. Several animal studies indicate that marijuana and its constituents exhibit anticonvulsant effects [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR38" id="__tag_486182722" rid="CR38" role="button">38</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR41" id="__tag_486182730" rid="CR41" role="button">41</a>] and reduce seizure-related mortality [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR39" id="__tag_486182625" rid="CR39" role="button">39</a>], but there is also evidence that cannabinoids can lower the threshold for seizures [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR42" id="__tag_486182717" rid="CR42" role="button">42</a>], and THC withdrawal increases susceptibility for convulsions [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR42" id="__tag_486182675" rid="CR42" role="button">42</a>]. Cross-sectional surveys indicate that 16–21 percent of patients with epilepsy smoke marijuana [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR43" id="__tag_486182698" rid="CR43" role="button">43</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR44" id="__tag_486182694" rid="CR44" role="button">44</a>], with some reporting positive effects (e.g., spasm reduction) and a belief that marijuana is an effective therapy [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR44" id="__tag_486182652" rid="CR44" role="button">44</a>], and others reporting increased seizure frequency and intensity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR43" id="__tag_486182627" rid="CR43" role="button">43</a>]. Based on a Cochrane review, the few RCTs that have been conducted in humans include a total of 48 participants [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR45" id="__tag_486182655" rid="CR45" role="button">45</a>] and only examine treatment with cannabidiol. These trials exhibited heterogeneity of effects: some indicated a reduction in seizure frequency [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR46" id="__tag_486182688" rid="CR46" role="button">46</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR47" id="__tag_486182618" rid="CR47" role="button">47</a>], while others demonstrated no effect compared to placebo [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR48" id="__tag_486182673" rid="CR48" role="button">48</a>]. In addition, none of the studies examined response at greater than 6-month follow-up [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR45" id="__tag_486182734" rid="CR45" role="button">45</a>]. Systematic reviews of the literature have concluded that there is insufficient clinical data to support or refute the use of cannabinoids for the treatment of epilepsy and seizures [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR5" id="__tag_486182640" rid="CR5" role="button">5</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR45" id="__tag_486182723" rid="CR45" role="button">45</a>].</p></div><div class="sec" id="Sec10"><h3 id="Sec10title">Glaucoma</h3><p class="p p-first-last" id="__p16">Glaucoma is a neurodegenerative eye disease that can cause blindness by damaging retinal ganglion cells and axons of the optic nerve. Intraocular pressure (IOP) can influence both onset and progression of glaucoma and is often a target for intervention. Small samples have demonstrated reduced IOP following smoked marijuana [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR49" id="__tag_486182681" rid="CR49" role="button">49</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR50" id="__tag_486182720" rid="CR50" role="button">50</a>], but the effect is only present in 60–65 percent of individuals [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR51" id="__tag_486182682" rid="CR51" role="button">51</a>] and lasts for 3–4 hours, requiring repeated dosing throughout the day [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR52" id="__tag_486182596" rid="CR52" role="button">52</a>]. Furthermore, patients discontinue marijuana use due to side effects (e.g., dizziness, anxiety, dry mouth, sedation, depression, confusion, weight gain, and distortion of perception [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR53" id="__tag_486182728" rid="CR53" role="button">53</a>]), and this treatment discontinuity may exacerbate optic nerve damage and obviate the benefits of reduced IOP [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR54" id="__tag_486182726" rid="CR54" role="button">54</a>]. Limited research and documented toxicity have resulted in the American Glaucoma Society [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR54" id="__tag_486182737" rid="CR54" role="button">54</a>], Canadian Opthalmological Society [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR55" id="__tag_486182610" rid="CR55" role="button">55</a>], and the American Academy of Ophthalmology’s Complementary Therapies Task Force [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR52" id="__tag_486182686" rid="CR52" role="button">52</a>] determining that there is insufficient evidence to indicate that marijuana is safer or more effective than existing pharmacotherapy or surgery for the reduction of IOP. Development of eye drops for topical application of THC would minimize psychoactive and other side effects but is complicated by the high lipophilicity and low water solubility of cannabinoids [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR52" id="__tag_486182709" rid="CR52" role="button">52</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR56" id="__tag_486182628" rid="CR56" role="button">56</a>]. Additionally, the distance from the application site to the retina may be too great to afford neuroprotective benefits [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR52" id="__tag_486182695" rid="CR52" role="button">52</a>], given that only 5 percent of an applied dose penetrates the cornea to the intraocular space [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR56" id="__tag_486182721" rid="CR56" role="button">56</a>].</p></div><div class="sec" id="Sec11"><h3 id="Sec11title">Hepatitis C virus</h3><p class="p p-first" id="__p17">There have been no RCTs examining the use of cannabinoids on HCV infection. Of the studies that have been conducted, one longitudinal study demonstrates that smoked marijuana has no effect on HCV progression in individuals with HIV [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR57" id="__tag_486182690" rid="CR57" role="button">57</a>]. In contrast, individuals with HCV who smoke marijuana have a higher fibrosis progression rate [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR58" id="__tag_486182648" rid="CR58" role="button">58</a>] and more severe steatosis [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR59" id="__tag_486182595" rid="CR59" role="button">59</a>], with daily smokers having a more rapid rate of progression and greater severity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR60" id="__tag_486182733" rid="CR60" role="button">60</a>] than occasional marijuana users [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR58" id="__tag_486182644" rid="CR58" role="button">58</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR59" id="__tag_486182671" rid="CR59" role="button">59</a>]. Marijuana may have independent negative effects on steatosis [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR59" id="__tag_486182611" rid="CR59" role="button">59</a>], but because none of these findings were in the context of a clinical trial, these correlations are not causal and it is possible that individuals who use marijuana do so to manage greater symptom severity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR60" id="__tag_486182607" rid="CR60" role="button">60</a>].</p><p class="p p-last" id="__p18">There may be secondary effects of cannabinoids on HCV treatment side effects: dronabinol and Nabilone stabilized treatment-induced weight-loss [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR61" id="__tag_486182735" rid="CR61" role="button">61</a>]; and dronabinol, Nabilone, and marijuana procured from a marijuana club (dose and method of administration unspecified) increased HCV treatment duration and reduced post-treatment virological relapse [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR61" id="__tag_486182602" rid="CR61" role="button">61</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR62" id="__tag_486182654" rid="CR62" role="button">62</a>]. However, there is also a potential drug-drug interaction between ribavirin, a traditional HCV treatment, and marijuana due to shared cytochrome 450 metabolism [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR63" id="__tag_540036974" rid="CR63" role="button">63</a>]. Because 90 percent of HCV infections are the result of injection drug use [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR64" id="__tag_486182631" rid="CR64" role="button">64</a>], treatment of symptoms with marijuana may be contraindicated for this subpopulation, particularly because marijuana use in the context of other substance use (i.e., alcohol) has multiplicative effects on the odds of fibrosis severity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR60" id="__tag_486182667" rid="CR60" role="button">60</a>]. Given that newer treatments for HCV (e.g., sofosbuvir) are replacing ribavirin, there will likely be less need for use of marijuana in management of treatment-related side effects. In sum, there is currently insufficient empirical support to recommend marijuana for the treatment of HCV.</p></div><div class="sec" id="Sec12"><h3 id="Sec12title">HIV/AIDS</h3><p class="p p-first-last" id="__p19">Marijuana use in HIV-infected patients is typically for the management of side effects (e.g., nausea) of older antiretroviral treatments and AIDS-related symptoms, including weight-loss and HIV-associated neuropathy (covered in cachexia and pain sections, respectively). Survey studies indicate that 23 percent of patients with HIV/AIDS smoked marijuana in the past month and do so largely to improve mood and appetite and reduce pain [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR65" id="__tag_486182593" rid="CR65" role="button">65</a>]; these patients may exhibit tolerance and need higher doses of THC than are currently approved by the FDA for use in clinical trials [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR25" id="__tag_540036978" rid="CR25" role="button">25</a>] to experience treatment effects. The few RCTs that have been conducted in a small number of patients with HIV/AIDS largely examined the effects of marijuana (synthetic or natural marijuana that is smoked or ingested) on symptoms (e.g., nausea and appetite) over a short treatment window (21–84 days; see [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR66" id="__tag_486182608" rid="CR66" role="button">66</a>] for systematic review). Studies examining the effects of marijuana on the pharmacokinetics of antiretroviral medication demonstrated that neither smoked marijuana nor dronabinol affects short-term clinical outcomes (e.g., viral load, CD4 and CD8 counts [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR67" id="__tag_486182656" rid="CR67" role="button">67</a>]), influences the efficacy of antiretroviral medication [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR68" id="__tag_486182732" rid="CR68" role="button">68</a>], or indicates that dose adjustments for protease inhibitors are necessary [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR21" id="__tag_486182647" rid="CR21" role="button">21</a>]. However, individuals who are dependent on marijuana have demonstrated poorer medication adherence and greater HIV symptoms and side effects than nonusers and nondependent users [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR69" id="__tag_486182622" rid="CR69" role="button">69</a>]. Furthermore, while some studies have no participant withdrawal due to adverse events [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR21" id="__tag_486182614" rid="CR21" role="button">21</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR70" id="__tag_486182665" rid="CR70" role="button">70</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR71" id="__tag_486182617" rid="CR71" role="button">71</a>], others reported treatment-limiting adverse events [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR26" id="__tag_486182724" rid="CR26" role="button">26</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR72" id="__tag_486182740" rid="CR72" role="button">72</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR73" id="__tag_486182710" rid="CR73" role="button">73</a>]. Finally, because drug use is a risk factor for HIV infection [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR74" rid="CR74" role="button">74</a>], treatment of symptoms with marijuana may be contraindicated for this subpopulation. In sum, there is variability in short-term outcomes and insufficient long-term data addressing the safety and efficacy of marijuana when used to manage symptoms of HIV/AIDS and its role in those also using newer, better-tolerated antiretroviral agents.</p></div><div class="sec" id="Sec13"><h3 id="Sec13title">Multiple sclerosis and muscle spasticity</h3><p class="p p-first" id="__p20">Muscle spasticity, a common feature of MS, is disordered sensorimotor control that leads to involuntary muscle activation [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR75" id="__tag_486182669" rid="CR75" role="button">75</a>] that results in pain, sleep disturbance, and increased morbidity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR76" id="__tag_540036982" rid="CR76" role="button">76</a>]. The majority of studies examining spasticity have compared oral or sublingual forms of cannabinoids to placebo and found reduced spasm severity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR77" id="__tag_486182668" rid="CR77" role="button">77</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR84" id="__tag_486182738" rid="CR84" role="button">84</a>], with symptom improvement enduring at long-term follow-up [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR85" id="__tag_486182645" rid="CR85" role="button">85</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR87" id="__tag_486182715" rid="CR87" role="button">87</a>], and also reduced spasm frequency and spasm-related pain and sleep disturbances [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR77" id="__tag_486182719" rid="CR77" role="button">77</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR88" id="__tag_486182714" rid="CR88" role="button">88</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR89" id="__tag_486182696" rid="CR89" role="button">89</a>]. With regard to smoked marijuana, one study found reductions in muscle spasticity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR90" id="__tag_486182672" rid="CR90" role="button">90</a>]; however, another study showed that smoking marijuana impaired posture and balance in individuals with spasticity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR91" id="__tag_486182697" rid="CR91" role="button">91</a>], so there is currently insufficient evidence to determine the efficacy of smoked marijuana on spasticity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR5" id="__tag_486182613" rid="CR5" role="button">5</a>].</p><p class="p p-last" id="__p21">Surveys of patient populations show that between 14 and 16 percent of patients with MS report using marijuana for symptom management [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR92" id="__tag_486182727" rid="CR92" role="button">92</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR93" id="__tag_486182601" rid="CR93" role="button">93</a>] and that compared to non-marijuana-using individuals with MS, marijuana-using individuals with MS have decreased cognitive functioning [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR90" id="__tag_486182725" rid="CR90" role="button">90</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR94" id="__tag_486182701" rid="CR94" role="button">94</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR95" id="__tag_486182661" rid="CR95" role="button">95</a>]. Because cognitive dysfunction is present in 40–60 percent of individuals with MS before marijuana administration [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR96" id="__tag_486182705" rid="CR96" role="button">96</a>], marijuana use may further compromise impaired cerebral functioning in a neurologically vulnerable population. Additionally, future studies should carefully consider outcome assessment. The primary methods of measuring spasticity, the Ashworth Scale and patient self-report, may not be appropriate measures because antispastic drugs do not decrease Ashworth ratings, and patient-reported spasticity severity may be poorly correlated with patient functioning (i.e., a patient whose spasticity compensated for motor weakness may be unable to ambulate with reduced spasticity) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR97" id="__tag_486182621" rid="CR97" role="button">97</a>]. Importantly for both MS and other neurological disorders, the American Academy of Neurology does not advocate the use of marijuana for the treatment of neurological disorders, due to insufficient evidence regarding treatment efficacy [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR98" rid="CR98" role="button">98</a>].</p></div><div class="sec" id="Sec14"><h3 id="Sec14title">Post-traumatic stress disorder</h3><p class="p p-first" id="__p22">There has been a recent emergence of empirical studies of the effects of marijuana on symptoms of PTSD, borne primarily out of the observation that individuals with PTSD report using marijuana to cope with PTSD symptoms; specifically, hyperarousal, negative affect, and sleep disturbances [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR99" id="__tag_486182711" rid="CR99" role="button">99</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR101" id="__tag_486182731" rid="CR101" role="button">101</a>]. Empirical work has consistently demonstrated that the endocannabinoid system plays a significant role in the etiology of PTSD, with greater availability of cannabinoid type 1 receptors documented among those with PTSD than in trauma-exposed or healthy controls [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR102" id="__tag_486182676" rid="CR102" role="button">102</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR103" id="__tag_486182663" rid="CR103" role="button">103</a>]. Though the use of marijuana and oral THC [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR104" id="__tag_486182702" rid="CR104" role="button">104</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR105" id="__tag_486182635" rid="CR105" role="button">105</a>] have been implicated as a potential mechanism for the mitigation of many PTSD symptoms by way of their effects on the endocannabinoid system, some researchers caution that endocannabinoid activation with plant-based extracts over extended periods may lead to a number of deleterious consequences, including receptor downregulation and addiction [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR102" id="__tag_486182700" rid="CR102" role="button">102</a>].</p><p class="p p-last" id="__p23">There have been no RCTs of marijuana for the treatment of PTSD, though there has been one small RCT of Nabilone that showed promise for reducing nightmares associated with PTSD [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR106" id="__tag_486182643" rid="CR106" role="button">106</a>]. One unpublished pilot study of 29 Israeli combat veterans showed reductions in PTSD symptoms following the administration of smoked marijuana, with effects seen up to one year post-treatment [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR107" rid="CR107" role="button">107</a>]. Remaining studies have been primarily observational in nature, documenting that PTSD is associated with greater odds of a cannabis use disorder diagnosis [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR108" id="__tag_486182687" rid="CR108" role="button">108</a>] and greater marijuana craving and withdrawal immediately prior to a marijuana cessation attempt [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR109" id="__tag_486182712" rid="CR109" role="button">109</a>]. Indeed, sleep difficulties (a hallmark of PTSD) have been associated with poor marijuana cessation outcomes [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR110" id="__tag_486182739" rid="CR110" role="button">110</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR111" id="__tag_486182664" rid="CR111" role="button">111</a>], while cannabis use disorders have been associated with poorer PTSD treatment outcomes [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#CR112" rid="CR112" role="button">112</a>]. Given the lack of RCTs studying marijuana as a treatment for PTSD, there is insufficient scientific evidence for its use at this time.</p></div><div class="sec" id="Sec15"><h3 id="Sec15title">Severe and chronic pain</h3><p class="p p-first-last" id="__p24">Clinical trials have examined smoked and oral administration of cannabinoids on different types of pain (e.g., neuropathic, post-operative, experimentally induced) in multiple patient populations (e.g., HIV, cancer, and fibromyalgia). Two meta-analyses have been conducted examining the association between marijuana and pain. In the first, 18 RCTs demonstrated that any marijuana preparation containing THC, applied by any route of administration, significantly decreased pain scores from baseline compared to placebo [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR113" id="__tag_486182716" rid="CR113" role="button">113</a>]. The second examined 19 RCTs of smoked marijuana in individuals with HIV, which also indicated greater efficacy in reducing pain (i.e., sensory neuropathy) compared to placebo [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR114" id="__tag_486182637" rid="CR114" role="button">114</a>]. Importantly, the first meta-analysis showed that marijuana increased the odds of altered perception, motor function, and cognition by 4 to 5 times [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR113" id="__tag_486182632" rid="CR113" role="button">113</a>], and the second study did not recommend marijuana as routine therapy [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR114" id="__tag_486182729" rid="CR114" role="button">114</a>]. Dosage is an important factor to consider for administration of cannabinoids for pain management, as some studies have found that higher doses of smoked marijuana are associated with improved analgesia [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR115" id="__tag_486182649" rid="CR115" role="button">115</a>], whereas other studies show that higher doses of smoked marijuana increase pain response [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR116" id="__tag_486182616" rid="CR116" role="button">116</a>]. Because the analgesic effects of marijuana are comparable to those of traditional pain medications [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR117" id="__tag_486182606" rid="CR117" role="button">117</a>], future research should aim to identify which analgesics provide the lowest risk profile for the management of severe and chronic pain. Although there is preliminary support to suggest that marijuana may have analgesic effects, there is insufficient research on dosing and side effect profile, which precludes recommending marijuana for the management of severe and chronic pain.</p></div><div class="sec sec-last" id="Sec16"><h3 id="Sec16title">Severe nausea</h3><p class="p p-first" id="__p25">The majority of research related to the effects of marijuana on severe nausea has involved oral administration of marijuana to individuals with chemotherapy-induced nausea and vomiting (CINV). Oral marijuana (i.e., THC suspension in sesame oil and gelatin) has been shown to be more effective in reducing CINV than placebo [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR118" id="__tag_486182677" rid="CR118" role="button">118</a>], including the number and volume of vomiting episodes, and the severity and duration of nausea [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR119" id="__tag_486182685" rid="CR119" role="button">119</a>]. When compared to traditional anti-emetics, some meta-analytic reviews indicate that oral THC is more effective in reducing CINV [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR120" id="__tag_486182624" rid="CR120" role="button">120</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR123" id="__tag_486182592" rid="CR123" role="button">123</a>], others find no significant difference [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR122" id="__tag_486182736" rid="CR122" role="button">122</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR124" id="__tag_486182670" rid="CR124" role="button">124</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR126" id="__tag_486182626" rid="CR126" role="button">126</a>], and another suggests that combining both is the most effective at reducing the duration and severity of CINV than either alone [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR127" id="__tag_486182630" rid="CR127" role="button">127</a>]. Recent advances in both anti-emetic agents and the mechanisms of cannabinoid administration (i.e., sublingual application) warrant future research.</p><p class="p p-last" id="__p26">Importantly, patients receiving cannabinoids for severe nausea reported toxicities, including paranoid delusions (5%), hallucinations (6%), and dysphoria (13%) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR122" id="__tag_486182629" rid="CR122" role="button">122</a>]. Additionally, cannabinoid hyperemesis syndrome has been documented, in which persistent and regular marijuana use (i.e., daily or weekly use for more than 1 year) is associated with cyclic vomiting (i.e., episodic nausea and vomiting) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR128" id="__tag_486182599" rid="CR128" role="button">128</a>] and nonresponse to treatment for cyclic vomiting [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR129" id="__tag_486182604" rid="CR129" role="button">129</a>]. Dronabinol has been FDA-approved for CINV in individuals who have not shown a treatment response to traditional anti-emetics, but in line with recommendations from the American Society of Clinical Oncology [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR130" id="__tag_540036980" rid="CR130" role="button">130</a>] and the European Society for Medical Oncology [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR131" id="__tag_540036983" rid="CR131" role="button">131</a>], cannabinoids should not be utilized as a first-line treatment for nausea and vomiting.</p></div></div><div class="tsec sec" id="Sec17"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="Sec17title">Conclusions</h2><p class="p p-first" id="__p27">The reviewed literature highlights the dearth of rigorous research on the effects of marijuana for the most common conditions for which it is currently recommended. It is paramount that well-designed RCTs with larger sample sizes be conducted to determine the actual medical benefits and adverse effects of marijuana for each of the above conditions. Indeed, recent reviews [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR4" id="__tag_540036975" rid="CR4" role="button">4</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR132" id="__tag_486182666" rid="CR132" role="button">132</a>] comprehensively discuss adverse events associated with marijuana use, and while it is beyond the scope of the current paper to review these effects in-depth, they are important to consider when evaluating whether or not to recommend marijuana for a medical or psychiatric disorder in place of other existing treatment options.</p><p class="p p-last" id="__p28">Given the extensive literature speaking to the harms associated with marijuana use, research on the comparative safety, tolerability, efficacy, and risk of marijuana compared to existing pharmacological agents is needed. The present literature also illuminates the need for research into the effects of isolated cannabinoids (e.g., THC, CBD) as well as species of smoked marijuana (e.g., indica and sativa), as the majority of medical marijuana users ingest marijuana by smoking the marijuana plant [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR133" id="__tag_486182594" rid="CR133" role="button">133</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR134" id="__tag_486182641" rid="CR134" role="button">134</a>], which contains a wide variety of phytocannabinoids at varying potencies [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR135" id="__tag_486182639" rid="CR135" role="button">135</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#CR136" id="__tag_486182612" rid="CR136" role="button">136</a>]. Furthermore, improved and objective measurement of clinical outcomes should be implemented in clinical trials to determine treatment efficacy. Finally, little research has considered the issues of dose, duration, and potency. If research identifies a therapeutic effect of marijuana for medical or psychiatric conditions, there will need to be revisions in marijuana policy to increase quality control so that dose and potency are valid and reliable. Additionally, risk of abuse and diversion can be decreased by developing prescribing practices with continued supervision of a medical professional, creating prescription monitoring programs to reduce the risk of “doctor shopping”, and identifying provisions for the safe disposal of unused cannabinoids. In sum, the current literature does not adequately support the widespread adoption and use of marijuana for medical and psychiatric conditions at this time.</p></div><div class="tsec sec" id="idm139726588977600"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139726588977600title">Acknowledgements</h2><div class="sec"><p id="__p48">Dr. Belendiuk’s salary was supported by National Institute of Mental Health R01 MH40564.</p><p id="__p49">Dr. Bonn-Miller’s salary was supported by the VA Center of Excellence for Substance Abuse Treatment and Education.</p><p id="__p50">Literature review and synthesis was supported by a grant from the VA Substance Use Disorder Quality Enhancement Research Initiative (SUDQ-LIP1410).</p><p id="__p51">The above funding agencies played no role in the writing of the manuscript or decision to submit the manuscript for publication. The expressed views do not necessarily represent those of the Department of Veterans Affairs.</p></div></div><div class="tsec sec" id="idm139726595129472"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139726595129472title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>THC</td><td>Δ<sup>9</sup>-tetrahydrocannabinol</td></tr><tr><td>HIV</td><td>Human immunodeficiency virus</td></tr><tr><td>AIDS</td><td>Acquired immunodeficiency syndrome</td></tr><tr><td>RCTs</td><td>Randomized controlled trials</td></tr><tr><td>IOP</td><td>Intraocular pressure</td></tr><tr><td>MS</td><td>Multiple sclerosis</td></tr><tr><td>CINV</td><td>Chemotherapy-induced nausea and vomiting</td></tr><tr><td>HCV</td><td>Hepatitis C virus</td></tr><tr><td>ALS</td><td>Amyotrophic lateral sclerosis</td></tr><tr><td>CD</td><td>Crohn’s disease</td></tr><tr><td>IBD</td><td>Inflammatory bowel disease</td></tr><tr><td>AD</td><td>Alzheimer’s disease</td></tr><tr><td>PTSD</td><td>Post-traumatic stress disorder</td></tr><tr><td>CB1</td><td>Cannabinoid type 1</td></tr><tr><td>CBD</td><td>Cannabidiol</td></tr></tbody></table></div></div></div><div class="tsec sec" id="idm139726588980768"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139726588980768title">Footnotes</h2><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139726588980640"></p><p class="p p-first" id="__p44"><strong>Competing interests</strong></p><p class="p p-last" id="__p45">Dr. Belendiuk holds stock in Shire Pharmaceuticals.</p><p></p><p class="fn sec" id="idm139726588979312"></p><p class="p p-first" id="__p46"><strong>Authors’ contributions</strong></p><p class="p p-last" id="__p47">Dr. KAB synthesized the literature and authored sections of the manuscript. Ms. LLB assisted with the literature search and synthesis. Dr. MOB-M conceived the review, assisted in the search and synthesis of existing literature, and authored sections of the manuscript. All authors read and approved the final manuscript.</p><p></p></div></div><div class="tsec sec" id="idm139726591926288aff-info"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139726591926288aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Katherine A Belendiuk, </span><span class="fm-affl"><span class="email-label">Email: </span><a class="oemail" data-email="ude.yelekreb@bak" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//mailto:dev@null">ude.yelekreb@bak</a></span>.</p><p><span class="fm-affl">Lisa L Baldini, </span><span class="fm-affl"><span class="email-label">Email: </span><a class="oemail" data-email="ude.uotlaolap@inidlabl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//mailto:dev@null">ude.uotlaolap@inidlabl</a></span>.</p><p><span class="fm-affl">Marcel O Bonn-Miller, </span><span class="fm-affl"><span class="email-label">Email: </span><a class="oemail" data-email="vog.av@relliM-nnoB.lecraM" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//mailto:dev@null">vog.av@relliM-nnoB.lecraM</a></span>.</p></div><div class="tsec sec" id="Bib1"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Substance Abuse and Mental Health Services Administration  . <span class="ref-journal">Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings.</span> Rockville, MD. U.S: Department of Health and Human Services; 2013.  <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?title=Results+from+the+2012+National+Survey+on+Drug+Use+and+Health:+Summary+of+National+Findings&amp;publication_year=2013&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Bonn-Miller MO, Harris AH, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. <span><span class="ref-journal">Psycholog Serv. </span>2012;<span class="ref-vol">9</span>:404–16.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22564034" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psycholog+Serv&amp;title=Prevalence+of+cannabis+use+disorder+diagnoses+among+veterans+in+2002,+2008,+and+2009&amp;author=MO+Bonn-Miller&amp;author=AH+Harris&amp;author=JA+Trafton&amp;volume=9&amp;publication_year=2012&amp;pages=404-16&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE.  <span class="ref-journal">Monitoring the Future national results on drug use: 1975–2013: Overview, Key Findings on Adolescent Drug Use.</span> Ann Arbor: Institute for Social Research, The University of Michigan; 2014.  <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?title=Monitoring+the+Future+national+results+on+drug+use:+1975–2013:+Overview,+Key+Findings+on+Adolescent+Drug+Use&amp;author=LD+Johnston&amp;author=PM+O'Malley&amp;author=RA+Miech&amp;author=JG+Bachman&amp;author=JE+Schulenberg&amp;publication_year=2014&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">370</span>:2219–27.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827335/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24897085" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Adverse+health+effects+of+marijuana+use&amp;author=ND+Volkow&amp;author=RD+Baler&amp;author=WM+Compton&amp;author=SR+Weiss&amp;volume=370&amp;publication_year=2014&amp;pages=2219-27&amp;pmid=24897085&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, et al.  Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development subcommittee of the American academy of neurology. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:1556–63.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011465/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24778283" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Systematic+review:+efficacy+and+safety+of+medical+marijuana+in+selected+neurologic+disorders:+report+of+the+guideline+development+subcommittee+of+the+American+academy+of+neurology&amp;author=BS+Koppel&amp;author=JC+Brust&amp;author=T+Fife&amp;author=J+Bronstein&amp;author=S+Youssof&amp;volume=82&amp;publication_year=2014&amp;pages=1556-63&amp;pmid=24778283&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="mixed-citation">Procon.org. 23 legal medical marijuana states and DC: Laws, fees, and possession limits. Retrieved April 9, 2015, from [<a data-ga-action="click_feat_suppl" href="http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. <span><span class="ref-journal">Am J Drug Alcohol Abuse. </span>2014;<span class="ref-vol">40</span>:23–30.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24205805" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Drug+Alcohol+Abuse&amp;title=Self-reported+cannabis+use+characteristics,+patterns+and+helpfulness+among+medical+cannabis+users&amp;author=MO+Bonn-Miller&amp;author=MT+Boden&amp;author=MM+Bucossi&amp;author=KA+Babson&amp;volume=40&amp;publication_year=2014&amp;pages=23-30&amp;pmid=24205805&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Ilgen MA, Bohnert K, Kleinberg F, Jannausch M, Bohnert ASB, Walton MA, et al.  Characteristics of adults seeking medical marijuana certification. <span><span class="ref-journal">Drug Alcohol Depend. </span>2013;<span class="ref-vol">132</span>:654–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23683791" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Depend&amp;title=Characteristics+of+adults+seeking+medical+marijuana+certification&amp;author=MA+Ilgen&amp;author=K+Bohnert&amp;author=F+Kleinberg&amp;author=M+Jannausch&amp;author=ASB+Bohnert&amp;volume=132&amp;publication_year=2013&amp;pages=654-9&amp;pmid=23683791&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Nunberg H, Kilmer B, Pacula RL, Burgdorf J. An analysis of applicants presenting to a medical marijuana specialty practice in California. <span><span class="ref-journal">J Drug Policy Anal. </span>2011;<span class="ref-vol">4</span>:1.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23750291" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Drug+Policy+Anal.&amp;title=An+analysis+of+applicants+presenting+to+a+medical+marijuana+specialty+practice+in+California&amp;author=H+Nunberg&amp;author=B+Kilmer&amp;author=RL+Pacula&amp;author=J+Burgdorf&amp;volume=4&amp;publication_year=2011&amp;pages=1&amp;pmid=23750291&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Minati L, Edginton T, Bruzzone MG, Giaccone G. Reviews: current concepts in Alzheimer's disease: a multidisciplinary review. <span><span class="ref-journal">Am J Alzheimers Dis Other Demen. </span>2009;<span class="ref-vol">24</span>:95–121.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19116299" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Alzheimers+Dis+Other+Demen&amp;title=Reviews:+current+concepts+in+Alzheimer's+disease:+a+multidisciplinary+review&amp;author=L+Minati&amp;author=T+Edginton&amp;author=MG+Bruzzone&amp;author=G+Giaccone&amp;volume=24&amp;publication_year=2009&amp;pages=95-121&amp;pmid=19116299&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Fagan SG, Campbell VA. The influence of cannabinoids on generic traits of neurodegeneration. <span><span class="ref-journal">Br J Pharmacol. </span>2014;<span class="ref-vol">171</span>:1347–60.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954477/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24172185" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=The+influence+of+cannabinoids+on+generic+traits+of+neurodegeneration&amp;author=SG+Fagan&amp;author=VA+Campbell&amp;volume=171&amp;publication_year=2014&amp;pages=1347-60&amp;pmid=24172185&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Gowran A, Noonan J, Campbell VA. The multiplicity of action of cannabinoids: implications for treating neurodegeneration. <span><span class="ref-journal">CNS Neurosci Ther. </span>2011;<span class="ref-vol">17</span>:637–44.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493861/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20875047" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=CNS+Neurosci+Ther&amp;title=The+multiplicity+of+action+of+cannabinoids:+implications+for+treating+neurodegeneration&amp;author=A+Gowran&amp;author=J+Noonan&amp;author=VA+Campbell&amp;volume=17&amp;publication_year=2011&amp;pages=637-44&amp;pmid=20875047&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Aso E, Ferrer I. Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. <span><span class="ref-journal">Front Pharmacol. </span>2014;<span class="ref-vol">5</span>:37.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942876/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24634659" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Front+Pharmacol&amp;title=Cannabinoids+for+treatment+of+Alzheimer’s+disease:+moving+toward+the+clinic&amp;author=E+Aso&amp;author=I+Ferrer&amp;volume=5&amp;publication_year=2014&amp;pages=37&amp;pmid=24634659&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Krishnan S, Cairns R, Howard R. Cannabinoids for the treatment of dementia. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2009;<span class="ref-vol">2</span>:CD007204.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19370677" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cochrane+Database+Syst+Rev&amp;title=Cannabinoids+for+the+treatment+of+dementia&amp;author=S+Krishnan&amp;author=R+Cairns&amp;author=R+Howard&amp;volume=2&amp;publication_year=2009&amp;pages=CD007204&amp;pmid=19370677&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. <span><span class="ref-journal">Int J Geriatr Psychiatry. </span>1997;<span class="ref-vol">12</span>:913–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9309469" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Int+J+Geriatr+Psychiatry&amp;title=Effects+of+dronabinol+on+anorexia+and+disturbed+behavior+in+patients+with+Alzheimer's+disease&amp;author=L+Volicer&amp;author=M+Stelly&amp;author=J+Morris&amp;author=J+McLaughlin&amp;author=BJ+Volicer&amp;volume=12&amp;publication_year=1997&amp;pages=913-9&amp;pmid=9309469&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Walther S, Schüpbach B, Seifritz E, Homan P, Strik W. Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia. <span><span class="ref-journal">J Clin Psychopharmacol. </span>2011;<span class="ref-vol">31</span>:256–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21364345" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychopharmacol&amp;title=Randomized,+controlled+crossover+trial+of+dronabinol,+2.5 mg,+for+agitation+in+2+patients+with+dementia&amp;author=S+Walther&amp;author=B+Schüpbach&amp;author=E+Seifritz&amp;author=P+Homan&amp;author=W+Strik&amp;volume=31&amp;publication_year=2011&amp;pages=256-8&amp;pmid=21364345&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Carter GT, Abood ME, Aggarwal SK, Weiss MD. Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. <span><span class="ref-journal">Am J Hosp Palliat Care. </span>2010;<span class="ref-vol">27</span>:347–56.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20439484" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hosp+Palliat+Care&amp;title=Cannabis+and+amyotrophic+lateral+sclerosis:+hypothetical+and+practical+applications,+and+a+call+for+clinical+trials&amp;author=GT+Carter&amp;author=ME+Abood&amp;author=SK+Aggarwal&amp;author=MD+Weiss&amp;volume=27&amp;publication_year=2010&amp;pages=347-56&amp;pmid=20439484&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. <span><span class="ref-journal">Am J Hosp Palliat Care. </span>2001;<span class="ref-vol">18</span>:264–70.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11467101" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hosp+Palliat+Care&amp;title=Marijuana+in+the+management+of+amyotrophic+lateral+sclerosis&amp;author=GT+Carter&amp;author=BS+Rosen&amp;volume=18&amp;publication_year=2001&amp;pages=264-70&amp;pmid=11467101&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Survey of cannabis use in patients with amyotrophic lateral sclerosis. <span><span class="ref-journal">Am J Hosp Palliat Care. </span>2004;<span class="ref-vol">21</span>:95–104.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15055508" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hosp+Palliat+Care&amp;title=Survey+of+cannabis+use+in+patients+with+amyotrophic+lateral+sclerosis&amp;author=D+Amtmann&amp;author=P+Weydt&amp;author=KL+Johnson&amp;author=MP+Jensen&amp;author=GT+Carter&amp;volume=21&amp;publication_year=2004&amp;pages=95-104&amp;pmid=15055508&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Weber M, Goldman B, Truniger S. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2010;<span class="ref-vol">81</span>:1135–40.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20498181" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&amp;title=Tetrahydrocannabinol+(THC)+for+cramps+in+amyotrophic+lateral+sclerosis:+a+randomised,+double-blind+crossover+trial&amp;author=M+Weber&amp;author=B+Goldman&amp;author=S+Truniger&amp;volume=81&amp;publication_year=2010&amp;pages=1135-40&amp;pmid=20498181&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, et al.  Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. <span><span class="ref-journal">Ann Intern Med. </span>2003;<span class="ref-vol">139</span>:258–66.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12965981" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Short-term+effects+of+cannabinoids+in+patients+with+HIV-1+infection:+a+randomized,+placebo-controlled+clinical+trial&amp;author=DI+Abrams&amp;author=JF+Hilton&amp;author=RJ+Leiser&amp;author=SB+Shade&amp;author=TA+Elbeik&amp;volume=139&amp;publication_year=2003&amp;pages=258-66&amp;pmid=12965981&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, et al.  Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. <span><span class="ref-journal">J Acquir Immune Defic Syndr. </span>2007;<span class="ref-vol">45</span>:545–54.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17589370" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Acquir+Immune+Defic+Syndr&amp;title=Dronabinol+and+marijuana+in+HIV-positive+marijuana+smokers:+caloric+intake,+mood,+and+sleep&amp;author=M+Haney&amp;author=EW+Gunderson&amp;author=J+Rabkin&amp;author=CL+Hart&amp;author=SK+Vosburg&amp;volume=45&amp;publication_year=2007&amp;pages=545-54&amp;pmid=17589370&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Foltin RW, Fischman MW, Byrne MF. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. <span><span class="ref-journal">Appetite. </span>1988;<span class="ref-vol">11</span>:1–14.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/3228283" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Appetite&amp;title=Effects+of+smoked+marijuana+on+food+intake+and+body+weight+of+humans+living+in+a+residential+laboratory&amp;author=RW+Foltin&amp;author=MW+Fischman&amp;author=MF+Byrne&amp;volume=11&amp;publication_year=1988&amp;pages=1-14&amp;pmid=3228283&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Haney M. Effects of smoked marijuana in healthy and HIV+ marijuana smokers. <span><span class="ref-journal">J Clin Pharmacol. </span>2002;<span class="ref-vol">42</span>:34S–40.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412834" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;title=Effects+of+smoked+marijuana+in+healthy+and+HIV++marijuana+smokers&amp;author=M+Haney&amp;volume=42&amp;publication_year=2002&amp;pages=34S-40&amp;pmid=12412834&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, et al.  Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. <span><span class="ref-journal">Psychopharmacol (Berl) </span>2010;<span class="ref-vol">212</span>:675–86.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325767/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20824270" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacol+(Berl)&amp;title=Efficacy+and+tolerability+of+high-dose+dronabinol+maintenance+in+HIV-positive+marijuana+smokers:+a+controlled+laboratory+study&amp;author=G+Bedi&amp;author=RW+Foltin&amp;author=EW+Gunderson&amp;author=J+Rabkin&amp;author=CL+Hart&amp;volume=212&amp;publication_year=2010&amp;pages=675-86&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, et al.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. <span><span class="ref-journal">J Pain Symptom Manage. </span>1995;<span class="ref-vol">10</span>:89–97.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7730690" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pain+Symptom+Manage&amp;title=Dronabinol+as+a+treatment+for+anorexia+associated+with+weight+loss+in+patients+with+AIDS&amp;author=JE+Beal&amp;author=R+Olson&amp;author=L+Laubenstein&amp;author=JO+Morales&amp;author=P+Bellman&amp;volume=10&amp;publication_year=1995&amp;pages=89-97&amp;pmid=7730690&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, et al.  Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. <span><span class="ref-journal">J Pain Symptom Manage. </span>1997;<span class="ref-vol">14</span>:7–14.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9223837" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pain+Symptom+Manage&amp;title=Long-term+efficacy+and+safety+of+dronabinol+for+acquired+immunodeficiency+syndrome-associated+anorexia&amp;author=JE+Beal&amp;author=R+Olson&amp;author=L+Lefkowitz&amp;author=L+Laubenstein&amp;author=P+Bellman&amp;volume=14&amp;publication_year=1997&amp;pages=7-14&amp;pmid=9223837&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Riggs PK, Vaida F, Rossi SS, Sorkin LS, Gouaux B, Grant I, et al.  A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. <span><span class="ref-journal">Brain Res. </span>2012;<span class="ref-vol">1431</span>:46–52.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200580/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22133305" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;title=A+pilot+study+of+the+effects+of+cannabis+on+appetite+hormones+in+HIV-infected+adult+men&amp;author=PK+Riggs&amp;author=F+Vaida&amp;author=SS+Rossi&amp;author=LS+Sorkin&amp;author=B+Gouaux&amp;volume=1431&amp;publication_year=2012&amp;pages=46-52&amp;pmid=22133305&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, et al.  Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a north central cancer treatment group study. <span><span class="ref-journal">J Clin Oncol. </span>2002;<span class="ref-vol">20</span>:567–73.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11786587" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Dronabinol+versus+megestrol+acetate+versus+combination+therapy+for+cancer-associated+anorexia:+a+north+central+cancer+treatment+group+study&amp;author=A+Jatoi&amp;author=HE+Windschitl&amp;author=CL+Loprinzi&amp;author=JA+Sloan&amp;author=SR+Dakhil&amp;volume=20&amp;publication_year=2002&amp;pages=567-73&amp;pmid=11786587&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Bowles DW, O’Bryant CL, Camidge DR, Jimeno A. The intersection between cannabis and cancer in the United States. <span><span class="ref-journal">Crit Rev Oncol Hematol. </span>2012;<span class="ref-vol">83</span>:1–10.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22019199" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Oncol+Hematol&amp;title=The+intersection+between+cannabis+and+cancer+in+the+United+States&amp;author=DW+Bowles&amp;author=CL+O’Bryant&amp;author=DR+Camidge&amp;author=A+Jimeno&amp;volume=83&amp;publication_year=2012&amp;pages=1-10&amp;pmid=22019199&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, et al.  Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. <span><span class="ref-journal">Best Prac Res Clin Endocrinol Metab. </span>2009;<span class="ref-vol">23</span>:117–31.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19285265" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Best+Prac+Res+Clin+Endocrinol+Metab&amp;title=Use+of+cannabinoid+receptor+agonists+in+cancer+therapy+as+palliative+and+curative+agents&amp;author=S+Pisanti&amp;author=AM+Malfitano&amp;author=C+Grimaldi&amp;author=A+Santoro&amp;author=P+Gazzerro&amp;volume=23&amp;publication_year=2009&amp;pages=117-31&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">McKallip RJ, Nagarkatti M, Nagarkatti PS. Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">174</span>:3281–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15749859" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Δ-9-tetrahydrocannabinol+enhances+breast+cancer+growth+and+metastasis+by+suppression+of+the+antitumor+immune+response&amp;author=RJ+McKallip&amp;author=M+Nagarkatti&amp;author=PS+Nagarkatti&amp;volume=174&amp;publication_year=2005&amp;pages=3281-9&amp;pmid=15749859&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Guzman M, Duarte MJ, Blazquez C, Ravina J, Rosa MC, Galve-Roperh I, et al.  A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. <span><span class="ref-journal">Br J Cancer. </span>2006;<span class="ref-vol">95</span>:197–203.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360617/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16804518" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Cancer&amp;title=A+pilot+clinical+study+of+Δ9-tetrahydrocannabinol+in+patients+with+recurrent+glioblastoma+multiforme&amp;author=M+Guzman&amp;author=MJ+Duarte&amp;author=C+Blazquez&amp;author=J+Ravina&amp;author=MC+Rosa&amp;volume=95&amp;publication_year=2006&amp;pages=197-203&amp;pmid=16804518&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease. <span><span class="ref-journal">Inflamm Bowel Dis. </span>2014;<span class="ref-vol">20</span>:472–80.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24407485" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Cannabis+use+provides+symptom+relief+in+patients+with+inflammatory+bowel+disease+but+is+associated+with+worse+disease+prognosis+in+patients+with+Crohn's+disease&amp;author=M+Storr&amp;author=S+Devlin&amp;author=GG+Kaplan&amp;author=R+Panaccione&amp;author=CN+Andrews&amp;volume=20&amp;publication_year=2014&amp;pages=472-80&amp;pmid=24407485&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS, Gordon A, et al.  Cannabis use amongst patients with inflammatory bowel disease. <span><span class="ref-journal">Eur J Gastroenterol Hepatol. </span>2011;<span class="ref-vol">23</span>:891–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21795981" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Gastroenterol+Hepatol&amp;title=Cannabis+use+amongst+patients+with+inflammatory+bowel+disease&amp;author=S+Lal&amp;author=N+Prasad&amp;author=M+Ryan&amp;author=S+Tangri&amp;author=MS+Silverberg&amp;volume=23&amp;publication_year=2011&amp;pages=891-6&amp;pmid=21795981&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Allegretti JR, Courtwright A, Lucci M, Korzenik JR, Levine J. Marijuana use patterns among patients with inflammatory bowel disease. <span><span class="ref-journal">Inflamm Bowel Dis. </span>2013;<span class="ref-vol">19</span>:2809–14.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126607/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24185313" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Marijuana+use+patterns+among+patients+with+inflammatory+bowel+disease&amp;author=JR+Allegretti&amp;author=A+Courtwright&amp;author=M+Lucci&amp;author=JR+Korzenik&amp;author=J+Levine&amp;volume=19&amp;publication_year=2013&amp;pages=2809-14&amp;pmid=24185313&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2013;<span class="ref-vol">11</span>:1276–80.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23648372" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Gastroenterol+Hepatol&amp;title=Cannabis+induces+a+clinical+response+in+patients+with+Crohn's+disease:+a+prospective+placebo-controlled+study&amp;author=T+Naftali&amp;author=L+Bar-Lev+Schleider&amp;author=I+Dotan&amp;author=EP+Lansky&amp;author=F+Sklerovsky+Benjaminov&amp;volume=11&amp;publication_year=2013&amp;pages=1276-80&amp;pmid=23648372&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, et al.  Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. <span><span class="ref-journal">Br J Pharmacol. </span>2013;<span class="ref-vol">170</span>:679–92.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792005/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23902406" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Cannabidivarin-rich+cannabis+extracts+are+anticonvulsant+in+mouse+and+rat+via+a+CB1+receptor-independent+mechanism&amp;author=TD+Hill&amp;author=MG+Cascio&amp;author=B+Romano&amp;author=M+Duncan&amp;author=RG+Pertwee&amp;volume=170&amp;publication_year=2013&amp;pages=679-92&amp;pmid=23902406&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Jones NA, Glyn SE, Akiyama S, Hill TD, Hill AJ, Weston SE, et al.  Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. <span><span class="ref-journal">Seizure. </span>2012;<span class="ref-vol">21</span>:344–52.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22520455" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Seizure&amp;title=Cannabidiol+exerts+anti-convulsant+effects+in+animal+models+of+temporal+lobe+and+partial+seizures&amp;author=NA+Jones&amp;author=SE+Glyn&amp;author=S+Akiyama&amp;author=TD+Hill&amp;author=AJ+Hill&amp;volume=21&amp;publication_year=2012&amp;pages=344-52&amp;pmid=22520455&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2003;<span class="ref-vol">307</span>:129–37.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12954810" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=The+endogenous+cannabinoid+system+regulates+seizure+frequency+and+duration+in+a+model+of+temporal+lobe+epilepsy&amp;author=MJ+Wallace&amp;author=RE+Blair&amp;author=KW+Falenski&amp;author=BR+Martin&amp;author=RJ+DeLorenzo&amp;volume=307&amp;publication_year=2003&amp;pages=129-37&amp;pmid=12954810&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, et al.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2010;<span class="ref-vol">332</span>:569–77.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819831/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19906779" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Cannabidiol+displays+antiepileptiform+and+antiseizure+properties+in+vitro+and+in+vivo&amp;author=NA+Jones&amp;author=AJ+Hill&amp;author=I+Smith&amp;author=SA+Bevan&amp;author=CM+Williams&amp;volume=332&amp;publication_year=2010&amp;pages=569-77&amp;pmid=19906779&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Gordon E, Devinsky O. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. <span><span class="ref-journal">Epilepsia. </span>2001;<span class="ref-vol">42</span>:1266–72.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11737161" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Alcohol+and+marijuana:+effects+on+epilepsy+and+use+by+patients+with+epilepsy&amp;author=E+Gordon&amp;author=O+Devinsky&amp;volume=42&amp;publication_year=2001&amp;pages=1266-72&amp;pmid=11737161&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Hamerle M, Ghaeni L, Kowski A, Weissinger F, Holtkamp M. Cannabis and other illicit drug use in epilepsy patients. <span><span class="ref-journal">Eur J Neurol. </span>2014;<span class="ref-vol">21</span>:167–70.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23311572" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurol&amp;title=Cannabis+and+other+illicit+drug+use+in+epilepsy+patients&amp;author=M+Hamerle&amp;author=L+Ghaeni&amp;author=A+Kowski&amp;author=F+Weissinger&amp;author=M+Holtkamp&amp;volume=21&amp;publication_year=2014&amp;pages=167-70&amp;pmid=23311572&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Gross DW, Hamm J, Ashworth NL, Quigley D. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:2095–7.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15184622" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Marijuana+use+and+epilepsy:+prevalence+in+patients+of+a+tertiary+care+epilepsy+center&amp;author=DW+Gross&amp;author=J+Hamm&amp;author=NL+Ashworth&amp;author=D+Quigley&amp;volume=62&amp;publication_year=2004&amp;pages=2095-7&amp;pmid=15184622&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Gloss D, Vickrey B. Cannabinoids for epilepsy. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2014;<span class="ref-vol">3</span>:CD009270.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24595491" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cochrane+Database+Syst+Rev&amp;title=Cannabinoids+for+epilepsy&amp;author=D+Gloss&amp;author=B+Vickrey&amp;volume=3&amp;publication_year=2014&amp;pages=CD009270&amp;pmid=24595491&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Mechoulam R, Carlini EA. Toward drugs derived from cannabis. <span><span class="ref-journal">Naturwissenschaften. </span>1978;<span class="ref-vol">65</span>:174–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/351429" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Naturwissenschaften&amp;title=Toward+drugs+derived+from+cannabis&amp;author=R+Mechoulam&amp;author=EA+Carlini&amp;volume=65&amp;publication_year=1978&amp;pages=174-9&amp;pmid=351429&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, et al.  Chronic administration of cannabidiol to healthy volunteers and epileptic patients. <span><span class="ref-journal">Pharmacology. </span>1980;<span class="ref-vol">21</span>:175–85.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7413719" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmacology&amp;title=Chronic+administration+of+cannabidiol+to+healthy+volunteers+and+epileptic+patients&amp;author=JM+Cunha&amp;author=EA+Carlini&amp;author=AE+Pereira&amp;author=OL+Ramos&amp;author=C+Pimentel&amp;volume=21&amp;publication_year=1980&amp;pages=175-85&amp;pmid=7413719&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Ames FR, Cridland S. Anticonvulsant effect of cannabidiol. <span><span class="ref-journal">S Afr Med J. </span>1986;<span class="ref-vol">69</span>:14.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/3941934" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=S+Afr+Med+J&amp;title=Anticonvulsant+effect+of+cannabidiol&amp;author=FR+Ames&amp;author=S+Cridland&amp;volume=69&amp;publication_year=1986&amp;pages=14&amp;pmid=3941934&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. <span><span class="ref-journal">Ophthalmology. </span>1980;<span class="ref-vol">87</span>:222–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7053160" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=Effect+of+marihuana+on+intraocular+and+blood+pressure+in+glaucoma&amp;author=JC+Merritt&amp;author=WJ+Crawford&amp;author=PC+Alexander&amp;author=AL+Anduze&amp;author=SS+Gelbart&amp;volume=87&amp;publication_year=1980&amp;pages=222-8&amp;pmid=7053160&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. <span><span class="ref-journal">JAMA. </span>1971;<span class="ref-vol">217</span>:1392.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/5109652" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Marihuana+smoking+and+intraocular+pressure&amp;author=RS+Hepler&amp;author=IR+Frank&amp;volume=217&amp;publication_year=1971&amp;pages=1392&amp;pmid=5109652&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. <span><span class="ref-journal">Arch Ophthalmol. </span>1998;<span class="ref-vol">116</span>:1433–7.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9823341" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Ophthalmol&amp;title=Marijuana+smoking+vs+cannabinoids+for+glaucoma+therapy&amp;author=K+Green&amp;volume=116&amp;publication_year=1998&amp;pages=1433-7&amp;pmid=9823341&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Nucci C, Bari M, Spanò A, Corasaniti M, Bagetta G, Maccarrone M, et al.  Potential roles of (endo) cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. <span><span class="ref-journal">Prog Brain Res. </span>2008;<span class="ref-vol">173</span>:451–64.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18929127" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Prog+Brain+Res&amp;title=Potential+roles+of+(endo)+cannabinoids+in+the+treatment+of+glaucoma:+from+intraocular+pressure+control+to+neuroprotection&amp;author=C+Nucci&amp;author=M+Bari&amp;author=A+Spanò&amp;author=M+Corasaniti&amp;author=G+Bagetta&amp;volume=173&amp;publication_year=2008&amp;pages=451-64&amp;pmid=18929127&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Flach AJ. Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma. <span><span class="ref-journal">Trans Am Ophthalmol Soc. </span>2002;<span class="ref-vol">100</span>:215–22.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1358964/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12545695" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Trans+Am+Ophthalmol+Soc&amp;title=Delta-9-tetrahydrocannabinol+(THC)+in+the+treatment+of+end-stage+open-angle+glaucoma&amp;author=AJ+Flach&amp;volume=100&amp;publication_year=2002&amp;pages=215-22&amp;pmid=12545695&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Jampel H. American glaucoma society position statement: marijuana and the treatment of glaucoma. <span><span class="ref-journal">J Glaucoma. </span>2010;<span class="ref-vol">19</span>:75–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20160576" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Glaucoma&amp;title=American+glaucoma+society+position+statement:+marijuana+and+the+treatment+of+glaucoma&amp;author=H+Jampel&amp;volume=19&amp;publication_year=2010&amp;pages=75-6&amp;pmid=20160576&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Buys YM, Rafuse PE. Canadian ophthalmological society policy statement on the medical use of marijuana for glaucoma. <span><span class="ref-journal">Can J Ophthalmol. </span>2010;<span class="ref-vol">45</span>:324–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20676153" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Can+J+Ophthalmol&amp;title=Canadian+ophthalmological+society+policy+statement+on+the+medical+use+of+marijuana+for+glaucoma&amp;author=YM+Buys&amp;author=PE+Rafuse&amp;volume=45&amp;publication_year=2010&amp;pages=324-6&amp;pmid=20676153&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. <span><span class="ref-journal">Br J Ophthalmol. </span>2004;<span class="ref-vol">88</span>:708–13.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772142/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15090428" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=Cannabinoids+and+glaucoma&amp;author=I+Tomida&amp;author=RG+Pertwee&amp;author=A+Azuara-Blanco&amp;volume=88&amp;publication_year=2004&amp;pages=708-13&amp;pmid=15090428&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, et al.  Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis. <span><span class="ref-journal">Clin Infect Dis. </span>2013;<span class="ref-vol">57</span>:663–70.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739469/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23811492" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Marijuana+smoking+does+not+accelerate+progression+of+liver+disease+in+HIV-hepatitis+C+coinfection:+a+longitudinal+cohort+analysis&amp;author=L+Brunet&amp;author=EE+Moodie&amp;author=K+Rollet&amp;author=C+Cooper&amp;author=S+Walmsley&amp;volume=57&amp;publication_year=2013&amp;pages=663-70&amp;pmid=23811492&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR58">58. <span class="element-citation">Hézode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani E-S, et al.  Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. <span><span class="ref-journal">Hepatology. </span>2005;<span class="ref-vol">42</span>:63–71.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15892090" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Daily+cannabis+smoking+as+a+risk+factor+for+progression+of+fibrosis+in+chronic+hepatitis+C&amp;author=C+Hézode&amp;author=F+Roudot-Thoraval&amp;author=S+Nguyen&amp;author=P+Grenard&amp;author=B+Julien&amp;volume=42&amp;publication_year=2005&amp;pages=63-71&amp;pmid=15892090&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR59">59. <span class="element-citation">Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier–Alias M, et al.  Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. <span><span class="ref-journal">Gastroenterology. </span>2008;<span class="ref-vol">134</span>:432–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18242211" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Daily+cannabis+use:+a+novel+risk+factor+of+steatosis+severity+in+patients+with+chronic+hepatitis+C&amp;author=C+Hézode&amp;author=ES+Zafrani&amp;author=F+Roudot-Thoraval&amp;author=C+Costentin&amp;author=A+Hessami&amp;volume=134&amp;publication_year=2008&amp;pages=432-9&amp;pmid=18242211&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR60">60. <span class="element-citation">Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, et al.  Influence of cannabis use on severity of hepatitis C disease. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2008;<span class="ref-vol">6</span>:69–75.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184401/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18166478" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Gastroenterol+Hepatol&amp;title=Influence+of+cannabis+use+on+severity+of+hepatitis+C+disease&amp;author=JH+Ishida&amp;author=MG+Peters&amp;author=C+Jin&amp;author=K+Louie&amp;author=V+Tan&amp;volume=6&amp;publication_year=2008&amp;pages=69-75&amp;pmid=18166478&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR61">61. <span class="element-citation">Costiniuk CT, Mills E, Cooper CL. Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus. <span><span class="ref-journal">Can J Gastroenterol. </span>2008;<span class="ref-vol">22</span>:376–80.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662895/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18414712" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Can+J+Gastroenterol&amp;title=Evaluation+of+oral+cannabinoid-containing+medications+for+the+management+of+interferon+and+ribavirin-induced+anorexia,+nausea+and+weight+loss+in+patients+treated+for+chronic+hepatitis+C+virus&amp;author=CT+Costiniuk&amp;author=E+Mills&amp;author=CL+Cooper&amp;volume=22&amp;publication_year=2008&amp;pages=376-80&amp;pmid=18414712&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR62">62. <span class="element-citation">Sylvestre DL, Clements BJ, Malibu Y. Cannabis use improves retention and virological outcomes in patients treated for hepatitis C. <span><span class="ref-journal">Eur J Gastroenterol Hepatol. </span>2006;<span class="ref-vol">18</span>:1057–63.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16957511" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Gastroenterol+Hepatol&amp;title=Cannabis+use+improves+retention+and+virological+outcomes+in+patients+treated+for+hepatitis+C&amp;author=DL+Sylvestre&amp;author=BJ+Clements&amp;author=Y+Malibu&amp;volume=18&amp;publication_year=2006&amp;pages=1057-63&amp;pmid=16957511&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR63">63. <span class="element-citation">Glue P. The clinical pharmacology of ribavirin. <span><span class="ref-journal">Semin Liver Dis. </span>1998;<span class="ref-vol">19S</span>:17–24.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10349689" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Semin+Liver+Dis&amp;title=The+clinical+pharmacology+of+ribavirin&amp;author=P+Glue&amp;volume=19S&amp;publication_year=1998&amp;pages=17-24&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR64">64. <span class="element-citation">Wasley A, Grytdal S, Gallagher K, Centers for Disease Control and Prevention (CDC)  Surveillance for acute viral hepatitis -- United States, 2006. <span><span class="ref-journal">MMWR Surveill Summ. </span>2008;<span class="ref-vol">57</span>:1–24.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18354374" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=MMWR+Surveill+Summ&amp;title=Surveillance+for+acute+viral+hepatitis+--+United+States,+2006&amp;author=A+Wasley&amp;author=S+Grytdal&amp;author=K+Gallagher&amp;volume=57&amp;publication_year=2008&amp;pages=1-24&amp;pmid=18354374&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR65">65. <span class="element-citation">Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. <span><span class="ref-journal">J Acquir Immune Defic Syndr. </span>2004;<span class="ref-vol">35</span>:38–45.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/14707790" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Acquir+Immune+Defic+Syndr&amp;title=Patterns+of+marijuana+use+among+patients+with+HIV/AIDS+followed+in+a+public+health+care+setting&amp;author=D+Prentiss&amp;author=R+Power&amp;author=G+Balmas&amp;author=G+Tzuang&amp;author=DM+Israelski&amp;volume=35&amp;publication_year=2004&amp;pages=38-45&amp;pmid=14707790&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR66">66. <span class="element-citation">Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2013;<span class="ref-vol">4</span>:CD005175.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23633327" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cochrane+Database+Syst+Rev&amp;title=The+medical+use+of+cannabis+for+reducing+morbidity+and+mortality+in+patients+with+HIV/AIDS&amp;author=EE+Lutge&amp;author=A+Gray&amp;author=N+Siegfried&amp;volume=4&amp;publication_year=2013&amp;pages=CD005175&amp;pmid=23633327&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR67">67. <span class="element-citation">Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI. Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. <span><span class="ref-journal">J Clin Pharmacol. </span>2002;<span class="ref-vol">42</span>:82S–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412840" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;title=Short-term+effects+of+cannabinoids+on+immune+phenotype+and+function+in+HIV-1-infected+patients&amp;author=BM+Bredt&amp;author=D+Higuera-Alhino&amp;author=SB+Shade&amp;author=SJ+Hebert&amp;author=JM+McCune&amp;volume=42&amp;publication_year=2002&amp;pages=82S-9&amp;pmid=12412840&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR68">68. <span class="element-citation">Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, et al.  The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. <span><span class="ref-journal">AIDS. </span>2002;<span class="ref-vol">16</span>:543–50.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11872997" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=The+effects+of+cannabinoids+on+the+pharmacokinetics+of+indinavir+and+nelfinavir&amp;author=BW+Kosel&amp;author=FT+Aweeka&amp;author=NL+Benowitz&amp;author=SB+Shade&amp;author=JF+Hilton&amp;volume=16&amp;publication_year=2002&amp;pages=543-50&amp;pmid=11872997&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR69">69. <span class="element-citation">Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. <span><span class="ref-journal">J Behav Med. </span>2014;<span class="ref-vol">37</span>:1–10.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23054178" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Behav+Med&amp;title=Cannabis+use+and+HIV+antiretroviral+therapy+adherence+and+HIV-related+symptoms&amp;author=MO+Bonn-Miller&amp;author=ML+Oser&amp;author=MM+Bucossi&amp;author=JA+Trafton&amp;volume=37&amp;publication_year=2014&amp;pages=1-10&amp;pmid=23054178&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR70">70. <span class="element-citation">Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. <span><span class="ref-journal">Psychopharmacology (Berl) </span>2005;<span class="ref-vol">181</span>:170–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15778874" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology+(Berl)&amp;title=Dronabinol+and+marijuana+in+HIV(+)+marijuana+smokers:+acute+effects+on+caloric+intake+and+mood&amp;author=M+Haney&amp;author=J+Rabkin&amp;author=E+Gunderson&amp;author=RW+Foltin&amp;volume=181&amp;publication_year=2005&amp;pages=170-8&amp;pmid=15778874&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR71">71. <span class="element-citation">Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al.  Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">68</span>:515–21.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17296917" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Cannabis+in+painful+HIV-associated+sensory+neuropathy:+a+randomized+placebo-controlled+trial&amp;author=DI+Abrams&amp;author=CA+Jay&amp;author=SB+Shade&amp;author=H+Vizoso&amp;author=H+Reda&amp;volume=68&amp;publication_year=2007&amp;pages=515-21&amp;pmid=17296917&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR72">72. <span class="element-citation">Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, et al.  Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. <span><span class="ref-journal">Neuropsychopharmacology. </span>2009;<span class="ref-vol">34</span>:672–80.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066045/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18688212" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Smoked+medicinal+cannabis+for+neuropathic+pain+in+HIV:+a+randomized,+crossover+clinical+trial&amp;author=RJ+Ellis&amp;author=W+Toperoff&amp;author=F+Vaida&amp;author=G+van+den+Brande&amp;author=J+Gonzales&amp;volume=34&amp;publication_year=2009&amp;pages=672-80&amp;pmid=18688212&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR73">73. <span class="element-citation">Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, et al.  Effect of dronabinol on nutritional status in HIV infection. <span><span class="ref-journal">Ann Pharmacother. </span>1993;<span class="ref-vol">27</span>:827–31.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8395916" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Pharmacother&amp;title=Effect+of+dronabinol+on+nutritional+status+in+HIV+infection&amp;author=M+Struwe&amp;author=SH+Kaempfer&amp;author=CJ+Geiger&amp;author=AT+Pavia&amp;author=TF+Plasse&amp;volume=27&amp;publication_year=1993&amp;pages=827-31&amp;pmid=8395916&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR74">74. <span class="mixed-citation">Centers for Disease Control and Prevention (CDC). HIV and substance use in the United States<em>.</em> Retrieved April 9, 2015, from [<a data-ga-action="click_feat_suppl" href="http://www.cdc.gov/hiv/risk/behavior/substanceuse.html" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/hiv/risk/behavior/substanceuse.html</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR75">75. <span class="element-citation">Pandyan AD, Gregoric M, Barnes MP, Wood D, van Wijck F, Burridge J, et al.  Spasticity: clinical perceptions, neurological realities and meaningful measurement. <span><span class="ref-journal">Disabil Rehabil. </span>2005;<span class="ref-vol">27</span>:2–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15799140" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Disabil+Rehabil&amp;title=Spasticity:+clinical+perceptions,+neurological+realities+and+meaningful+measurement&amp;author=AD+Pandyan&amp;author=M+Gregoric&amp;author=MP+Barnes&amp;author=D+Wood&amp;author=F+van+Wijck&amp;volume=27&amp;publication_year=2005&amp;pages=2-6&amp;pmid=15799140&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR76">76. <span class="element-citation">Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. <span><span class="ref-journal">Health Technol Assess. </span>2003;<span class="ref-vol">7</span>(40):1–111.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/14636486" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Health+Technol+Assess&amp;title=Treatments+for+spasticity+and+pain+in+multiple+sclerosis:+a+systematic+review&amp;author=S+Beard&amp;author=A+Hunn&amp;author=J+Wight&amp;volume=7&amp;issue=40&amp;publication_year=2003&amp;pages=1-111&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR77">77. <span class="element-citation">Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, et al.  A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols*(Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. <span><span class="ref-journal">Eur J Neurol. </span>2011;<span class="ref-vol">18</span>:1122–31.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21362108" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurol&amp;title=A+randomized,+double-blind,+placebo-controlled,+parallel-group,+enriched-design+study+of+nabiximols*(Sativex®),+as+add-on+therapy,+in+subjects+with+refractory+spasticity+caused+by+multiple+sclerosis&amp;author=A+Novotna&amp;author=J+Mares&amp;author=S+Ratcliffe&amp;author=I+Novakova&amp;author=M+Vachova&amp;volume=18&amp;publication_year=2011&amp;pages=1122-31&amp;pmid=21362108&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR78">78. <span class="element-citation">Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. <span><span class="ref-journal">Mult Scler. </span>2004;<span class="ref-vol">10</span>:434–41.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15327042" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;title=Do+cannabis-based+medicinal+extracts+have+general+or+specific+effects+on+symptoms+in+multiple+sclerosis?+A+double-blind,+randomized,+placebo-controlled+study+on+160+patients&amp;author=DT+Wade&amp;author=P+Makela&amp;author=P+Robson&amp;author=H+House&amp;author=C+Bateman&amp;volume=10&amp;publication_year=2004&amp;pages=434-41&amp;pmid=15327042&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR79">79. <span class="element-citation">Collin C, Davies P, Mutiboko IK, Ratcliffe S. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. <span><span class="ref-journal">Eur J Neurol. </span>2007;<span class="ref-vol">14</span>:290–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17355549" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurol&amp;title=Randomized+controlled+trial+of+cannabis-based+medicine+in+spasticity+caused+by+multiple+sclerosis&amp;author=C+Collin&amp;author=P+Davies&amp;author=IK+Mutiboko&amp;author=S+Ratcliffe&amp;volume=14&amp;publication_year=2007&amp;pages=290-6&amp;pmid=17355549&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR80">80. <span class="element-citation">Wade DT, Collin C, Stott C, Duncombe P. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. <span><span class="ref-journal">Mult Scler. </span>2010;<span class="ref-vol">16</span>:707–14.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20558502" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;title=Meta-analysis+of+the+efficacy+and+safety+of+Sativex+(nabiximols),+on+spasticity+in+people+with+multiple+sclerosis&amp;author=DT+Wade&amp;author=C+Collin&amp;author=C+Stott&amp;author=P+Duncombe&amp;volume=16&amp;publication_year=2010&amp;pages=707-14&amp;pmid=20558502&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR81">81. <span class="element-citation">Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. <span><span class="ref-journal">Clin Rehabil. </span>2003;<span class="ref-vol">17</span>:21–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12617376" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Rehabil&amp;title=A+preliminary+controlled+study+to+determine+whether+whole-plant+cannabis+extracts+can+improve+intractable+neurogenic+symptoms&amp;author=DT+Wade&amp;author=P+Robson&amp;author=H+House&amp;author=P+Makela&amp;author=J+Aram&amp;volume=17&amp;publication_year=2003&amp;pages=21-9&amp;pmid=12617376&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR82">82. <span class="element-citation">Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, et al.  Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2005;<span class="ref-vol">76</span>:1664–9.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739436/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16291891" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&amp;title=Cannabinoids+in+multiple+sclerosis+(CAMS)+study:+safety+and+efficacy+data+for+12 months+follow+up&amp;author=JP+Zajicek&amp;author=HP+Sanders&amp;author=DE+Wright&amp;author=PJ+Vickery&amp;author=WM+Ingram&amp;volume=76&amp;publication_year=2005&amp;pages=1664-9&amp;pmid=16291891&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR83">83. <span class="element-citation">Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, et al.  Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>:1517–26.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/14615106" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Cannabinoids+for+treatment+of+spasticity+and+other+symptoms+related+to+multiple+sclerosis+(CAMS+study):+multicentre+randomised+placebo-controlled+trial&amp;author=J+Zajicek&amp;author=P+Fox&amp;author=H+Sanders&amp;author=D+Wright&amp;author=J+Vickery&amp;volume=362&amp;publication_year=2003&amp;pages=1517-26&amp;pmid=14615106&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR84">84. <span class="element-citation">Pooyania S, Ethans K, Szturm T, Casey A, Perry D. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. <span><span class="ref-journal">Arch Phys Med Rehabil. </span>2010;<span class="ref-vol">91</span>:703–7.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20434606" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Phys+Med+Rehabil&amp;title=A+randomized,+double-blinded,+crossover+pilot+study+assessing+the+effect+of+nabilone+on+spasticity+in+persons+with+spinal+cord+injury&amp;author=S+Pooyania&amp;author=K+Ethans&amp;author=T+Szturm&amp;author=A+Casey&amp;author=D+Perry&amp;volume=91&amp;publication_year=2010&amp;pages=703-7&amp;pmid=20434606&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR85">85. <span class="element-citation">Wade DT, Makela PM, House H, Bateman C, Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. <span><span class="ref-journal">Mult Scler. </span>2006;<span class="ref-vol">12</span>:639–45.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17086911" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;title=Long-term+use+of+a+cannabis-based+medicine+in+the+treatment+of+spasticity+and+other+symptoms+in+multiple+sclerosis&amp;author=DT+Wade&amp;author=PM+Makela&amp;author=H+House&amp;author=C+Bateman&amp;author=P+Robson&amp;volume=12&amp;publication_year=2006&amp;pages=639-45&amp;pmid=17086911&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR86">86. <span class="element-citation">Serpell MG, Notcutt W, Collin C. Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. <span><span class="ref-journal">J Neurol. </span>2013;<span class="ref-vol">260</span>:285–95.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22878432" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Neurol&amp;title=Sativex+long-term+use:+an+open-label+trial+in+patients+with+spasticity+due+to+multiple+sclerosis&amp;author=MG+Serpell&amp;author=W+Notcutt&amp;author=C+Collin&amp;volume=260&amp;publication_year=2013&amp;pages=285-95&amp;pmid=22878432&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR87">87. <span class="element-citation">Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R. A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex®(nabiximols) <span><span class="ref-journal">Mult Scler. </span>2012;<span class="ref-vol">18</span>:219–28.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21878454" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;title=A+placebo-controlled,+parallel-group,+randomized+withdrawal+study+of+subjects+with+symptoms+of+spasticity+due+to+multiple+sclerosis+who+are+receiving+long-term+Sativex®(nabiximols)&amp;author=W+Notcutt&amp;author=R+Langford&amp;author=P+Davies&amp;author=S+Ratcliffe&amp;author=R+Potts&amp;volume=18&amp;publication_year=2012&amp;pages=219-28&amp;pmid=21878454&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR88">88. <span class="element-citation">Flachenecker P, Henze T, Zettl UK. Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice—results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. <span><span class="ref-journal">Eur Neurol. </span>2014;<span class="ref-vol">71</span>:271–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24525548" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+Neurol&amp;title=Nabiximols+(THC/CBD+oromucosal+spray,+Sativex®)+in+clinical+practice—results+of+a+multicenter,+non-interventional+study+(MOVE+2)+in+patients+with+multiple+sclerosis+spasticity&amp;author=P+Flachenecker&amp;author=T+Henze&amp;author=UK+Zettl&amp;volume=71&amp;publication_year=2014&amp;pages=271-9&amp;pmid=24525548&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR89">89. <span class="element-citation">Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">65</span>:812–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16186518" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Randomized,+controlled+trial+of+cannabis-based+medicine+in+central+pain+in+multiple+sclerosis&amp;author=DJ+Rog&amp;author=TJ+Nurmikko&amp;author=T+Friede&amp;author=CA+Young&amp;volume=65&amp;publication_year=2005&amp;pages=812-9&amp;pmid=16186518&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR90">90. <span class="element-citation">Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, et al.  Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. <span><span class="ref-journal">CMAJ. </span>2012;<span class="ref-vol">184</span>:1143–50.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394820/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22586334" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=CMAJ&amp;title=Smoked+cannabis+for+spasticity+in+multiple+sclerosis:+a+randomized,+placebo-controlled+trial&amp;author=J+Corey-Bloom&amp;author=T+Wolfson&amp;author=A+Gamst&amp;author=S+Jin&amp;author=TD+Marcotte&amp;volume=184&amp;publication_year=2012&amp;pages=1143-50&amp;pmid=22586334&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR91">91. <span class="element-citation">Greenberg HS, Werness SA, Pugh JE, Andrus RO, Anderson DJ, Domino EF. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. <span><span class="ref-journal">Clin Pharmacol Ther. </span>1994;<span class="ref-vol">55</span>:324–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8143398" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Short-term+effects+of+smoking+marijuana+on+balance+in+patients+with+multiple+sclerosis+and+normal+volunteers&amp;author=HS+Greenberg&amp;author=SA+Werness&amp;author=JE+Pugh&amp;author=RO+Andrus&amp;author=DJ+Anderson&amp;volume=55&amp;publication_year=1994&amp;pages=324-8&amp;pmid=8143398&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR92">92. <span class="element-citation">Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:2098–100.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15184623" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Patterns+of+cannabis+use+among+patients+with+multiple+sclerosis&amp;author=AJ+Clark&amp;author=MA+Ware&amp;author=E+Yazer&amp;author=TJ+Murray&amp;author=ME+Lynch&amp;volume=62&amp;publication_year=2004&amp;pages=2098-100&amp;pmid=15184623&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR93">93. <span class="element-citation">Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. <span><span class="ref-journal">Can J Neurol Sci. </span>2003;<span class="ref-vol">30</span>:201–5.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12945941" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Can+J+Neurol+Sci&amp;title=Cannabis+use+as+described+by+people+with+multiple+sclerosis&amp;author=SA+Page&amp;author=MJ+Verhoef&amp;author=RA+Stebbins&amp;author=LM+Metz&amp;author=JC+Levy&amp;volume=30&amp;publication_year=2003&amp;pages=201-5&amp;pmid=12945941&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR94">94. <span class="element-citation">Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A. Effects of cannabis on cognition in patients with MS: a psychometric and MRI study. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:1879–87.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105254/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24789863" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Effects+of+cannabis+on+cognition+in+patients+with+MS:+a+psychometric+and+MRI+study&amp;author=B+Pavisian&amp;author=BJ+MacIntosh&amp;author=G+Szilagyi&amp;author=RW+Staines&amp;author=P+O'Connor&amp;volume=82&amp;publication_year=2014&amp;pages=1879-87&amp;pmid=24789863&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR95">95. <span class="element-citation">Honarmand K, Tierney MC, O'Connor P, Feinstein A. Effects of cannabis on cognitive function in patients with multiple sclerosis. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:1153–60.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068013/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21444900" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Effects+of+cannabis+on+cognitive+function+in+patients+with+multiple+sclerosis&amp;author=K+Honarmand&amp;author=MC+Tierney&amp;author=P+O'Connor&amp;author=A+Feinstein&amp;volume=76&amp;publication_year=2011&amp;pages=1153-60&amp;pmid=21444900&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR96">96. <span class="element-citation">Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. <span><span class="ref-journal">Neurology. </span>1991;<span class="ref-vol">41</span>:685–91.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/2027484" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Cognitive+dysfunction+in+multiple+sclerosis.+I.+Frequency,+patterns,+and+prediction&amp;author=SM+Rao&amp;author=GJ+Leo&amp;author=L+Bernardin&amp;author=F+Unverzagt&amp;volume=41&amp;publication_year=1991&amp;pages=685-91&amp;pmid=2027484&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR97">97. <span class="element-citation">Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC. Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. <span><span class="ref-journal">Ther Adv Neurol Disord. </span>2012;<span class="ref-vol">5</span>:255–66.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22973422" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ther+Adv+Neurol+Disord&amp;title=Symptomatic+therapy+in+multiple+sclerosis:+the+role+of+cannabinoids+in+treating+spasticity&amp;author=VI+Leussink&amp;author=L+Husseini&amp;author=C+Warnke&amp;author=E+Broussalis&amp;author=HP+Hartung&amp;volume=5&amp;publication_year=2012&amp;pages=255-66&amp;pmid=22973422&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR98">98. <span class="mixed-citation">American Academy of Neurology. Position statement<em>:</em> Use of medical marijuana for neurologic disorders. Retrieved April 9, 2015, from [<a data-ga-action="click_feat_suppl" href="https://www.aan.com/uploadedFiles/Website_Library_Assets/Documents/6.Public_Policy/1.Stay_Informed/2.Position_Statements/3.PDFs_of_all_Position_Statements/Final%20Medical%20Marijuana%20Position%20Statement.pdf" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.aan.com/uploadedFiles/Website_Library_Assets/Documents/6.Public_Policy/1.Stay_Informed/2.Position_Statements/3.PDFs_of_all_Position_Statements/Final%20Medical%20Marijuana%20Position%20Statement.pdf</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR99">99. <span class="element-citation">Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. <span><span class="ref-journal">J Trauma Stress. </span>2007;<span class="ref-vol">20</span>:577–86.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17721963" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Trauma+Stress&amp;title=Posttraumatic+stress+symptom+severity+predicts+marijuana+use+coping+motives+among+traumatic+event-exposed+marijuana+users&amp;author=MO+Bonn-Miller&amp;author=AA+Vujanovic&amp;author=MT+Feldner&amp;author=A+Bernstein&amp;author=MJ+Zvolensky&amp;volume=20&amp;publication_year=2007&amp;pages=577-86&amp;pmid=17721963&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR100">100. <span class="element-citation">Bremner JD, Southwick SM, Darnell A, Charney DS. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. <span><span class="ref-journal">Amer J Psychiatry. </span>1996;<span class="ref-vol">153</span>:369–75.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8610824" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Amer+J+Psychiatry&amp;title=Chronic+PTSD+in+Vietnam+combat+veterans:+course+of+illness+and+substance+abuse&amp;author=JD+Bremner&amp;author=SM+Southwick&amp;author=A+Darnell&amp;author=DS+Charney&amp;volume=153&amp;publication_year=1996&amp;pages=369-75&amp;pmid=8610824&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR101">101. <span class="element-citation">Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO. Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders. <span><span class="ref-journal">Int Rev Psychiatry. </span>2014;<span class="ref-vol">26</span>:237–47.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052373/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24892898" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Int+Rev+Psychiatry&amp;title=Interactions+between+disordered+sleep,+post-traumatic+stress+disorder,+and+substance+use+disorders&amp;author=R+Vandrey&amp;author=KA+Babson&amp;author=ES+Herrmann&amp;author=MO+Bonn-Miller&amp;volume=26&amp;publication_year=2014&amp;pages=237-47&amp;pmid=24892898&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR102">102. <span class="element-citation">Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, et al.  Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. <span><span class="ref-journal">Mol Psychiatry. </span>2013;<span class="ref-vol">18</span>:1034–40.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23670490" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mol+Psychiatry&amp;title=Elevated+brain+cannabinoid+CB1+receptor+availability+in+post-traumatic+stress+disorder:+a+positron+emission+tomography+study&amp;author=A+Neumeister&amp;author=MD+Normandin&amp;author=RH+Pietrzak&amp;author=D+Piomelli&amp;author=MQ+Zheng&amp;volume=18&amp;publication_year=2013&amp;pages=1034-40&amp;pmid=23670490&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR103">103. <span class="element-citation">Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH. Mitigation of post-traumatic stress symptoms by cannabis resin: a review of the clinical and neurobiological evidence. <span><span class="ref-journal">Drug Test Anal. </span>2012;<span class="ref-vol">4</span>:649–59.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22736575" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Drug+Test+Anal&amp;title=Mitigation+of+post-traumatic+stress+symptoms+by+cannabis+resin:+a+review+of+the+clinical+and+neurobiological+evidence&amp;author=T+Passie&amp;author=HM+Emrich&amp;author=M+Karst&amp;author=SD+Brandt&amp;author=JH+Halpern&amp;volume=4&amp;publication_year=2012&amp;pages=649-59&amp;pmid=22736575&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR104">104. <span class="element-citation">Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral Δ-tetrahydrocannabinol in chronic post-traumatic stress disorder. <span><span class="ref-journal">Clin Drug Investig. </span>2014;<span class="ref-vol">34</span>:587–91.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24935052" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Drug+Investig&amp;title=Preliminary,+open-label,+pilot+study+of+add-on+oral+Δ-tetrahydrocannabinol+in+chronic+post-traumatic+stress+disorder&amp;author=P+Roitman&amp;author=R+Mechoulam&amp;author=R+Cooper-Kazaz&amp;author=A+Shalev&amp;volume=34&amp;publication_year=2014&amp;pages=587-91&amp;pmid=24935052&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR105">105. <span class="element-citation">Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD) <span><span class="ref-journal">CNS Neurosci Ther. </span>2009;<span class="ref-vol">15</span>:84–8.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494011/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19228182" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=CNS+Neurosci+Ther&amp;title=The+use+of+a+synthetic+cannabinoid+in+the+management+of+treatment-resistant+nightmares+in+posttraumatic+stress+disorder+(PTSD)&amp;author=GA+Fraser&amp;volume=15&amp;publication_year=2009&amp;pages=84-8&amp;pmid=19228182&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR106">106. <span class="element-citation">Jetly R, Heber A, Fraser G, Boisvert D. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study. <span><span class="ref-journal">Psychoneuroendocrinology. </span>2015;<span class="ref-vol">51</span>:585–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/25467221" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychoneuroendocrinology&amp;title=The+efficacy+of+nabilone,+a+synthetic+cannabinoid,+in+the+treatment+of+PTSD-associated+nightmares:+a+preliminary+randomized,+double-blind,+placebo-controlled+cross-over+design+study&amp;author=R+Jetly&amp;author=A+Heber&amp;author=G+Fraser&amp;author=D+Boisvert&amp;volume=51&amp;publication_year=2015&amp;pages=585-8&amp;pmid=25467221&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR107">107. <span class="mixed-citation">Mashiah M. Medical cannabis as treatment for chronic combat PTSD: Promising results in an open pilot study [presentation]. Patients Out of Time Conference; Tuscon, Arizona; 2012.</span></div><div class="ref-cit-blk half_rhythm" id="CR108">108. <span class="element-citation">Cougle JR, Bonn-Miller MO, Vujanovic AA, Zvolensky MJ, Hawkins KA. Posttraumatic stress disorder and cannabis use in a nationally representative sample. <span><span class="ref-journal">Psychol Addict Behav. </span>2011;<span class="ref-vol">25</span>:554–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21480682" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychol+Addict+Behav&amp;title=Posttraumatic+stress+disorder+and+cannabis+use+in+a+nationally+representative+sample&amp;author=JR+Cougle&amp;author=MO+Bonn-Miller&amp;author=AA+Vujanovic&amp;author=MJ+Zvolensky&amp;author=KA+Hawkins&amp;volume=25&amp;publication_year=2011&amp;pages=554-8&amp;pmid=21480682&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR109">109. <span class="element-citation">Boden MT, Babson KA, Vujanovic AA, Short NA, Bonn-Miller MO. Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. <span><span class="ref-journal">Am J Addict. </span>2013;<span class="ref-vol">22</span>:277–84.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23617872" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Addict&amp;title=Posttraumatic+stress+disorder+and+cannabis+use+characteristics+among+military+veterans+with+cannabis+dependence&amp;author=MT+Boden&amp;author=KA+Babson&amp;author=AA+Vujanovic&amp;author=NA+Short&amp;author=MO+Bonn-Miller&amp;volume=22&amp;publication_year=2013&amp;pages=277-84&amp;pmid=23617872&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR110">110. <span class="element-citation">Babson KA, Boden MT, Harris AH, Stickle TR, Bonn-Miller MO. Poor sleep quality as a risk factor for lapse following a cannabis quit attempt. <span><span class="ref-journal">J Subst Abuse Treat. </span>2013;<span class="ref-vol">44</span>:438–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23098380" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Subst+Abuse+Treat&amp;title=Poor+sleep+quality+as+a+risk+factor+for+lapse+following+a+cannabis+quit+attempt&amp;author=KA+Babson&amp;author=MT+Boden&amp;author=AH+Harris&amp;author=TR+Stickle&amp;author=MO+Bonn-Miller&amp;volume=44&amp;publication_year=2013&amp;pages=438-43&amp;pmid=23098380&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR111">111. <span class="element-citation">Babson KA, Boden MT, Bonn-Miller MO. The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt. <span><span class="ref-journal">Addict Behav. </span>2013;<span class="ref-vol">38</span>:2707–13.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23906725" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Addict+Behav&amp;title=The+impact+of+perceived+sleep+quality+and+sleep+efficiency/duration+on+cannabis+use+during+a+self-guided+quit+attempt&amp;author=KA+Babson&amp;author=MT+Boden&amp;author=MO+Bonn-Miller&amp;volume=38&amp;publication_year=2013&amp;pages=2707-13&amp;pmid=23906725&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR112">112. <span class="element-citation">Bonn-Miller MO, Boden MT, Vujanovic AA, Drescher KD. Prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment. <span><span class="ref-journal">Psychological Trauma: Theory, Research, Practice, and Policy. </span>2013;<span class="ref-vol">5</span>:193–200.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychological+Trauma:+Theory,+Research,+Practice,+and+Policy&amp;title=Prospective+investigation+of+the+impact+of+cannabis+use+disorders+on+posttraumatic+stress+disorder+symptoms+among+veterans+in+residential+treatment&amp;author=MO+Bonn-Miller&amp;author=MT+Boden&amp;author=AA+Vujanovic&amp;author=KD+Drescher&amp;volume=5&amp;publication_year=2013&amp;pages=193-200&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR113">113. <span class="element-citation">Martín-Sánchez E, Furukawa TA, Taylor J, Martin JL. Systematic review and meta-analysis of cannabis treatment for chronic pain. <span><span class="ref-journal">Pain Med. </span>2009;<span class="ref-vol">10</span>:1353–68.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19732371" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pain+Med&amp;title=Systematic+review+and+meta-analysis+of+cannabis+treatment+for+chronic+pain&amp;author=E+Martín-Sánchez&amp;author=TA+Furukawa&amp;author=J+Taylor&amp;author=JL+Martin&amp;volume=10&amp;publication_year=2009&amp;pages=1353-68&amp;pmid=19732371&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR114">114. <span class="element-citation">Phillips TJC, Cherry CL, Cox S, Marshall SJ, Rice ASC. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>:e14433.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21203440" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Pharmacological+treatment+of+painful+HIV-associated+sensory+neuropathy:+a+systematic+review+and+meta-analysis+of+randomised+controlled+trials&amp;author=TJC+Phillips&amp;author=CL+Cherry&amp;author=S+Cox&amp;author=SJ+Marshall&amp;author=ASC+Rice&amp;volume=5&amp;publication_year=2010&amp;pages=e14433&amp;pmid=21203440&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR115">115. <span class="element-citation">Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, et al.  Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. <span><span class="ref-journal">CMAJ. </span>2010;<span class="ref-vol">182</span>:E694–701.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20805210" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=CMAJ&amp;title=Smoked+cannabis+for+chronic+neuropathic+pain:+a+randomized+controlled+trial&amp;author=MA+Ware&amp;author=T+Wang&amp;author=S+Shapiro&amp;author=A+Robinson&amp;author=T+Ducruet&amp;volume=182&amp;publication_year=2010&amp;pages=E694-701&amp;pmid=20805210&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR116">116. <span class="element-citation">Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, et al.  Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. <span><span class="ref-journal">Anesthesiology. </span>2007;<span class="ref-vol">107</span>:785–96.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18073554" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;title=Dose-dependent+effects+of+smoked+cannabis+on+capsaicin-induced+pain+and+hyperalgesia+in+healthy+volunteers&amp;author=M+Wallace&amp;author=G+Schulteis&amp;author=JH+Atkinson&amp;author=T+Wolfson&amp;author=D+Lazzaretto&amp;volume=107&amp;publication_year=2007&amp;pages=785-96&amp;pmid=18073554&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR117">117. <span class="element-citation">Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. <span><span class="ref-journal">J Pain. </span>2013;<span class="ref-vol">14</span>:136–48.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23237736" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pain&amp;title=Low-dose+vaporized+cannabis+significantly+improves+neuropathic+pain&amp;author=B+Wilsey&amp;author=T+Marcotte&amp;author=R+Deutsch&amp;author=B+Gouaux&amp;author=S+Sakai&amp;volume=14&amp;publication_year=2013&amp;pages=136-48&amp;pmid=23237736&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR118">118. <span class="element-citation">Sallan SE, Zinberg NE, Frei E., 3rd Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. <span><span class="ref-journal">N Engl J Med. </span>1975;<span class="ref-vol">293</span>:795–7.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/1099449" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Antiemetic+effect+of+delta-9-tetrahydrocannabinol+in+patients+receiving+cancer+chemotherapy&amp;author=SE+Sallan&amp;author=NE+Zinberg&amp;author=E+Frei&amp;volume=293&amp;publication_year=1975&amp;pages=795-7&amp;pmid=1099449&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR119">119. <span class="element-citation">Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky I, et al.  Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate: a prospective, randomized evaluation. <span><span class="ref-journal">Ann Intern Med. </span>1979;<span class="ref-vol">91</span>:819–24.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/293141" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Delta-9-tetrahydrocannabinol+as+an+antiemetic+in+cancer+patients+receiving+high-dose+methotrexate:+a+prospective,+randomized+evaluation&amp;author=AE+Chang&amp;author=DJ+Shiling&amp;author=RC+Stillman&amp;author=NH+Goldberg&amp;author=CA+Seipp&amp;volume=91&amp;publication_year=1979&amp;pages=819-24&amp;pmid=293141&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR120">120. <span class="element-citation">Orr LE, McKernan JF, Bloome B. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. <span><span class="ref-journal">Arch Intern Med. </span>1980;<span class="ref-vol">140</span>:1431–3.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/6254456" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Antiemetic+effect+of+tetrahydrocannabinol.+Compared+with+placebo+and+prochlorperazine+in+chemotherapy-associated+nausea+and+emesis&amp;author=LE+Orr&amp;author=JF+McKernan&amp;author=B+Bloome&amp;volume=140&amp;publication_year=1980&amp;pages=1431-3&amp;pmid=6254456&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR121">121. <span class="element-citation">Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. <span><span class="ref-journal">J Ethnopharmacol. </span>2006;<span class="ref-vol">105</span>:1–25.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16540272" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Ethnopharmacol&amp;title=Cannabinoids+in+medicine:+a+review+of+their+therapeutic+potential&amp;author=M+Ben+Amar&amp;volume=105&amp;publication_year=2006&amp;pages=1-25&amp;pmid=16540272&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR122">122. <span class="element-citation">Machado Rocha FC, Stefano SC, De Cassia HR, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. <span><span class="ref-journal">Eur J Cancer Care (Engl) </span>2008;<span class="ref-vol">17</span>:431–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18625004" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer+Care+(Engl)&amp;title=Therapeutic+use+of+Cannabis+sativa+on+chemotherapy-induced+nausea+and+vomiting+among+cancer+patients:+systematic+review+and+meta-analysis&amp;author=FC+Machado+Rocha&amp;author=SC+Stefano&amp;author=HR+De+Cassia&amp;author=LM+Rosa+Oliveira&amp;author=DX+Da+Silveira&amp;volume=17&amp;publication_year=2008&amp;pages=431-43&amp;pmid=18625004&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR123">123. <span class="element-citation">Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. <span><span class="ref-journal">BMJ. </span>2001;<span class="ref-vol">323</span>:16–21.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34325/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11440936" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Cannabinoids+for+control+of+chemotherapy+induced+nausea+and+vomiting:+quantitative+systematic+review&amp;author=MR+Tramèr&amp;author=D+Carroll&amp;author=FA+Campbell&amp;author=DJ+Reynolds&amp;author=RA+Moore&amp;volume=323&amp;publication_year=2001&amp;pages=16-21&amp;pmid=11440936&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR124">124. <span class="element-citation">Frytak S, Moertel CG, O'Fallon JR, Rubin J, Creagan ET, O'Connell MJ, et al.  Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. <span><span class="ref-journal">Ann Intern Med. </span>1979;<span class="ref-vol">91</span>:825–30.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/517882" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Delta-9-tetrahydrocannabinol+as+an+antiemetic+for+patients+receiving+cancer+chemotherapy.+A+comparison+with+prochlorperazine+and+a+placebo&amp;author=S+Frytak&amp;author=CG+Moertel&amp;author=JR+O'Fallon&amp;author=J+Rubin&amp;author=ET+Creagan&amp;volume=91&amp;publication_year=1979&amp;pages=825-30&amp;pmid=517882&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR125">125. <span class="element-citation">Ungerleider JT, Andrysiak T, Fairbanks L, Goodnight J, Sarna G, Jamison K. Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. <span><span class="ref-journal">Cancer. </span>1982;<span class="ref-vol">50</span>:636–45.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/6284334" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Cannabis+and+cancer+chemotherapy:+a+comparison+of+oral+delta-9-THC+and+prochlorperazine&amp;author=JT+Ungerleider&amp;author=T+Andrysiak&amp;author=L+Fairbanks&amp;author=J+Goodnight&amp;author=G+Sarna&amp;volume=50&amp;publication_year=1982&amp;pages=636-45&amp;pmid=6284334&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR126">126. <span class="element-citation">Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, et al.  Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. <span><span class="ref-journal">Curr Med Res Opin. </span>2007;<span class="ref-vol">23</span>:533–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17355735" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Res+Opin&amp;title=Efficacy+of+dronabinol+alone+and+in+combination+with+ondansetron+versus+ondansetron+alone+for+delayed+chemotherapy-induced+nausea+and+vomiting&amp;author=E+Meiri&amp;author=H+Jhangiani&amp;author=JJ+Vredenburgh&amp;author=LM+Barbato&amp;author=FJ+Carter&amp;volume=23&amp;publication_year=2007&amp;pages=533-43&amp;pmid=17355735&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR127">127. <span class="element-citation">Lane M, Vogel CL, Ferguson J, Krasnow S, Saiers JL, Hamm J, et al.  Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. <span><span class="ref-journal">J Pain Symptom Manage. </span>1991;<span class="ref-vol">6</span>:352–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/1652611" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pain+Symptom+Manage&amp;title=Dronabinol+and+prochlorperazine+in+combination+for+treatment+of+cancer+chemotherapy-induced+nausea+and+vomiting&amp;author=M+Lane&amp;author=CL+Vogel&amp;author=J+Ferguson&amp;author=S+Krasnow&amp;author=JL+Saiers&amp;volume=6&amp;publication_year=1991&amp;pages=352-9&amp;pmid=1652611&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR128">128. <span class="element-citation">Sun S, Zimmermann AE. Cannabinoid hyperemesis syndrome. <span><span class="ref-journal">Hosp Pharm. </span>2013;<span class="ref-vol">48</span>:650–5.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847982/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24421535" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Hosp+Pharm&amp;title=Cannabinoid+hyperemesis+syndrome&amp;author=S+Sun&amp;author=AE+Zimmermann&amp;volume=48&amp;publication_year=2013&amp;pages=650-5&amp;pmid=24421535&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR129">129. <span class="element-citation">Hejazi RA, McCallum RW. Review article: cyclic vomiting syndrome in adults–rediscovering and redefining an old entity. <span><span class="ref-journal">Aliment Pharmacol Ther. </span>2011;<span class="ref-vol">34</span>:263–73.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21668458" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Aliment+Pharmacol+Ther&amp;title=Review+article:+cyclic+vomiting+syndrome+in+adults–rediscovering+and+redefining+an+old+entity&amp;author=RA+Hejazi&amp;author=RW+McCallum&amp;volume=34&amp;publication_year=2011&amp;pages=263-73&amp;pmid=21668458&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR130">130. <span class="element-citation">Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, et al.  Antiemetics: American society of clinical oncology clinical practice guideline update. <span><span class="ref-journal">J Clin Oncol. </span>2011;<span class="ref-vol">29</span>:4189–98.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876353/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21947834" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Antiemetics:+American+society+of+clinical+oncology+clinical+practice+guideline+update&amp;author=E+Basch&amp;author=AA+Prestrud&amp;author=PJ+Hesketh&amp;author=MG+Kris&amp;author=PC+Feyer&amp;volume=29&amp;publication_year=2011&amp;pages=4189-98&amp;pmid=21947834&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR131">131. <span class="element-citation">Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, et al.  Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. <span><span class="ref-journal">Ann Onco. </span>2010;<span class="ref-vol">21</span>(5):232–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20555089" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Onco&amp;title=Guideline+update+for+MASCC+and+ESMO+in+the+prevention+of+chemotherapy-and+radiotherapy-induced+nausea+and+vomiting:+results+of+the+Perugia+consensus+conference&amp;author=F+Roila&amp;author=J+Herrstedt&amp;author=M+Aapro&amp;author=RJ+Gralla&amp;author=LH+Einhorn&amp;volume=21&amp;issue=5&amp;publication_year=2010&amp;pages=232-43&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR132">132. <span class="element-citation">Gordon AJ, Conley JW, Gordon JM. Medical consequences of marijuana use: a review of current literature. <span><span class="ref-journal">Curr Psychiatry Rep. </span>2013;<span class="ref-vol">15</span>:419.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24234874" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Curr+Psychiatry+Rep&amp;title=Medical+consequences+of+marijuana+use:+a+review+of+current+literature&amp;author=AJ+Gordon&amp;author=JW+Conley&amp;author=JM+Gordon&amp;volume=15&amp;publication_year=2013&amp;pages=419&amp;pmid=24234874&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR133">133. <span class="element-citation">Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. <span><span class="ref-journal">J Psychoactive Drugs. </span>2011;<span class="ref-vol">43</span>:128–35.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21858958" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Psychoactive+Drugs&amp;title=Who+are+medical+marijuana+patients?+Population+characteristics+from+nine+California+assessment+clinics&amp;author=C+Reinarman&amp;author=H+Nunberg&amp;author=F+Lanthier&amp;author=T+Heddleston&amp;volume=43&amp;publication_year=2011&amp;pages=128-35&amp;pmid=21858958&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR134">134. <span class="element-citation">Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, et al.  Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. <span><span class="ref-journal">Int J Drug Policy. </span>2013;<span class="ref-vol">24</span>:511–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/24095000" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Int+J+Drug+Policy&amp;title=Cannabis+for+therapeutic+purposes:+patient+characteristics,+access,+and+reasons+for+use&amp;author=Z+Walsh&amp;author=R+Callaway&amp;author=L+Belle-Isle&amp;author=R+Capler&amp;author=R+Kay&amp;volume=24&amp;publication_year=2013&amp;pages=511-6&amp;pmid=24095000&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR135">135. <span class="element-citation">Potter DJ, Clark P, Brown MB. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. <span><span class="ref-journal">J Forensic Sci. </span>2008;<span class="ref-vol">53</span>:90–4.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18279244" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Forensic+Sci&amp;title=Potency+of+delta+9-THC+and+other+cannabinoids+in+cannabis+in+England+in+2005:+implications+for+psychoactivity+and+pharmacology&amp;author=DJ+Potter&amp;author=P+Clark&amp;author=MB+Brown&amp;volume=53&amp;publication_year=2008&amp;pages=90-4&amp;pmid=18279244&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR136">136. <span class="element-citation">Hillig KW, Mahlberg PG. A chemotaxonomic analysis of cannabinoid variation in cannabis (Cannabaceae) <span><span class="ref-journal">Am J Bot. </span>2004;<span class="ref-vol">91</span>:966–75.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21653452" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Bot&amp;title=A+chemotaxonomic+analysis+of+cannabinoid+variation+in+cannabis+(Cannabaceae)&amp;author=KW+Hillig&amp;author=PG+Mahlberg&amp;volume=91&amp;publication_year=2004&amp;pages=966-75&amp;pmid=21653452&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu" style="display: none; width: 200px; top: -100px; left: -100px;"><ul id="ui-ncbiinpagenav-2"><li><a href="https://www.ncbi.nlm.nih.gov/#Abs1title">Abstract</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#Sec1title">Introduction</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#Sec2title">Methods</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#Sec3title">Results</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#Sec17title">Conclusions</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm139726588977600title">Acknowledgements</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm139726595129472title">Abbreviations</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm139726588980768title">Footnotes</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm139726591926288aff-infotitle">Contributor Information</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#Bib1title">References</a></li></ul></div></div><div class="courtesy-note whole_rhythm small"><hr/>Articles from <span class="acknowledgment-journal-title">Addiction Science &amp; Clinical Practice</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>
</div>
</div>
<div class="four_col col last" id="rightcolumn">
<div class="col6">
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//pmc/articles/PMC4636852/epub/">ePub (beta)</a></li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/pdf/13722_2015_Article_32.pdf">PDF (456K)</a></li> | <li><a aria-expanded="false" aria-haspopup="true" class="citationexporter ctxp" data-citationid="PMC4636852" href="https://www.ncbi.nlm.nih.gov/#" role="button">Citation</a></li></ul></div></div><div class="share-buttons" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><h2>Share</h2><ul><li class="facebook"><a aria-expanded="false" aria-haspopup="true" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4636852%2F" role="button" target="_blank"><img alt="Share on Facebook" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626"/>
                             Facebook
                        </a></li><li class="twitter"><a aria-expanded="false" aria-haspopup="true" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4636852%2F&amp;text=Narrative%20review%20of%20the%20safety%20and%20efficacy%20of%20marijuana%20for%20the%20treatment%20of%20commonly%20state-approved%20medical%20and%20psychiatric%20disorders" role="button" target="_blank"><img alt="Share on Twitter" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627"/>
                             Twitter
                        </a></li><li class="gplus"><a aria-expanded="false" aria-haspopup="true" href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4636852%2F" role="button" target="_blank"><img alt="Share on Google Plus" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628"/>
                             Google+
                        </a></li></ul></div>
<div data-accid="PMC4636852" data-aid="4636852" data-aiid="4636852" data-domain="ascp" data-domainid="1002" data-iid="247429" data-md5="ade12419540d19d1ffb51a89fdaf88aa" data-pmid="25896576" id="ajax-portlets">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="pmfavad" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-4"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-4"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input id="absid" name="absid" type="hidden" value="4636852"/><div class="empty" data-db="pmc" id="pubmed_favoritesad">
<span role="menubar"><div aria-expanded="false" aria-haspopup="true" class="ui-ncbisetswitch ltd-hover" role="menuitem"><a class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/" id="favList"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" href="https://www.ncbi.nlm.nih.gov/#" title="View more options"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper" style="display: none; width: 200px; top: -100px; left: -100px;"><ul class="ui-ncbisetswitch-options" id="favUL"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="https://www.ncbi.nlm.nih.gov/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" type="submit" value="1"/></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PBooksDiscovery_RA" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-5"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5">
<ul>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/26443472" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.</a><span class="source">[Res Social Adm Pharm. 2016]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-6" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Parmar JR, Forrest BD, Freeman RA. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Res Social Adm Pharm. 2016 Jul-Aug; 12(4):638-54. Epub 2015 Sep 16.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/27804883" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.</a><span class="source">[Curr Neuropharmacol. 2017]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Suryadevara U, Bruijnzeel DM, Nuthi M, Jagnarine DA, Tandon R, Bruijnzeel AW. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Curr Neuropharmacol. 2017; 15(6):800-814. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/26767992" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Medical use of cannabis products: Lessons to be learned from Israel and Canada.</a><span class="source">[Schmerz. 2016]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Schmerz. 2016 Feb; 30(1):3-13. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/26398734" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Medical marijuana: Showdown at the cannabis corral.</a><span class="source">[Nature. 2015]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Eisenstein M. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Nature. 2015 Sep 24; 525(7570):S15-7. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/24205805" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.</a><span class="source">[Am J Drug Alcohol Abuse. 2014]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Am J Drug Alcohol Abuse. 2014 Jan; 40(1):23-30. Epub 2013 Nov 8.</em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25896576&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25896576&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PMCVCitedByPmcArticlesP" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-11"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-11">
<ul>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//pmc/articles/PMC6487235/" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Substance Abusing Mothers with a History of Childhood Abuse and Their Children’s Depressive Symptoms: The Efficacy of Family Therapy</a><span class="source">[Journal of marital and family ...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-12" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Wu Q, Slesnick N. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Journal of marital and family therapy. 2018 Oct 28;10.1111/jmft.12364</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//pmc/articles/PMC6481668/" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Maternal Cannabis Use During a Child’s Lifetime Associated With Earlier Initiation</a><span class="source">[American journal of preventive...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Sokol NA, Okechukwu CA, Chen JT, Subramanian SV, Rees VW. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">American journal of preventive medicine. 2018 Sep 24; 55(5): 592-602</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455811/" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Medical and Non-Medical Marijuana Use in Depression: Longitudinal Associations with Suicidal Ideation, Everyday Functioning, and Psychiatry Service Utilization</a><span class="source">[Journal of affective disorders...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Bahorik AL, Sterling SA, Campbell CI, Weisner C, Ramo D, Satre DD. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Journal of affective disorders. 2018 Jul 17; 241: 8-14</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Cannabinoids and Pain: New Insights From Old Molecules</a><span class="source">[Frontiers in Pharmacology. 2018]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Vučković S, Srebro D, Vujović KS, Vučetić Č, Prostran M. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Frontiers in Pharmacology. 2018 Nov 13; 9: 1259</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123285/" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Cannabis regulatory science: risk-benefit considerations for mental disorders</a><span class="source">[International review of psychi...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Borodovsky JT, Budney AJ. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">International review of psychiatry (Abingdon, England). 2018 May 29; 30(3): 183-202</em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852/citedby/" ref="reftype=relart&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PMCVCitedByPmcArticlesP" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-17"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-17"><ul>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=books&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_books_refs&amp;IdsFromResult=4636852" ref="reftype=Cited%20in%20Books&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Books&amp;rendering-type=normal" role="button">Cited in Books</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" style="top: -100px; left: -100px; display: none;">Cited in Books<div class="brieflinkpopdesc">PubMed Central articles cited in books</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=4636852" ref="reftype=MedGen&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button">MedGen</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/25896576/" ref="reftype=PubMed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button">PubMed</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=4636852" ref="reftype=Taxonomy&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button">Taxonomy</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="recent_activity" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-22"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-22"><div class="" id="HTDisplay" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<div class="action">
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//javascript:historyDisplayState('ClearHT')">Clear</a><a class="HTOn" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//javascript:historyDisplayState('HTOff')">Turn Off</a><a class="HTOff" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//javascript:historyDisplayState('HTOn')">Turn On</a>
</div>
<ul id="activity"><li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=5d2aef5bdde08907a2f80cda" ref="log$=activity&amp;linkpos=1">Narrative review of the safety and efficacy of marijuana for the treatment of co...</a><div class="ralinkpop offscreen_noflow">Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders<div class="brieflinkpopdesc">Addiction Science &amp;#x0026; Clinical Practice. 2015; 10()</div>
</div>
<div class="tertiary"></div>
</li></ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p class="HTOff" id="turnOn"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636852//javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p2" name="crb--__p2" rid="__p2" style="position: absolute; visibility: visible; width: 370px; top: 958px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-23"><ul><li class="two_line" reference_id="CR2">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22564034/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.</a><span class="one_line_source">[Psychol Serv.  2012]</span><div class="alt-note">
<div class="authors">Bonn-Miller MO, Harris AHS, Trafton JA</div>
<div class="citation">Psychol Serv. 2012 Nov; 9(4):404-416.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p5" name="crb--__p5" rid="__p5" style="position: absolute; visibility: visible; width: 370px; top: 1474px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-24"><ul>
<li class="two_line" reference_id="CR4">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24897085/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Adverse health effects of marijuana use.</a><span class="one_line_source">[N Engl J Med.  2014]</span><div class="alt-note">
<div class="authors">Volkow ND, Baler RD, Compton WM, Weiss SR</div>
<div class="citation">N Engl J Med. 2014 Jun 5; 370(23):2219-27.</div>
</div>
</li>
<li class="two_line" reference_id="CR5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24778283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.</a><span class="one_line_source">[Neurology.  2014]</span><div class="alt-note">
<div class="authors">Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D</div>
<div class="citation">Neurology. 2014 Apr 29; 82(17):1556-63.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 1968px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-25"><ul>
<li class="two_line" reference_id="CR7">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24205805/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.</a><span class="one_line_source">[Am J Drug Alcohol Abuse.  2014]</span><div class="alt-note">
<div class="authors">Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA</div>
<div class="citation">Am J Drug Alcohol Abuse. 2014 Jan; 40(1):23-30.</div>
</div>
</li>
<li class="two_line" reference_id="CR9">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23750291/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California.</a><span class="one_line_source">[J Drug Policy Anal.  2011]</span><div class="alt-note">
<div class="authors">Nunberg H, Kilmer B, Pacula RL, Burgdorf J</div>
<div class="citation">J Drug Policy Anal. 2011 Feb; 4(1):.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p9" name="crb--__p9" rid="__p9" style="position: absolute; visibility: visible; width: 370px; top: 2310px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-26"><ul>
<li class="two_line" reference_id="CR10">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19116299/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Current concepts in Alzheimer's disease: a multidisciplinary review.</a><span class="one_line_source">[Am J Alzheimers Dis Other Demen.  2009]</span><div class="alt-note">
<div class="authors">Minati L, Edginton T, Bruzzone MG, Giaccone G</div>
<div class="citation">Am J Alzheimers Dis Other Demen. 2009 Apr-May; 24(2):95-121.</div>
</div>
</li>
<li class="two_line" reference_id="CR11">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24172185/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The influence of cannabinoids on generic traits of neurodegeneration.</a><span class="one_line_source">[Br J Pharmacol.  2014]</span><div class="alt-note">
<div class="authors">Fagan SG, Campbell VA</div>
<div class="citation">Br J Pharmacol. 2014 Mar; 171(6):1347-60.</div>
</div>
</li>
<li class="two_line" reference_id="CR12">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20875047/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The multiplicity of action of cannabinoids: implications for treating neurodegeneration.</a><span class="one_line_source">[CNS Neurosci Ther.  2011]</span><div class="alt-note">
<div class="authors">Gowran A, Noonan J, Campbell VA</div>
<div class="citation">CNS Neurosci Ther. 2011 Dec; 17(6):637-44.</div>
</div>
</li>
<li class="two_line" reference_id="CR13">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24634659/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.</a><span class="one_line_source">[Front Pharmacol.  2014]</span><div class="alt-note">
<div class="authors">Aso E, Ferrer I</div>
<div class="citation">Front Pharmacol. 2014; 5():37.</div>
</div>
</li>
<li class="two_line" reference_id="CR14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19370677/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabinoids for the treatment of dementia.</a><span class="one_line_source">[Cochrane Database Syst Rev.  2009]</span><div class="alt-note">
<div class="authors">Krishnan S, Cairns R, Howard R</div>
<div class="citation">Cochrane Database Syst Rev. 2009 Apr 15; (2):CD007204.</div>
</div>
</li>
<li class="two_line" reference_id="CR15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9309469/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease.</a><span class="one_line_source">[Int J Geriatr Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ</div>
<div class="citation">Int J Geriatr Psychiatry. 1997 Sep; 12(9):913-9.</div>
</div>
</li>
<li class="two_line" reference_id="CR16">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21364345/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.</a><span class="one_line_source">[J Clin Psychopharmacol.  2011]</span><div class="alt-note">
<div class="authors">Walther S, Schüpbach B, Seifritz E, Homan P, Strik W</div>
<div class="citation">J Clin Psychopharmacol. 2011 Apr; 31(2):256-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p10" name="crb--__p10" rid="__p10" style="position: absolute; visibility: visible; width: 370px; top: 2655px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul>
<li class="two_line" reference_id="CR17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20439484/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.</a><span class="one_line_source">[Am J Hosp Palliat Care.  2010]</span><div class="alt-note">
<div class="authors">Carter GT, Abood ME, Aggarwal SK, Weiss MD</div>
<div class="citation">Am J Hosp Palliat Care. 2010 Aug; 27(5):347-56.</div>
</div>
</li>
<li class="two_line" reference_id="CR18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11467101/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Marijuana in the management of amyotrophic lateral sclerosis.</a><span class="one_line_source">[Am J Hosp Palliat Care.  2001]</span><div class="alt-note">
<div class="authors">Carter GT, Rosen BS</div>
<div class="citation">Am J Hosp Palliat Care. 2001 Jul-Aug; 18(4):264-70.</div>
</div>
</li>
<li class="two_line" reference_id="CR19">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15055508/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Survey of cannabis use in patients with amyotrophic lateral sclerosis.</a><span class="one_line_source">[Am J Hosp Palliat Care.  2004]</span><div class="alt-note">
<div class="authors">Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT</div>
<div class="citation">Am J Hosp Palliat Care. 2004 Mar-Apr; 21(2):95-104.</div>
</div>
</li>
<li class="two_line" reference_id="CR20">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20498181/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.</a><span class="one_line_source">[J Neurol Neurosurg Psychiatry.  2010]</span><div class="alt-note">
<div class="authors">Weber M, Goldman B, Truniger S</div>
<div class="citation">J Neurol Neurosurg Psychiatry. 2010 Oct; 81(10):1135-40.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p11" name="crb--__p11" rid="__p11" style="position: absolute; visibility: visible; width: 370px; top: 3021px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul>
<li class="two_line" reference_id="CR21">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12965981/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.</a><span class="one_line_source">[Ann Intern Med.  2003]</span><div class="alt-note">
<div class="authors">Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M</div>
<div class="citation">Ann Intern Med. 2003 Aug 19; 139(4):258-66.</div>
</div>
</li>
<li class="two_line" reference_id="CR22">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17589370/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.</a><span class="one_line_source">[J Acquir Immune Defic Syndr.  2007]</span><div class="alt-note">
<div class="authors">Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW</div>
<div class="citation">J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):545-54.</div>
</div>
</li>
<li class="two_line" reference_id="CR23">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3228283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.</a><span class="one_line_source">[Appetite.  1988]</span><div class="alt-note">
<div class="authors">Foltin RW, Fischman MW, Byrne MF</div>
<div class="citation">Appetite. 1988 Aug; 11(1):1-14.</div>
</div>
</li>
<li class="two_line" reference_id="CR24">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412834/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Effects of smoked marijuana in healthy and HIV + marijuana smokers.</a><span class="one_line_source">[J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Haney M</div>
<div class="citation">J Clin Pharmacol. 2002 Nov; 42(S1):34S-40S.</div>
</div>
</li>
<li class="two_line" reference_id="CR25" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20824270/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.</a><span class="one_line_source">[Psychopharmacology (Berl).  2010]</span><div class="alt-note">
<div class="authors">Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, Vosburg SK, Haney M</div>
<div class="citation">Psychopharmacology (Berl). 2010 Dec; 212(4):675-86.</div>
</div>
</li>
<li class="two_line" reference_id="CR26" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7730690/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.</a><span class="one_line_source">[J Pain Symptom Manage.  1995]</span><div class="alt-note">
<div class="authors">Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV</div>
<div class="citation">J Pain Symptom Manage. 1995 Feb; 10(2):89-97.</div>
</div>
</li>
<li class="two_line" reference_id="CR27" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9223837/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia.</a><span class="one_line_source">[J Pain Symptom Manage.  1997]</span><div class="alt-note">
<div class="authors">Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV</div>
<div class="citation">J Pain Symptom Manage. 1997 Jul; 14(1):7-14.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p12" name="crb--__p12" rid="__p12" style="position: absolute; visibility: visible; width: 370px; top: 3221px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="CR22">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17589370/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.</a><span class="one_line_source">[J Acquir Immune Defic Syndr.  2007]</span><div class="alt-note">
<div class="authors">Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW</div>
<div class="citation">J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):545-54.</div>
</div>
</li>
<li class="two_line" reference_id="CR25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20824270/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.</a><span class="one_line_source">[Psychopharmacology (Berl).  2010]</span><div class="alt-note">
<div class="authors">Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, Vosburg SK, Haney M</div>
<div class="citation">Psychopharmacology (Berl). 2010 Dec; 212(4):675-86.</div>
</div>
</li>
<li class="two_line" reference_id="CR28">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22133305/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men.</a><span class="one_line_source">[Brain Res.  2012]</span><div class="alt-note">
<div class="authors">Riggs PK, Vaida F, Rossi SS, Sorkin LS, Gouaux B, Grant I, Ellis RJ</div>
<div class="citation">Brain Res. 2012 Jan 11; 1431():46-52.</div>
</div>
</li>
<li class="two_line" reference_id="CR23">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3228283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.</a><span class="one_line_source">[Appetite.  1988]</span><div class="alt-note">
<div class="authors">Foltin RW, Fischman MW, Byrne MF</div>
<div class="citation">Appetite. 1988 Aug; 11(1):1-14.</div>
</div>
</li>
<li class="two_line" reference_id="CR29">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11786587/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.</a><span class="one_line_source">[J Clin Oncol.  2002]</span><div class="alt-note">
<div class="authors">Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B</div>
<div class="citation">J Clin Oncol. 2002 Jan 15; 20(2):567-73.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p13" name="crb--__p13" rid="__p13" style="position: absolute; visibility: visible; width: 370px; top: 3502px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="CR30">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22019199/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The intersection between cannabis and cancer in the United States.</a><span class="one_line_source">[Crit Rev Oncol Hematol.  2012]</span><div class="alt-note">
<div class="authors">Bowles DW, O'Bryant CL, Camidge DR, Jimeno A</div>
<div class="citation">Crit Rev Oncol Hematol. 2012 Jul; 83(1):1-10.</div>
</div>
</li>
<li class="two_line" reference_id="CR31">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19285265/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.</a><span class="one_line_source">[Best Pract Res Clin Endocrinol Metab.  2009]</span><div class="alt-note">
<div class="authors">Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M</div>
<div class="citation">Best Pract Res Clin Endocrinol Metab. 2009 Feb; 23(1):117-31.</div>
</div>
</li>
<li class="two_line" reference_id="CR32">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15749859/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.</a><span class="one_line_source">[J Immunol.  2005]</span><div class="alt-note">
<div class="authors">McKallip RJ, Nagarkatti M, Nagarkatti PS</div>
<div class="citation">J Immunol. 2005 Mar 15; 174(6):3281-9.</div>
</div>
</li>
<li class="two_line" reference_id="CR33">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16804518/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.</a><span class="one_line_source">[Br J Cancer.  2006]</span><div class="alt-note">
<div class="authors">Guzmán M, Duarte MJ, Blázquez C, Ravina J, Rosa MC, Galve-Roperh I, Sánchez C, Velasco G, González-Feria L</div>
<div class="citation">Br J Cancer. 2006 Jul 17; 95(2):197-203.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p14" name="crb--__p14" rid="__p14" style="position: absolute; visibility: visible; width: 370px; top: 3868px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul>
<li class="two_line" reference_id="CR34">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24407485/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.</a><span class="one_line_source">[Inflamm Bowel Dis.  2014]</span><div class="alt-note">
<div class="authors">Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN</div>
<div class="citation">Inflamm Bowel Dis. 2014 Mar; 20(3):472-80.</div>
</div>
</li>
<li class="two_line" reference_id="CR36">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24185313/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marijuana use patterns among patients with inflammatory bowel disease.</a><span class="one_line_source">[Inflamm Bowel Dis.  2013]</span><div class="alt-note">
<div class="authors">Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J</div>
<div class="citation">Inflamm Bowel Dis. 2013 Dec; 19(13):2809-14.</div>
</div>
</li>
<li class="two_line" reference_id="CR37">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23648372/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.</a><span class="one_line_source">[Clin Gastroenterol Hepatol.  2013]</span><div class="alt-note">
<div class="authors">Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM</div>
<div class="citation">Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1276-1280.e1.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p15" name="crb--__p15" rid="__p15" style="position: absolute; visibility: visible; width: 370px; top: 4213px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="CR38">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23902406/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.</a><span class="one_line_source">[Br J Pharmacol.  2013]</span><div class="alt-note">
<div class="authors">Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, Whalley BJ, Hill AJ</div>
<div class="citation">Br J Pharmacol. 2013 Oct; 170(3):679-92.</div>
</div>
</li>
<li class="two_line" reference_id="CR41">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19906779/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.</a><span class="one_line_source">[J Pharmacol Exp Ther.  2010]</span><div class="alt-note">
<div class="authors">Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, Stephens GJ</div>
<div class="citation">J Pharmacol Exp Ther. 2010 Feb; 332(2):569-77.</div>
</div>
</li>
<li class="two_line" reference_id="CR39">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22520455/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.</a><span class="one_line_source">[Seizure.  2012]</span><div class="alt-note">
<div class="authors">Jones NA, Glyn SE, Akiyama S, Hill TD, Hill AJ, Weston SE, Burnett MD, Yamasaki Y, Stephens GJ, Whalley BJ, Williams CM</div>
<div class="citation">Seizure. 2012 Jun; 21(5):344-52.</div>
</div>
</li>
<li class="two_line" reference_id="CR42">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11737161/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.</a><span class="one_line_source">[Epilepsia.  2001]</span><div class="alt-note">
<div class="authors">Gordon E, Devinsky O</div>
<div class="citation">Epilepsia. 2001 Oct; 42(10):1266-72.</div>
</div>
</li>
<li class="two_line" reference_id="CR43">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23311572/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis and other illicit drug use in epilepsy patients.</a><span class="one_line_source">[Eur J Neurol.  2014]</span><div class="alt-note">
<div class="authors">Hamerle M, Ghaeni L, Kowski A, Weissinger F, Holtkamp M</div>
<div class="citation">Eur J Neurol. 2014; 21(1):167-70.</div>
</div>
</li>
<li class="two_line" reference_id="CR44">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15184622/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center.</a><span class="one_line_source">[Neurology.  2004]</span><div class="alt-note">
<div class="authors">Gross DW, Hamm J, Ashworth NL, Quigley D</div>
<div class="citation">Neurology. 2004 Jun 8; 62(11):2095-7.</div>
</div>
</li>
<li class="two_line" reference_id="CR45" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24595491/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabinoids for epilepsy.</a><span class="one_line_source">[Cochrane Database Syst Rev.  2014]</span><div class="alt-note">
<div class="authors">Gloss D, Vickrey B</div>
<div class="citation">Cochrane Database Syst Rev. 2014 Mar 5; (3):CD009270.</div>
</div>
</li>
<li class="two_line" reference_id="CR46" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/351429/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Toward drugs derived from cannabis.</a><span class="one_line_source">[Naturwissenschaften.  1978]</span><div class="alt-note">
<div class="authors">Mechoulam R, Carlini EA</div>
<div class="citation">Naturwissenschaften. 1978 Apr; 65(4):174-9.</div>
</div>
</li>
<li class="two_line" reference_id="CR47" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7413719/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Chronic administration of cannabidiol to healthy volunteers and epileptic patients.</a><span class="one_line_source">[Pharmacology.  1980]</span><div class="alt-note">
<div class="authors">Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R</div>
<div class="citation">Pharmacology. 1980; 21(3):175-85.</div>
</div>
</li>
<li class="two_line" reference_id="CR48" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3941934/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Anticonvulsant effect of cannabidiol.</a><span class="one_line_source">[S Afr Med J.  1986]</span><div class="alt-note">
<div class="authors">Ames FR, Cridland S</div>
<div class="citation">S Afr Med J. 1986 Jan 4; 69(1):14.</div>
</div>
</li>
<li class="two_line" reference_id="CR5" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24778283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.</a><span class="one_line_source">[Neurology.  2014]</span><div class="alt-note">
<div class="authors">Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D</div>
<div class="citation">Neurology. 2014 Apr 29; 82(17):1556-63.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p16" name="crb--__p16" rid="__p16" style="position: absolute; visibility: visible; width: 370px; top: 4536px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="CR49">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7053160/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of marihuana on intraocular and blood pressure in glaucoma.</a><span class="one_line_source">[Ophthalmology.  1980]</span><div class="alt-note">
<div class="authors">Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS</div>
<div class="citation">Ophthalmology. 1980 Mar; 87(3):222-8.</div>
</div>
</li>
<li class="two_line" reference_id="CR50">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5109652/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marihuana smoking and intraocular pressure.</a><span class="one_line_source">[JAMA.  1971]</span><div class="alt-note">
<div class="authors">Hepler RS, Frank IR</div>
<div class="citation">JAMA. 1971 Sep 6; 217(10):1392.</div>
</div>
</li>
<li class="two_line" reference_id="CR51">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9823341/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Marijuana smoking vs cannabinoids for glaucoma therapy.</a><span class="one_line_source">[Arch Ophthalmol.  1998]</span><div class="alt-note">
<div class="authors">Green K</div>
<div class="citation">Arch Ophthalmol. 1998 Nov; 116(11):1433-7.</div>
</div>
</li>
<li class="two_line" reference_id="CR52">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18929127/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.</a><span class="one_line_source">[Prog Brain Res.  2008]</span><div class="alt-note">
<div class="authors">Nucci C, Bari M, Spanò A, Corasaniti M, Bagetta G, Maccarrone M, Morrone LA</div>
<div class="citation">Prog Brain Res. 2008; 173():451-64.</div>
</div>
</li>
<li class="two_line" reference_id="CR53">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12545695/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma.</a><span class="one_line_source">[Trans Am Ophthalmol Soc.  2002]</span><div class="alt-note">
<div class="authors">Flach AJ</div>
<div class="citation">Trans Am Ophthalmol Soc. 2002; 100():215-22; discussion 222-4.</div>
</div>
</li>
<li class="two_line" reference_id="CR54">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20160576/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">American glaucoma society position statement: marijuana and the treatment of glaucoma.</a><span class="one_line_source">[J Glaucoma.  2010]</span><div class="alt-note">
<div class="authors">Jampel H</div>
<div class="citation">J Glaucoma. 2010 Feb; 19(2):75-6.</div>
</div>
</li>
<li class="two_line" reference_id="CR55">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20676153/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma.</a><span class="one_line_source">[Can J Ophthalmol.  2010]</span><div class="alt-note">
<div class="authors">Buys YM, Rafuse PE</div>
<div class="citation">Can J Ophthalmol. 2010 Aug; 45(4):324-6.</div>
</div>
</li>
<li class="two_line" reference_id="CR56">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15090428/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabinoids and glaucoma.</a><span class="one_line_source">[Br J Ophthalmol.  2004]</span><div class="alt-note">
<div class="authors">Tomida I, Pertwee RG, Azuara-Blanco A</div>
<div class="citation">Br J Ophthalmol. 2004 May; 88(5):708-13.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p17" name="crb--__p17" rid="__p17" style="position: absolute; visibility: visible; width: 370px; top: 4923px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul>
<li class="two_line" reference_id="CR57">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23811492/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis.</a><span class="one_line_source">[Clin Infect Dis.  2013]</span><div class="alt-note">
<div class="authors">Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB, Canadian Co-infection Cohort Investigators.</div>
<div class="citation">Clin Infect Dis. 2013 Sep; 57(5):663-70.</div>
</div>
</li>
<li class="two_line" reference_id="CR58">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15892090/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.</a><span class="one_line_source">[Hepatology.  2005]</span><div class="alt-note">
<div class="authors">Hézode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani ES, Pawlotsky JM, Dhumeaux D, Lotersztajn S, Mallat A</div>
<div class="citation">Hepatology. 2005 Jul; 42(1):63-71.</div>
</div>
</li>
<li class="two_line" reference_id="CR59">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18242211/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.</a><span class="one_line_source">[Gastroenterology.  2008]</span><div class="alt-note">
<div class="authors">Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A</div>
<div class="citation">Gastroenterology. 2008 Feb; 134(2):432-9.</div>
</div>
</li>
<li class="two_line" reference_id="CR60">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18166478/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Influence of cannabis use on severity of hepatitis C disease.</a><span class="one_line_source">[Clin Gastroenterol Hepatol.  2008]</span><div class="alt-note">
<div class="authors">Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA</div>
<div class="citation">Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p18" name="crb--__p18" rid="__p18" style="position: absolute; visibility: visible; width: 370px; top: 5102px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul>
<li class="two_line" reference_id="CR61">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18414712/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.</a><span class="one_line_source">[Can J Gastroenterol.  2008]</span><div class="alt-note">
<div class="authors">Costiniuk CT, Mills E, Cooper CL</div>
<div class="citation">Can J Gastroenterol. 2008 Apr; 22(4):376-80.</div>
</div>
</li>
<li class="two_line" reference_id="CR62">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16957511/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.</a><span class="one_line_source">[Eur J Gastroenterol Hepatol.  2006]</span><div class="alt-note">
<div class="authors">Sylvestre DL, Clements BJ, Malibu Y</div>
<div class="citation">Eur J Gastroenterol Hepatol. 2006 Oct; 18(10):1057-63.</div>
</div>
</li>
<li class="two_line" reference_id="CR63">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10349689/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The clinical pharmacology of ribavirin.</a><span class="one_line_source">[Semin Liver Dis.  1999]</span><div class="alt-note">
<div class="authors">Glue P</div>
<div class="citation">Semin Liver Dis. 1999; 19 Suppl 1():17-24.</div>
</div>
</li>
<li class="two_line" reference_id="CR64">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18354374/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Surveillance for acute viral hepatitis--United States, 2006.</a><span class="one_line_source">[MMWR Surveill Summ.  2008]</span><div class="alt-note">
<div class="authors">Wasley A, Grytdal S, Gallagher K, Centers for Disease Control and Prevention (CDC).</div>
<div class="citation">MMWR Surveill Summ. 2008 Mar 21; 57(2):1-24.</div>
</div>
</li>
<li class="two_line" reference_id="CR60">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18166478/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Influence of cannabis use on severity of hepatitis C disease.</a><span class="one_line_source">[Clin Gastroenterol Hepatol.  2008]</span><div class="alt-note">
<div class="authors">Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA</div>
<div class="citation">Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p19" name="crb--__p19" rid="__p19" style="position: absolute; visibility: visible; width: 370px; top: 5384px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul>
<li class="two_line" reference_id="CR65">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14707790/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting.</a><span class="one_line_source">[J Acquir Immune Defic Syndr.  2004]</span><div class="alt-note">
<div class="authors">Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM</div>
<div class="citation">J Acquir Immune Defic Syndr. 2004 Jan 1; 35(1):38-45.</div>
</div>
</li>
<li class="two_line" reference_id="CR25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20824270/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.</a><span class="one_line_source">[Psychopharmacology (Berl).  2010]</span><div class="alt-note">
<div class="authors">Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, Vosburg SK, Haney M</div>
<div class="citation">Psychopharmacology (Berl). 2010 Dec; 212(4):675-86.</div>
</div>
</li>
<li class="two_line" reference_id="CR66">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23633327/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.</a><span class="one_line_source">[Cochrane Database Syst Rev.  2013]</span><div class="alt-note">
<div class="authors">Lutge EE, Gray A, Siegfried N</div>
<div class="citation">Cochrane Database Syst Rev. 2013 Apr 30; (4):CD005175.</div>
</div>
</li>
<li class="two_line" reference_id="CR67">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412840/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients.</a><span class="one_line_source">[J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI</div>
<div class="citation">J Clin Pharmacol. 2002 Nov; 42(S1):82S-89S.</div>
</div>
</li>
<li class="two_line" reference_id="CR68">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11872997/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir.</a><span class="one_line_source">[AIDS.  2002]</span><div class="alt-note">
<div class="authors">Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, Abrams DI</div>
<div class="citation">AIDS. 2002 Mar 8; 16(4):543-50.</div>
</div>
</li>
<li class="two_line" reference_id="CR21">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12965981/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.</a><span class="one_line_source">[Ann Intern Med.  2003]</span><div class="alt-note">
<div class="authors">Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M</div>
<div class="citation">Ann Intern Med. 2003 Aug 19; 139(4):258-66.</div>
</div>
</li>
<li class="two_line" reference_id="CR69">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23054178/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.</a><span class="one_line_source">[J Behav Med.  2014]</span><div class="alt-note">
<div class="authors">Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA</div>
<div class="citation">J Behav Med. 2014 Feb; 37(1):1-10.</div>
</div>
</li>
<li class="two_line" reference_id="CR70">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15778874/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.</a><span class="one_line_source">[Psychopharmacology (Berl).  2005]</span><div class="alt-note">
<div class="authors">Haney M, Rabkin J, Gunderson E, Foltin RW</div>
<div class="citation">Psychopharmacology (Berl). 2005 Aug; 181(1):170-8.</div>
</div>
</li>
<li class="two_line" reference_id="CR71">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17296917/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.</a><span class="one_line_source">[Neurology.  2007]</span><div class="alt-note">
<div class="authors">Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL</div>
<div class="citation">Neurology. 2007 Feb 13; 68(7):515-21.</div>
</div>
</li>
<li class="two_line" reference_id="CR26">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7730690/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.</a><span class="one_line_source">[J Pain Symptom Manage.  1995]</span><div class="alt-note">
<div class="authors">Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV</div>
<div class="citation">J Pain Symptom Manage. 1995 Feb; 10(2):89-97.</div>
</div>
</li>
<li class="two_line" reference_id="CR72" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18688212/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.</a><span class="one_line_source">[Neuropsychopharmacology.  2009]</span><div class="alt-note">
<div class="authors">Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH</div>
<div class="citation">Neuropsychopharmacology. 2009 Feb; 34(3):672-80.</div>
</div>
</li>
<li class="two_line" reference_id="CR73" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8395916/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of dronabinol on nutritional status in HIV infection.</a><span class="one_line_source">[Ann Pharmacother.  1993]</span><div class="alt-note">
<div class="authors">Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG</div>
<div class="citation">Ann Pharmacother. 1993 Jul-Aug; 27(7-8):827-31.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p20" name="crb--__p20" rid="__p20" style="position: absolute; visibility: visible; width: 370px; top: 5854px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="two_line" reference_id="CR75">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15799140/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Spasticity: clinical perceptions, neurological realities and meaningful measurement.</a><span class="one_line_source">[Disabil Rehabil.  2005]</span><div class="alt-note">
<div class="authors">Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J, Hermens H, Johnson GR</div>
<div class="citation">Disabil Rehabil. 2005 Jan 7-21; 27(1-2):2-6.</div>
</div>
</li>
<li class="two_line" reference_id="CR76">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14636486/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Treatments for spasticity and pain in multiple sclerosis: a systematic review.</a><span class="one_line_source">[Health Technol Assess.  2003]</span><div class="alt-note">
<div class="authors">Beard S, Hunn A, Wight J</div>
<div class="citation">Health Technol Assess. 2003; 7(40):iii, ix-x, 1-111.</div>
</div>
</li>
<li class="two_line" reference_id="CR77">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21362108/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.</a><span class="one_line_source">[Eur J Neurol.  2011]</span><div class="alt-note">
<div class="authors">Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P, Sativex Spasticity Study Group.</div>
<div class="citation">Eur J Neurol. 2011 Sep; 18(9):1122-31.</div>
</div>
</li>
<li class="two_line" reference_id="CR84" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20434606/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.</a><span class="one_line_source">[Arch Phys Med Rehabil.  2010]</span><div class="alt-note">
<div class="authors">Pooyania S, Ethans K, Szturm T, Casey A, Perry D</div>
<div class="citation">Arch Phys Med Rehabil. 2010 May; 91(5):703-7.</div>
</div>
</li>
<li class="two_line" reference_id="CR85" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17086911/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.</a><span class="one_line_source">[Mult Scler.  2006]</span><div class="alt-note">
<div class="authors">Wade DT, Makela PM, House H, Bateman C, Robson P</div>
<div class="citation">Mult Scler. 2006 Oct; 12(5):639-45.</div>
</div>
</li>
<li class="two_line" reference_id="CR87" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21878454/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).</a><span class="one_line_source">[Mult Scler.  2012]</span><div class="alt-note">
<div class="authors">Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R</div>
<div class="citation">Mult Scler. 2012 Feb; 18(2):219-28.</div>
</div>
</li>
<li class="two_line" reference_id="CR88" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24525548/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.</a><span class="one_line_source">[Eur Neurol.  2014]</span><div class="alt-note">
<div class="authors">Flachenecker P, Henze T, Zettl UK</div>
<div class="citation">Eur Neurol. 2014; 71(5-6):271-9.</div>
</div>
</li>
<li class="two_line" reference_id="CR89" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16186518/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.</a><span class="one_line_source">[Neurology.  2005]</span><div class="alt-note">
<div class="authors">Rog DJ, Nurmikko TJ, Friede T, Young CA</div>
<div class="citation">Neurology. 2005 Sep 27; 65(6):812-9.</div>
</div>
</li>
<li class="two_line" reference_id="CR90" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22586334/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.</a><span class="one_line_source">[CMAJ.  2012]</span><div class="alt-note">
<div class="authors">Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B</div>
<div class="citation">CMAJ. 2012 Jul 10; 184(10):1143-50.</div>
</div>
</li>
<li class="two_line" reference_id="CR91" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8143398/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  1994]</span><div class="alt-note">
<div class="authors">Greenberg HS, Werness SA, Pugh JE, Andrus RO, Anderson DJ, Domino EF</div>
<div class="citation">Clin Pharmacol Ther. 1994 Mar; 55(3):324-8.</div>
</div>
</li>
<li class="two_line" reference_id="CR5" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24778283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.</a><span class="one_line_source">[Neurology.  2014]</span><div class="alt-note">
<div class="authors">Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D</div>
<div class="citation">Neurology. 2014 Apr 29; 82(17):1556-63.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 6033px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="CR92">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15184623/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Patterns of cannabis use among patients with multiple sclerosis.</a><span class="one_line_source">[Neurology.  2004]</span><div class="alt-note">
<div class="authors">Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME</div>
<div class="citation">Neurology. 2004 Jun 8; 62(11):2098-100.</div>
</div>
</li>
<li class="two_line" reference_id="CR93">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12945941/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis use as described by people with multiple sclerosis.</a><span class="one_line_source">[Can J Neurol Sci.  2003]</span><div class="alt-note">
<div class="authors">Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC</div>
<div class="citation">Can J Neurol Sci. 2003 Aug; 30(3):201-5.</div>
</div>
</li>
<li class="two_line" reference_id="CR90">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22586334/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.</a><span class="one_line_source">[CMAJ.  2012]</span><div class="alt-note">
<div class="authors">Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B</div>
<div class="citation">CMAJ. 2012 Jul 10; 184(10):1143-50.</div>
</div>
</li>
<li class="two_line" reference_id="CR94">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24789863/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.</a><span class="one_line_source">[Neurology.  2014]</span><div class="alt-note">
<div class="authors">Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A</div>
<div class="citation">Neurology. 2014 May 27; 82(21):1879-87.</div>
</div>
</li>
<li class="two_line" reference_id="CR95">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21444900/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of cannabis on cognitive function in patients with multiple sclerosis.</a><span class="one_line_source">[Neurology.  2011]</span><div class="alt-note">
<div class="authors">Honarmand K, Tierney MC, O'Connor P, Feinstein A</div>
<div class="citation">Neurology. 2011 Mar 29; 76(13):1153-60.</div>
</div>
</li>
<li class="two_line" reference_id="CR96" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2027484/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.</a><span class="one_line_source">[Neurology.  1991]</span><div class="alt-note">
<div class="authors">Rao SM, Leo GJ, Bernardin L, Unverzagt F</div>
<div class="citation">Neurology. 1991 May; 41(5):685-91.</div>
</div>
</li>
<li class="two_line" reference_id="CR97" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22973422/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.</a><span class="one_line_source">[Ther Adv Neurol Disord.  2012]</span><div class="alt-note">
<div class="authors">Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC</div>
<div class="citation">Ther Adv Neurol Disord. 2012 Sep; 5(5):255-66.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p22" name="crb--__p22" rid="__p22" style="position: absolute; visibility: visible; width: 370px; top: 6336px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul>
<li class="two_line" reference_id="CR99">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17721963/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users.</a><span class="one_line_source">[J Trauma Stress.  2007]</span><div class="alt-note">
<div class="authors">Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ</div>
<div class="citation">J Trauma Stress. 2007 Aug; 20(4):577-86.</div>
</div>
</li>
<li class="two_line" reference_id="CR101">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24892898/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.</a><span class="one_line_source">[Int Rev Psychiatry.  2014]</span><div class="alt-note">
<div class="authors">Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO</div>
<div class="citation">Int Rev Psychiatry. 2014 Apr; 26(2):237-47.</div>
</div>
</li>
<li class="two_line" reference_id="CR102">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23670490/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.</a><span class="one_line_source">[Mol Psychiatry.  2013]</span><div class="alt-note">
<div class="authors">Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, Ropchan J, Henry S, Corsi-Travali S, Carson RE, Huang Y</div>
<div class="citation">Mol Psychiatry. 2013 Sep; 18(9):1034-40.</div>
</div>
</li>
<li class="two_line" reference_id="CR103">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22736575/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.</a><span class="one_line_source">[Drug Test Anal.  2012]</span><div class="alt-note">
<div class="authors">Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH</div>
<div class="citation">Drug Test Anal. 2012 Jul-Aug; 4(7-8):649-59.</div>
</div>
</li>
<li class="two_line" reference_id="CR104" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24935052/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.</a><span class="one_line_source">[Clin Drug Investig.  2014]</span><div class="alt-note">
<div class="authors">Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A</div>
<div class="citation">Clin Drug Investig. 2014 Aug; 34(8):587-91.</div>
</div>
</li>
<li class="two_line" reference_id="CR105" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19228182/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).</a><span class="one_line_source">[CNS Neurosci Ther.  2009]</span><div class="alt-note">
<div class="authors">Fraser GA</div>
<div class="citation">CNS Neurosci Ther. 2009 Winter; 15(1):84-8.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p23" name="crb--__p23" rid="__p23" style="position: absolute; visibility: visible; width: 370px; top: 6557px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="CR106">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/25467221/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.</a><span class="one_line_source">[Psychoneuroendocrinology.  2015]</span><div class="alt-note">
<div class="authors">Jetly R, Heber A, Fraser G, Boisvert D</div>
<div class="citation">Psychoneuroendocrinology. 2015 Jan; 51():585-8.</div>
</div>
</li>
<li class="two_line" reference_id="CR108">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21480682/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Posttraumatic stress disorder and cannabis use in a nationally representative sample.</a><span class="one_line_source">[Psychol Addict Behav.  2011]</span><div class="alt-note">
<div class="authors">Cougle JR, Bonn-Miller MO, Vujanovic AA, Zvolensky MJ, Hawkins KA</div>
<div class="citation">Psychol Addict Behav. 2011 Sep; 25(3):554-8.</div>
</div>
</li>
<li class="two_line" reference_id="CR109">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23617872/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence.</a><span class="one_line_source">[Am J Addict.  2013]</span><div class="alt-note">
<div class="authors">Boden MT, Babson KA, Vujanovic AA, Short NA, Bonn-Miller MO</div>
<div class="citation">Am J Addict. 2013 May-Jun; 22(3):277-84.</div>
</div>
</li>
<li class="two_line" reference_id="CR110">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23098380/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Poor sleep quality as a risk factor for lapse following a cannabis quit attempt.</a><span class="one_line_source">[J Subst Abuse Treat.  2013]</span><div class="alt-note">
<div class="authors">Babson KA, Boden MT, Harris AH, Stickle TR, Bonn-Miller MO</div>
<div class="citation">J Subst Abuse Treat. 2013 Apr; 44(4):438-43.</div>
</div>
</li>
<li class="two_line" reference_id="CR111">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23906725/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt.</a><span class="one_line_source">[Addict Behav.  2013]</span><div class="alt-note">
<div class="authors">Babson KA, Boden MT, Bonn-Miller MO</div>
<div class="citation">Addict Behav. 2013 Nov; 38(11):2707-13.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p24" name="crb--__p24" rid="__p24" style="position: absolute; visibility: visible; width: 370px; top: 6818px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul>
<li class="two_line" reference_id="CR113">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19732371/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Systematic review and meta-analysis of cannabis treatment for chronic pain.</a><span class="one_line_source">[Pain Med.  2009]</span><div class="alt-note">
<div class="authors">Martín-Sánchez E, Furukawa TA, Taylor J, Martin JL</div>
<div class="citation">Pain Med. 2009 Nov; 10(8):1353-68.</div>
</div>
</li>
<li class="two_line" reference_id="CR114">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21203440/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.</a><span class="one_line_source">[PLoS One.  2010]</span><div class="alt-note">
<div class="authors">Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS</div>
<div class="citation">PLoS One. 2010 Dec 28; 5(12):e14433.</div>
</div>
</li>
<li class="two_line" reference_id="CR115">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20805210/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.</a><span class="one_line_source">[CMAJ.  2010]</span><div class="alt-note">
<div class="authors">Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, Bennett GJ, Collet JP</div>
<div class="citation">CMAJ. 2010 Oct 5; 182(14):E694-701.</div>
</div>
</li>
<li class="two_line" reference_id="CR116">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18073554/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.</a><span class="one_line_source">[Anesthesiology.  2007]</span><div class="alt-note">
<div class="authors">Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I</div>
<div class="citation">Anesthesiology. 2007 Nov; 107(5):785-96.</div>
</div>
</li>
<li class="two_line" reference_id="CR117">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23237736/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Low-dose vaporized cannabis significantly improves neuropathic pain.</a><span class="one_line_source">[J Pain.  2013]</span><div class="alt-note">
<div class="authors">Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H</div>
<div class="citation">J Pain. 2013 Feb; 14(2):136-48.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p25" name="crb--__p25" rid="__p25" style="position: absolute; visibility: visible; width: 370px; top: 7225px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul>
<li class="two_line" reference_id="CR118">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1099449/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.</a><span class="one_line_source">[N Engl J Med.  1975]</span><div class="alt-note">
<div class="authors">Sallan SE, Zinberg NE, Frei E 3rd</div>
<div class="citation">N Engl J Med. 1975 Oct 16; 293(16):795-7.</div>
</div>
</li>
<li class="two_line" reference_id="CR119">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/293141/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.</a><span class="one_line_source">[Ann Intern Med.  1979]</span><div class="alt-note">
<div class="authors">Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky I, Simon RM, Rosenberg SA</div>
<div class="citation">Ann Intern Med. 1979 Dec; 91(6):819-24.</div>
</div>
</li>
<li class="two_line" reference_id="CR120">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6254456/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.</a><span class="one_line_source">[Arch Intern Med.  1980]</span><div class="alt-note">
<div class="authors">Orr LE, McKernan JF, Bloome B</div>
<div class="citation">Arch Intern Med. 1980 Nov; 140(11):1431-3.</div>
</div>
</li>
<li class="two_line" reference_id="CR123">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11440936/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.</a><span class="one_line_source">[BMJ.  2001]</span><div class="alt-note">
<div class="authors">Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ</div>
<div class="citation">BMJ. 2001 Jul 7; 323(7303):16-21.</div>
</div>
</li>
<li class="two_line" reference_id="CR122" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18625004/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.</a><span class="one_line_source">[Eur J Cancer Care (Engl).  2008]</span><div class="alt-note">
<div class="authors">Machado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LM, Da Silveira DX</div>
<div class="citation">Eur J Cancer Care (Engl). 2008 Sep; 17(5):431-43.</div>
</div>
</li>
<li class="two_line" reference_id="CR124" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/517882/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.</a><span class="one_line_source">[Ann Intern Med.  1979]</span><div class="alt-note">
<div class="authors">Frytak S, Moertel CG, O'Fallon JR, Rubin J, Creagan ET, O'Connell MJ, Schutt AJ, Schwartau NW</div>
<div class="citation">Ann Intern Med. 1979 Dec; 91(6):825-30.</div>
</div>
</li>
<li class="two_line" reference_id="CR126" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17355735/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.</a><span class="one_line_source">[Curr Med Res Opin.  2007]</span><div class="alt-note">
<div class="authors">Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, Baranowski V</div>
<div class="citation">Curr Med Res Opin. 2007 Mar; 23(3):533-43.</div>
</div>
</li>
<li class="two_line" reference_id="CR127" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1652611/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.</a><span class="one_line_source">[J Pain Symptom Manage.  1991]</span><div class="alt-note">
<div class="authors">Lane M, Vogel CL, Ferguson J, Krasnow S, Saiers JL, Hamm J, Salva K, Wiernik PH, Holroyde CP, Hammill S</div>
<div class="citation">J Pain Symptom Manage. 1991 Aug; 6(6):352-9.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 7425px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul>
<li class="two_line" reference_id="CR122">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18625004/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.</a><span class="one_line_source">[Eur J Cancer Care (Engl).  2008]</span><div class="alt-note">
<div class="authors">Machado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LM, Da Silveira DX</div>
<div class="citation">Eur J Cancer Care (Engl). 2008 Sep; 17(5):431-43.</div>
</div>
</li>
<li class="two_line" reference_id="CR128">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24421535/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoid hyperemesis syndrome.</a><span class="one_line_source">[Hosp Pharm.  2013]</span><div class="alt-note">
<div class="authors">Sun S, Zimmermann AE</div>
<div class="citation">Hosp Pharm. 2013 Sep; 48(8):650-5.</div>
</div>
</li>
<li class="two_line" reference_id="CR129">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21668458/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Review article: cyclic vomiting syndrome in adults--rediscovering and redefining an old entity.</a><span class="one_line_source">[Aliment Pharmacol Ther.  2011]</span><div class="alt-note">
<div class="authors">Hejazi RA, McCallum RW</div>
<div class="citation">Aliment Pharmacol Ther. 2011 Aug; 34(3):263-73.</div>
</div>
</li>
<li class="two_line" reference_id="CR130">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21947834/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antiemetics: American Society of Clinical Oncology clinical practice guideline update.</a><span class="one_line_source">[J Clin Oncol.  2011]</span><div class="alt-note">
<div class="authors">Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical Oncology.</div>
<div class="citation">J Clin Oncol. 2011 Nov 1; 29(31):4189-98.</div>
</div>
</li>
<li class="two_line" reference_id="CR131" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20555089/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.</a><span class="one_line_source">[Ann Oncol.  2010]</span><div class="alt-note">
<div class="authors">Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, ESMO/MASCC Guidelines Working Group.</div>
<div class="citation">Ann Oncol. 2010 May; 21 Suppl 5():v232-43.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p27" name="crb--__p27" rid="__p27" style="position: absolute; visibility: visible; width: 370px; top: 7666px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul>
<li class="two_line" reference_id="CR4">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24897085/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Adverse health effects of marijuana use.</a><span class="one_line_source">[N Engl J Med.  2014]</span><div class="alt-note">
<div class="authors">Volkow ND, Baler RD, Compton WM, Weiss SR</div>
<div class="citation">N Engl J Med. 2014 Jun 5; 370(23):2219-27.</div>
</div>
</li>
<li class="two_line" reference_id="CR132">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24234874/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Medical consequences of marijuana use: a review of current literature.</a><span class="one_line_source">[Curr Psychiatry Rep.  2013]</span><div class="alt-note">
<div class="authors">Gordon AJ, Conley JW, Gordon JM</div>
<div class="citation">Curr Psychiatry Rep. 2013 Dec; 15(12):419.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p28" name="crb--__p28" rid="__p28" style="position: absolute; visibility: visible; width: 370px; top: 7824px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul>
<li class="two_line" reference_id="CR133">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21858958/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Who are medical marijuana patients? Population characteristics from nine California assessment clinics.</a><span class="one_line_source">[J Psychoactive Drugs.  2011]</span><div class="alt-note">
<div class="authors">Reinarman C, Nunberg H, Lanthier F, Heddleston T</div>
<div class="citation">J Psychoactive Drugs. 2011 Apr-Jun; 43(2):128-35.</div>
</div>
</li>
<li class="two_line" reference_id="CR134">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/24095000/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.</a><span class="one_line_source">[Int J Drug Policy.  2013]</span><div class="alt-note">
<div class="authors">Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, Holtzman S</div>
<div class="citation">Int J Drug Policy. 2013 Nov; 24(6):511-6.</div>
</div>
</li>
<li class="two_line" reference_id="CR135">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18279244/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.</a><span class="one_line_source">[J Forensic Sci.  2008]</span><div class="alt-note">
<div class="authors">Potter DJ, Clark P, Brown MB</div>
<div class="citation">J Forensic Sci. 2008 Jan; 53(1):90-4.</div>
</div>
</li>
<li class="two_line" reference_id="CR136">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21653452/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae).</a><span class="one_line_source">[Am J Bot.  2004]</span><div class="alt-note">
<div class="authors">Hillig KW, Mahlberg PG</div>
<div class="citation">Am J Bot. 2004 Jun; 91(6):966-75.</div>
</div>
</li>
</ul></div>
</div>
</div>
</div>
<div class="col7">
</div>
</div>
</div>
<div class="col8">
</div>
<div class="col9">
</div>
<script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
<div id="body-link-poppers"><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR1" style="display: none; width: 30em; top: -100px; left: -100px;">1. <span class="element-citation">Substance Abuse and Mental Health Services Administration  . <span class="ref-journal">Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings.</span> Rockville, MD. U.S: Department of Health and Human Services; 2013.  <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?title=Results+from+the+2012+National+Survey+on+Drug+Use+and+Health:+Summary+of+National+Findings&amp;publication_year=2013&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#CR1">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR2" style="display: none; width: 30em; top: -100px; left: -100px;">Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.<div class="authors">Bonn-Miller MO, Harris AHS, Trafton JA</div><div class="citation">Psychol Serv. 2012 Nov; 9(4):404-416.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22564034/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR2">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR3" style="display: none; width: 30em; top: -100px; left: -100px;">3. <span class="element-citation">Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE.  <span class="ref-journal">Monitoring the Future national results on drug use: 1975–2013: Overview, Key Findings on Adolescent Drug Use.</span> Ann Arbor: Institute for Social Research, The University of Michigan; 2014.  <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?title=Monitoring+the+Future+national+results+on+drug+use:+1975–2013:+Overview,+Key+Findings+on+Adolescent+Drug+Use&amp;author=LD+Johnston&amp;author=PM+O'Malley&amp;author=RA+Miech&amp;author=JG+Bachman&amp;author=JE+Schulenberg&amp;publication_year=2014&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#CR3">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR4" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Adverse health effects of marijuana use.<div class="authors">Volkow ND, Baler RD, Compton WM, Weiss SR</div><div class="citation">N Engl J Med. 2014 Jun 5; 370(23):2219-27.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24897085/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR4">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR5" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.<div class="authors">Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D</div><div class="citation">Neurology. 2014 Apr 29; 82(17):1556-63.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24778283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR5">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR6" style="display: none; width: 30em; top: -100px; left: -100px;">6. <span class="mixed-citation">Procon.org. 23 legal medical marijuana states and DC: Laws, fees, and possession limits. Retrieved April 9, 2015, from [<a data-ga-action="click_feat_suppl" href="http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/#CR6">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR7" style="display: none; width: 30em; top: -100px; left: -100px;">Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.<div class="authors">Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA</div><div class="citation">Am J Drug Alcohol Abuse. 2014 Jan; 40(1):23-30.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24205805/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR7">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR9" style="display: none; width: 30em; top: -100px; left: -100px;">An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California.<div class="authors">Nunberg H, Kilmer B, Pacula RL, Burgdorf J</div><div class="citation">J Drug Policy Anal. 2011 Feb; 4(1):.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23750291/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR9">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR10" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Current concepts in Alzheimer's disease: a multidisciplinary review.<div class="authors">Minati L, Edginton T, Bruzzone MG, Giaccone G</div><div class="citation">Am J Alzheimers Dis Other Demen. 2009 Apr-May; 24(2):95-121.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19116299/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR10">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR11" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> The influence of cannabinoids on generic traits of neurodegeneration.<div class="authors">Fagan SG, Campbell VA</div><div class="citation">Br J Pharmacol. 2014 Mar; 171(6):1347-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24172185/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR11">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR12" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> The multiplicity of action of cannabinoids: implications for treating neurodegeneration.<div class="authors">Gowran A, Noonan J, Campbell VA</div><div class="citation">CNS Neurosci Ther. 2011 Dec; 17(6):637-44.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20875047/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR12">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR13" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.<div class="authors">Aso E, Ferrer I</div><div class="citation">Front Pharmacol. 2014; 5():37.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24634659/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR13">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR14" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Cannabinoids for the treatment of dementia.<div class="authors">Krishnan S, Cairns R, Howard R</div><div class="citation">Cochrane Database Syst Rev. 2009 Apr 15; (2):CD007204.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19370677/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR14">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR15" style="display: none; width: 30em; top: -100px; left: -100px;">Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease.<div class="authors">Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ</div><div class="citation">Int J Geriatr Psychiatry. 1997 Sep; 12(9):913-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9309469/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR15">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR16" style="display: none; width: 30em; top: -100px; left: -100px;">Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.<div class="authors">Walther S, Schüpbach B, Seifritz E, Homan P, Strik W</div><div class="citation">J Clin Psychopharmacol. 2011 Apr; 31(2):256-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21364345/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR16">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR17" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.<div class="authors">Carter GT, Abood ME, Aggarwal SK, Weiss MD</div><div class="citation">Am J Hosp Palliat Care. 2010 Aug; 27(5):347-56.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20439484/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR17">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR18" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Marijuana in the management of amyotrophic lateral sclerosis.<div class="authors">Carter GT, Rosen BS</div><div class="citation">Am J Hosp Palliat Care. 2001 Jul-Aug; 18(4):264-70.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11467101/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR18">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR19" style="display: none; width: 30em; top: -100px; left: -100px;">Survey of cannabis use in patients with amyotrophic lateral sclerosis.<div class="authors">Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT</div><div class="citation">Am J Hosp Palliat Care. 2004 Mar-Apr; 21(2):95-104.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15055508/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR19">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR20" style="display: none; width: 30em; top: -100px; left: -100px;">Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.<div class="authors">Weber M, Goldman B, Truniger S</div><div class="citation">J Neurol Neurosurg Psychiatry. 2010 Oct; 81(10):1135-40.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20498181/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR20">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR21" style="display: none; width: 30em; top: -100px; left: -100px;">Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.<div class="authors">Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M</div><div class="citation">Ann Intern Med. 2003 Aug 19; 139(4):258-66.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12965981/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR21">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR22" style="display: none; width: 30em; top: -100px; left: -100px;">Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.<div class="authors">Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW</div><div class="citation">J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):545-54.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17589370/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR22">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR23" style="display: none; width: 30em; top: -100px; left: -100px;">Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.<div class="authors">Foltin RW, Fischman MW, Byrne MF</div><div class="citation">Appetite. 1988 Aug; 11(1):1-14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3228283/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR23">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR24" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Effects of smoked marijuana in healthy and HIV + marijuana smokers.<div class="authors">Haney M</div><div class="citation">J Clin Pharmacol. 2002 Nov; 42(S1):34S-40S.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412834/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR24">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR25" style="display: none; width: 30em; top: -100px; left: -100px;">Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.<div class="authors">Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, Vosburg SK, Haney M</div><div class="citation">Psychopharmacology (Berl). 2010 Dec; 212(4):675-86.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20824270/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR25">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR26" style="display: none; width: 30em; top: -100px; left: -100px;">Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.<div class="authors">Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV</div><div class="citation">J Pain Symptom Manage. 1995 Feb; 10(2):89-97.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7730690/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR26">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR27" style="display: none; width: 30em; top: -100px; left: -100px;">Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia.<div class="authors">Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV</div><div class="citation">J Pain Symptom Manage. 1997 Jul; 14(1):7-14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9223837/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR27">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR28" style="display: none; width: 30em; top: -100px; left: -100px;">A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men.<div class="authors">Riggs PK, Vaida F, Rossi SS, Sorkin LS, Gouaux B, Grant I, Ellis RJ</div><div class="citation">Brain Res. 2012 Jan 11; 1431():46-52.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22133305/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR28">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR29" style="display: none; width: 30em; top: -100px; left: -100px;">Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.<div class="authors">Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B</div><div class="citation">J Clin Oncol. 2002 Jan 15; 20(2):567-73.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11786587/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR29">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR30" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> The intersection between cannabis and cancer in the United States.<div class="authors">Bowles DW, O'Bryant CL, Camidge DR, Jimeno A</div><div class="citation">Crit Rev Oncol Hematol. 2012 Jul; 83(1):1-10.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22019199/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR30">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR31" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.<div class="authors">Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M</div><div class="citation">Best Pract Res Clin Endocrinol Metab. 2009 Feb; 23(1):117-31.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19285265/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR31">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR32" style="display: none; width: 30em; top: -100px; left: -100px;">Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.<div class="authors">McKallip RJ, Nagarkatti M, Nagarkatti PS</div><div class="citation">J Immunol. 2005 Mar 15; 174(6):3281-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15749859/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR32">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR33" style="display: none; width: 30em; top: -100px; left: -100px;">A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.<div class="authors">Guzmán M, Duarte MJ, Blázquez C, Ravina J, Rosa MC, Galve-Roperh I, Sánchez C, Velasco G, González-Feria L</div><div class="citation">Br J Cancer. 2006 Jul 17; 95(2):197-203.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16804518/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR33">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR34" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.<div class="authors">Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN</div><div class="citation">Inflamm Bowel Dis. 2014 Mar; 20(3):472-80.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24407485/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR34">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR36" style="display: none; width: 30em; top: -100px; left: -100px;">Marijuana use patterns among patients with inflammatory bowel disease.<div class="authors">Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J</div><div class="citation">Inflamm Bowel Dis. 2013 Dec; 19(13):2809-14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24185313/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR36">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR37" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.<div class="authors">Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM</div><div class="citation">Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1276-1280.e1.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23648372/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR37">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR38" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.<div class="authors">Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, Whalley BJ, Hill AJ</div><div class="citation">Br J Pharmacol. 2013 Oct; 170(3):679-92.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23902406/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR38">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR41" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.<div class="authors">Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, Stephens GJ</div><div class="citation">J Pharmacol Exp Ther. 2010 Feb; 332(2):569-77.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19906779/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR41">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR39" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.<div class="authors">Jones NA, Glyn SE, Akiyama S, Hill TD, Hill AJ, Weston SE, Burnett MD, Yamasaki Y, Stephens GJ, Whalley BJ, Williams CM</div><div class="citation">Seizure. 2012 Jun; 21(5):344-52.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22520455/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR39">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR42" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.<div class="authors">Gordon E, Devinsky O</div><div class="citation">Epilepsia. 2001 Oct; 42(10):1266-72.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11737161/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR42">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR43" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis and other illicit drug use in epilepsy patients.<div class="authors">Hamerle M, Ghaeni L, Kowski A, Weissinger F, Holtkamp M</div><div class="citation">Eur J Neurol. 2014; 21(1):167-70.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23311572/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR43">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR44" style="display: none; width: 30em; top: -100px; left: -100px;">Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center.<div class="authors">Gross DW, Hamm J, Ashworth NL, Quigley D</div><div class="citation">Neurology. 2004 Jun 8; 62(11):2095-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15184622/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR44">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR45" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Cannabinoids for epilepsy.<div class="authors">Gloss D, Vickrey B</div><div class="citation">Cochrane Database Syst Rev. 2014 Mar 5; (3):CD009270.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24595491/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR45">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR46" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Toward drugs derived from cannabis.<div class="authors">Mechoulam R, Carlini EA</div><div class="citation">Naturwissenschaften. 1978 Apr; 65(4):174-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/351429/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR46">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR47" style="display: none; width: 30em; top: -100px; left: -100px;">Chronic administration of cannabidiol to healthy volunteers and epileptic patients.<div class="authors">Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R</div><div class="citation">Pharmacology. 1980; 21(3):175-85.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7413719/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR47">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR48" style="display: none; width: 30em; top: -100px; left: -100px;">Anticonvulsant effect of cannabidiol.<div class="authors">Ames FR, Cridland S</div><div class="citation">S Afr Med J. 1986 Jan 4; 69(1):14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3941934/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR48">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR49" style="display: none; width: 30em; top: -100px; left: -100px;">Effect of marihuana on intraocular and blood pressure in glaucoma.<div class="authors">Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS</div><div class="citation">Ophthalmology. 1980 Mar; 87(3):222-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7053160/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR49">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR50" style="display: none; width: 30em; top: -100px; left: -100px;">Marihuana smoking and intraocular pressure.<div class="authors">Hepler RS, Frank IR</div><div class="citation">JAMA. 1971 Sep 6; 217(10):1392.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5109652/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR50">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR51" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Marijuana smoking vs cannabinoids for glaucoma therapy.<div class="authors">Green K</div><div class="citation">Arch Ophthalmol. 1998 Nov; 116(11):1433-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9823341/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR51">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR52" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.<div class="authors">Nucci C, Bari M, Spanò A, Corasaniti M, Bagetta G, Maccarrone M, Morrone LA</div><div class="citation">Prog Brain Res. 2008; 173():451-64.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18929127/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR52">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR53" style="display: none; width: 30em; top: -100px; left: -100px;">Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma.<div class="authors">Flach AJ</div><div class="citation">Trans Am Ophthalmol Soc. 2002; 100():215-22; discussion 222-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12545695/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR53">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR54" style="display: none; width: 30em; top: -100px; left: -100px;">American glaucoma society position statement: marijuana and the treatment of glaucoma.<div class="authors">Jampel H</div><div class="citation">J Glaucoma. 2010 Feb; 19(2):75-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20160576/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR54">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR55" style="display: none; width: 30em; top: -100px; left: -100px;">Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma.<div class="authors">Buys YM, Rafuse PE</div><div class="citation">Can J Ophthalmol. 2010 Aug; 45(4):324-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20676153/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR55">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR56" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Cannabinoids and glaucoma.<div class="authors">Tomida I, Pertwee RG, Azuara-Blanco A</div><div class="citation">Br J Ophthalmol. 2004 May; 88(5):708-13.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15090428/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR56">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR57" style="display: none; width: 30em; top: -100px; left: -100px;">Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis.<div class="authors">Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB, Canadian Co-infection Cohort Investigators.</div><div class="citation">Clin Infect Dis. 2013 Sep; 57(5):663-70.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23811492/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR57">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR58" style="display: none; width: 30em; top: -100px; left: -100px;">Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.<div class="authors">Hézode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani ES, Pawlotsky JM, Dhumeaux D, Lotersztajn S, Mallat A</div><div class="citation">Hepatology. 2005 Jul; 42(1):63-71.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15892090/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR58">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR59" style="display: none; width: 30em; top: -100px; left: -100px;">Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.<div class="authors">Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A</div><div class="citation">Gastroenterology. 2008 Feb; 134(2):432-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18242211/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR59">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR60" style="display: none; width: 30em; top: -100px; left: -100px;">Influence of cannabis use on severity of hepatitis C disease.<div class="authors">Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA</div><div class="citation">Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18166478/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR60">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR61" style="display: none; width: 30em; top: -100px; left: -100px;">Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.<div class="authors">Costiniuk CT, Mills E, Cooper CL</div><div class="citation">Can J Gastroenterol. 2008 Apr; 22(4):376-80.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18414712/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR61">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR62" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.<div class="authors">Sylvestre DL, Clements BJ, Malibu Y</div><div class="citation">Eur J Gastroenterol Hepatol. 2006 Oct; 18(10):1057-63.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16957511/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR62">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR63" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> The clinical pharmacology of ribavirin.<div class="authors">Glue P</div><div class="citation">Semin Liver Dis. 1999; 19 Suppl 1():17-24.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10349689/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR63">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR64" style="display: none; width: 30em; top: -100px; left: -100px;">Surveillance for acute viral hepatitis--United States, 2006.<div class="authors">Wasley A, Grytdal S, Gallagher K, Centers for Disease Control and Prevention (CDC).</div><div class="citation">MMWR Surveill Summ. 2008 Mar 21; 57(2):1-24.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18354374/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR64">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR65" style="display: none; width: 30em; top: -100px; left: -100px;">Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting.<div class="authors">Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM</div><div class="citation">J Acquir Immune Defic Syndr. 2004 Jan 1; 35(1):38-45.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14707790/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR65">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR66" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.<div class="authors">Lutge EE, Gray A, Siegfried N</div><div class="citation">Cochrane Database Syst Rev. 2013 Apr 30; (4):CD005175.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23633327/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR66">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR67" style="display: none; width: 30em; top: -100px; left: -100px;">Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients.<div class="authors">Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI</div><div class="citation">J Clin Pharmacol. 2002 Nov; 42(S1):82S-89S.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412840/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR67">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR68" style="display: none; width: 30em; top: -100px; left: -100px;">The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir.<div class="authors">Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, Abrams DI</div><div class="citation">AIDS. 2002 Mar 8; 16(4):543-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11872997/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR68">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR69" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.<div class="authors">Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA</div><div class="citation">J Behav Med. 2014 Feb; 37(1):1-10.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23054178/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR69">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR70" style="display: none; width: 30em; top: -100px; left: -100px;">Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.<div class="authors">Haney M, Rabkin J, Gunderson E, Foltin RW</div><div class="citation">Psychopharmacology (Berl). 2005 Aug; 181(1):170-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15778874/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR70">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR71" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.<div class="authors">Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL</div><div class="citation">Neurology. 2007 Feb 13; 68(7):515-21.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17296917/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR71">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR72" style="display: none; width: 30em; top: -100px; left: -100px;">Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.<div class="authors">Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH</div><div class="citation">Neuropsychopharmacology. 2009 Feb; 34(3):672-80.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18688212/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR72">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR73" style="display: none; width: 30em; top: -100px; left: -100px;">Effect of dronabinol on nutritional status in HIV infection.<div class="authors">Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG</div><div class="citation">Ann Pharmacother. 1993 Jul-Aug; 27(7-8):827-31.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8395916/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR73">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR74" style="display: none; width: 30em; top: -100px; left: -100px;">74. <span class="mixed-citation">Centers for Disease Control and Prevention (CDC). HIV and substance use in the United States<em>.</em> Retrieved April 9, 2015, from [<a data-ga-action="click_feat_suppl" href="http://www.cdc.gov/hiv/risk/behavior/substanceuse.html" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/hiv/risk/behavior/substanceuse.html</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/#CR74">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR75" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Spasticity: clinical perceptions, neurological realities and meaningful measurement.<div class="authors">Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J, Hermens H, Johnson GR</div><div class="citation">Disabil Rehabil. 2005 Jan 7-21; 27(1-2):2-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15799140/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR75">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR76" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Treatments for spasticity and pain in multiple sclerosis: a systematic review.<div class="authors">Beard S, Hunn A, Wight J</div><div class="citation">Health Technol Assess. 2003; 7(40):iii, ix-x, 1-111.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14636486/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR76">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR77" style="display: none; width: 30em; top: -100px; left: -100px;">A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.<div class="authors">Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P, Sativex Spasticity Study Group.</div><div class="citation">Eur J Neurol. 2011 Sep; 18(9):1122-31.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21362108/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR77">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR84" style="display: none; width: 30em; top: -100px; left: -100px;">A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.<div class="authors">Pooyania S, Ethans K, Szturm T, Casey A, Perry D</div><div class="citation">Arch Phys Med Rehabil. 2010 May; 91(5):703-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20434606/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR84">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR85" style="display: none; width: 30em; top: -100px; left: -100px;">Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.<div class="authors">Wade DT, Makela PM, House H, Bateman C, Robson P</div><div class="citation">Mult Scler. 2006 Oct; 12(5):639-45.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17086911/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR85">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR87" style="display: none; width: 30em; top: -100px; left: -100px;">A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).<div class="authors">Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R</div><div class="citation">Mult Scler. 2012 Feb; 18(2):219-28.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21878454/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR87">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR88" style="display: none; width: 30em; top: -100px; left: -100px;">Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.<div class="authors">Flachenecker P, Henze T, Zettl UK</div><div class="citation">Eur Neurol. 2014; 71(5-6):271-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24525548/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR88">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR89" style="display: none; width: 30em; top: -100px; left: -100px;">Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.<div class="authors">Rog DJ, Nurmikko TJ, Friede T, Young CA</div><div class="citation">Neurology. 2005 Sep 27; 65(6):812-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16186518/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR89">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR90" style="display: none; width: 30em; top: -100px; left: -100px;">Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.<div class="authors">Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B</div><div class="citation">CMAJ. 2012 Jul 10; 184(10):1143-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22586334/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR90">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR91" style="display: none; width: 30em; top: -100px; left: -100px;">Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.<div class="authors">Greenberg HS, Werness SA, Pugh JE, Andrus RO, Anderson DJ, Domino EF</div><div class="citation">Clin Pharmacol Ther. 1994 Mar; 55(3):324-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8143398/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR91">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR92" style="display: none; width: 30em; top: -100px; left: -100px;">Patterns of cannabis use among patients with multiple sclerosis.<div class="authors">Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME</div><div class="citation">Neurology. 2004 Jun 8; 62(11):2098-100.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15184623/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR92">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR93" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis use as described by people with multiple sclerosis.<div class="authors">Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC</div><div class="citation">Can J Neurol Sci. 2003 Aug; 30(3):201-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12945941/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR93">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR94" style="display: none; width: 30em; top: -100px; left: -100px;">Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.<div class="authors">Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A</div><div class="citation">Neurology. 2014 May 27; 82(21):1879-87.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24789863/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR94">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR95" style="display: none; width: 30em; top: -100px; left: -100px;">Effects of cannabis on cognitive function in patients with multiple sclerosis.<div class="authors">Honarmand K, Tierney MC, O'Connor P, Feinstein A</div><div class="citation">Neurology. 2011 Mar 29; 76(13):1153-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21444900/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR95">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR96" style="display: none; width: 30em; top: -100px; left: -100px;">Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.<div class="authors">Rao SM, Leo GJ, Bernardin L, Unverzagt F</div><div class="citation">Neurology. 1991 May; 41(5):685-91.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2027484/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR96">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR97" style="display: none; width: 30em; top: -100px; left: -100px;">Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.<div class="authors">Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC</div><div class="citation">Ther Adv Neurol Disord. 2012 Sep; 5(5):255-66.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22973422/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR97">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR98" style="display: none; width: 30em; top: -100px; left: -100px;">98. <span class="mixed-citation">American Academy of Neurology. Position statement<em>:</em> Use of medical marijuana for neurologic disorders. Retrieved April 9, 2015, from [<a data-ga-action="click_feat_suppl" href="https://www.aan.com/uploadedFiles/Website_Library_Assets/Documents/6.Public_Policy/1.Stay_Informed/2.Position_Statements/3.PDFs_of_all_Position_Statements/Final%20Medical%20Marijuana%20Position%20Statement.pdf" ref="reftype=extlink&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.aan.com/uploadedFiles/Website_Library_Assets/Documents/6.Public_Policy/1.Stay_Informed/2.Position_Statements/3.PDFs_of_all_Position_Statements/Final%20Medical%20Marijuana%20Position%20Statement.pdf</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/#CR98">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR99" style="display: none; width: 30em; top: -100px; left: -100px;">Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users.<div class="authors">Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ</div><div class="citation">J Trauma Stress. 2007 Aug; 20(4):577-86.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17721963/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR99">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR101" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.<div class="authors">Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO</div><div class="citation">Int Rev Psychiatry. 2014 Apr; 26(2):237-47.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24892898/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR101">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR102" style="display: none; width: 30em; top: -100px; left: -100px;">Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.<div class="authors">Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, Ropchan J, Henry S, Corsi-Travali S, Carson RE, Huang Y</div><div class="citation">Mol Psychiatry. 2013 Sep; 18(9):1034-40.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23670490/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR102">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR103" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.<div class="authors">Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH</div><div class="citation">Drug Test Anal. 2012 Jul-Aug; 4(7-8):649-59.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22736575/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR103">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR104" style="display: none; width: 30em; top: -100px; left: -100px;">Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.<div class="authors">Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A</div><div class="citation">Clin Drug Investig. 2014 Aug; 34(8):587-91.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24935052/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR104">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR105" style="display: none; width: 30em; top: -100px; left: -100px;">The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).<div class="authors">Fraser GA</div><div class="citation">CNS Neurosci Ther. 2009 Winter; 15(1):84-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19228182/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR105">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR106" style="display: none; width: 30em; top: -100px; left: -100px;">The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.<div class="authors">Jetly R, Heber A, Fraser G, Boisvert D</div><div class="citation">Psychoneuroendocrinology. 2015 Jan; 51():585-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/25467221/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR106">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR107" style="display: none; width: 30em; top: -100px; left: -100px;">107. <span class="mixed-citation">Mashiah M. Medical cannabis as treatment for chronic combat PTSD: Promising results in an open pilot study [presentation]. Patients Out of Time Conference; Tuscon, Arizona; 2012.</span> [<a href="https://www.ncbi.nlm.nih.gov/#CR107">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR108" style="display: none; width: 30em; top: -100px; left: -100px;">Posttraumatic stress disorder and cannabis use in a nationally representative sample.<div class="authors">Cougle JR, Bonn-Miller MO, Vujanovic AA, Zvolensky MJ, Hawkins KA</div><div class="citation">Psychol Addict Behav. 2011 Sep; 25(3):554-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21480682/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR108">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR109" style="display: none; width: 30em; top: -100px; left: -100px;">Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence.<div class="authors">Boden MT, Babson KA, Vujanovic AA, Short NA, Bonn-Miller MO</div><div class="citation">Am J Addict. 2013 May-Jun; 22(3):277-84.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23617872/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR109">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR110" style="display: none; width: 30em; top: -100px; left: -100px;">Poor sleep quality as a risk factor for lapse following a cannabis quit attempt.<div class="authors">Babson KA, Boden MT, Harris AH, Stickle TR, Bonn-Miller MO</div><div class="citation">J Subst Abuse Treat. 2013 Apr; 44(4):438-43.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23098380/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR110">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR111" style="display: none; width: 30em; top: -100px; left: -100px;">The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt.<div class="authors">Babson KA, Boden MT, Bonn-Miller MO</div><div class="citation">Addict Behav. 2013 Nov; 38(11):2707-13.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23906725/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR111">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR112" style="display: none; width: 30em; top: -100px; left: -100px;">112. <span class="element-citation">Bonn-Miller MO, Boden MT, Vujanovic AA, Drescher KD. Prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment. <span><span class="ref-journal">Psychological Trauma: Theory, Research, Practice, and Policy. </span>2013;<span class="ref-vol">5</span>:193–200.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychological+Trauma:+Theory,+Research,+Practice,+and+Policy&amp;title=Prospective+investigation+of+the+impact+of+cannabis+use+disorders+on+posttraumatic+stress+disorder+symptoms+among+veterans+in+residential+treatment&amp;author=MO+Bonn-Miller&amp;author=MT+Boden&amp;author=AA+Vujanovic&amp;author=KD+Drescher&amp;volume=5&amp;publication_year=2013&amp;pages=193-200&amp;" ref="reftype=other&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#CR112">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR113" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Systematic review and meta-analysis of cannabis treatment for chronic pain.<div class="authors">Martín-Sánchez E, Furukawa TA, Taylor J, Martin JL</div><div class="citation">Pain Med. 2009 Nov; 10(8):1353-68.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19732371/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR113">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR114" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.<div class="authors">Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS</div><div class="citation">PLoS One. 2010 Dec 28; 5(12):e14433.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21203440/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR114">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR115" style="display: none; width: 30em; top: -100px; left: -100px;">Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.<div class="authors">Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, Bennett GJ, Collet JP</div><div class="citation">CMAJ. 2010 Oct 5; 182(14):E694-701.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20805210/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR115">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR116" style="display: none; width: 30em; top: -100px; left: -100px;">Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.<div class="authors">Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I</div><div class="citation">Anesthesiology. 2007 Nov; 107(5):785-96.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18073554/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR116">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR117" style="display: none; width: 30em; top: -100px; left: -100px;">Low-dose vaporized cannabis significantly improves neuropathic pain.<div class="authors">Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H</div><div class="citation">J Pain. 2013 Feb; 14(2):136-48.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23237736/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR117">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR118" style="display: none; width: 30em; top: -100px; left: -100px;">Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.<div class="authors">Sallan SE, Zinberg NE, Frei E 3rd</div><div class="citation">N Engl J Med. 1975 Oct 16; 293(16):795-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1099449/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR118">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR119" style="display: none; width: 30em; top: -100px; left: -100px;">Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.<div class="authors">Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky I, Simon RM, Rosenberg SA</div><div class="citation">Ann Intern Med. 1979 Dec; 91(6):819-24.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/293141/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR119">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR120" style="display: none; width: 30em; top: -100px; left: -100px;">Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.<div class="authors">Orr LE, McKernan JF, Bloome B</div><div class="citation">Arch Intern Med. 1980 Nov; 140(11):1431-3.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6254456/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR120">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR123" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.<div class="authors">Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ</div><div class="citation">BMJ. 2001 Jul 7; 323(7303):16-21.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11440936/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR123">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR122" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.<div class="authors">Machado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LM, Da Silveira DX</div><div class="citation">Eur J Cancer Care (Engl). 2008 Sep; 17(5):431-43.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18625004/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR122">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR124" style="display: none; width: 30em; top: -100px; left: -100px;">Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.<div class="authors">Frytak S, Moertel CG, O'Fallon JR, Rubin J, Creagan ET, O'Connell MJ, Schutt AJ, Schwartau NW</div><div class="citation">Ann Intern Med. 1979 Dec; 91(6):825-30.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/517882/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR124">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR126" style="display: none; width: 30em; top: -100px; left: -100px;">Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.<div class="authors">Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, Baranowski V</div><div class="citation">Curr Med Res Opin. 2007 Mar; 23(3):533-43.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17355735/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR126">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR127" style="display: none; width: 30em; top: -100px; left: -100px;">Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.<div class="authors">Lane M, Vogel CL, Ferguson J, Krasnow S, Saiers JL, Hamm J, Salva K, Wiernik PH, Holroyde CP, Hammill S</div><div class="citation">J Pain Symptom Manage. 1991 Aug; 6(6):352-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1652611/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR127">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR128" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabinoid hyperemesis syndrome.<div class="authors">Sun S, Zimmermann AE</div><div class="citation">Hosp Pharm. 2013 Sep; 48(8):650-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24421535/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR128">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR129" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Review article: cyclic vomiting syndrome in adults--rediscovering and redefining an old entity.<div class="authors">Hejazi RA, McCallum RW</div><div class="citation">Aliment Pharmacol Ther. 2011 Aug; 34(3):263-73.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21668458/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR129">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR130" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Antiemetics: American Society of Clinical Oncology clinical practice guideline update.<div class="authors">Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical Oncology.</div><div class="citation">J Clin Oncol. 2011 Nov 1; 29(31):4189-98.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21947834/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR130">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR131" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.<div class="authors">Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, ESMO/MASCC Guidelines Working Group.</div><div class="citation">Ann Oncol. 2010 May; 21 Suppl 5():v232-43.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20555089/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR131">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR132" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Medical consequences of marijuana use: a review of current literature.<div class="authors">Gordon AJ, Conley JW, Gordon JM</div><div class="citation">Curr Psychiatry Rep. 2013 Dec; 15(12):419.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24234874/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR132">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR133" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Who are medical marijuana patients? Population characteristics from nine California assessment clinics.<div class="authors">Reinarman C, Nunberg H, Lanthier F, Heddleston T</div><div class="citation">J Psychoactive Drugs. 2011 Apr-Jun; 43(2):128-35.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21858958/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR133">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR134" style="display: none; width: 30em; top: -100px; left: -100px;">Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.<div class="authors">Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, Holtzman S</div><div class="citation">Int J Drug Policy. 2013 Nov; 24(6):511-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/24095000/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR134">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR135" style="display: none; width: 30em; top: -100px; left: -100px;">Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.<div class="authors">Potter DJ, Clark P, Brown MB</div><div class="citation">J Forensic Sci. 2008 Jan; 53(1):90-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18279244/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR135">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-CR136" style="display: none; width: 30em; top: -100px; left: -100px;">A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae).<div class="authors">Hillig KW, Mahlberg PG</div><div class="citation">Am J Bot. 2004 Jun; 91(6):966-75.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21653452/" ref="reftype=pubmed&amp;article-id=4636852&amp;issue-id=247429&amp;journal-id=1002&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#CR136">Ref list</a>]</p></div></div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<a class="help_desk" href="https://www.ncbi.nlm.nih.gov/" id="help-desk-link" target="_blank">Support Center</a>
<a class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-07-14T05:01:15-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8CDA45D2ADCC4100000000088A04DB&amp;ncbi_session=CE8CDA45D2AEF5B1_2186SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4636852%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" id="help-desk-link" target="_blank">Support Center</a>
</div>
<div class="footer" id="footer">
<div class="subfooter"> </div><script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/preloaderWidget.js" type="text/javascript"> </script>
<div class="offscreen_noflow" id="external-disclaimer">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>
<div class="contact_info" id="ncbifooter">
<div id="footer-contents-right">
<div id="nlm_thumb_logo">
<a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
</div>
<div id="nih_thumb_logo">
<a href="https://www.nih.gov" title="NIH">NIH</a>
</div>
<div id="hhs_thumb_logo">
<a href="https://www.hhs.gov" title="DHHS">DHHS</a>
</div>
<div id="usagov_thumb_logo">
<a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
</div>
</div>
<div id="footer-contents-left">
<p class="address vcard">
<span class="url">
<a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
<span class="adr">
<span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
<span class="region">MD</span>, <span class="postal-code">20894</span>
<span class="country-name">USA</span>
</span>
</p>
<a href="https://www.ncbi.nlm.nih.gov/home/about/policies.shtml">Policies and Guidelines</a> | <a href="https://www.ncbi.nlm.nih.gov/home/about/contact.shtml">Contact</a>
</div>
</div>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1" type="text/javascript"> </script>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/hfjs2.js" type="text/javascript"> </script>
</div>
</div>
</div>
</div>
</div>
<div aria-live="assertive" class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" style="display: none; top: 63.5938px; left: 651.688px; width: 670px; z-index: 1001;"><ul aria-activedescendant="term" class="ui-ncbiautocomplete-options" role="listbox"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" href="https://www.ncbi.nlm.nih.gov/#" style="display: block;">Turn off</a></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; top: -100px; left: -100px;">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
<span class="PAFAppResources"></span>
<noscript><img alt="statistics" src="https://www.ncbi.nlm.nih.gov/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=ascp&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4636852/&amp;ncbi_app=pmc"/></noscript>
<script snapshot="pmc" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" type="text/javascript"></script>
<div aria-describedby="epubDialog" aria-labelledby="ui-id-1" class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" role="dialog" style="display: none;" tabindex="-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span class="ui-dialog-title" id="ui-id-1">Making articles easier to read in PMC</span><button class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close" type="button"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div class="ui-dialog-content ui-widget-content" id="epubDialog" style="display: block;"> <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p> <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p> <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button class="ui-state-default ui-corner-all" id="cancelEpub">Cancel</button><button class="ui-state-default ui-corner-all" id="downloadEpub" style="float: left">Download article</button></div> </div></div></body></html>